<SEC-DOCUMENT>0001214659-22-015103.txt : 20221219
<SEC-HEADER>0001214659-22-015103.hdr.sgml : 20221219
<ACCEPTANCE-DATETIME>20221219163042
ACCESSION NUMBER:		0001214659-22-015103
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20221219
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221219
DATE AS OF CHANGE:		20221219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BitNile Holdings, Inc.
		CENTRAL INDEX KEY:			0000896493
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRONIC COMPONENTS, NEC [3679]
		IRS NUMBER:				941721931
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12711
		FILM NUMBER:		221471490

	BUSINESS ADDRESS:	
		STREET 1:		11411 SOUTHERN HIGHLANDS PARKWAY
		STREET 2:		SUITE 240
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89141
		BUSINESS PHONE:		(949) 444-5464 3679

	MAIL ADDRESS:	
		STREET 1:		11411 SOUTHERN HIGHLANDS PARKWAY
		STREET 2:		SUITE 240
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89141

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Ault Global Holdings, Inc.
		DATE OF NAME CHANGE:	20210119

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DPW Holdings, Inc.
		DATE OF NAME CHANGE:	20171229

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DIGITAL POWER CORP
		DATE OF NAME CHANGE:	19960823
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>b12192208k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:NILE="http://NILE/20221219">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_03A_NILE_NILE_20221219 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20221219_20221219 -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0000896493 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-12-19to2022-12-19" name="dei:EntityCentralIndexKey">0000896493</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-12-19to2022-12-19" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="nile-20221219.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-12-19to2022-12-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000896493</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-12-19</xbrli:startDate>
        <xbrli:endDate>2022-12-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-12-192022-12-19_custom_CommonStock0.001ParValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000896493</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NILE:CommonStock0.001ParValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-12-19</xbrli:startDate>
        <xbrli:endDate>2022-12-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-12-192022-12-19_custom_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000896493</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NILE:Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-12-19</xbrli:startDate>
        <xbrli:endDate>2022-12-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page -->


<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">____________________________________________________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90D_edei--DocumentType_c20221219__20221219_zBa5HrOEDRO1"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">___________________________________________________________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):&#160;&#160;<span id="xdx_902_edei--DocumentPeriodEndDate_c20221219__20221219_zE0XMdmuzUwi"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">December
19, 2022</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityRegistrantName_c20221219__20221219_zVKch1rYFul6"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" name="dei:EntityRegistrantName">BITNILE HOLDINGS, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 31%; text-align: center"><span style="text-decoration: underline"><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20221219__20221219_zl12eI6vx0ei"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 28%; text-align: center"><span style="text-decoration: underline"><span id="xdx_909_edei--EntityFileNumber_c20221219__20221219_zMtRmAGMwC3j"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" name="dei:EntityFileNumber">001-12711</ix:nonNumeric></span></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 39%; text-align: center"><span style="text-decoration: underline"><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20221219__20221219_z84HdNGYwnY3"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" name="dei:EntityTaxIdentificationNumber">94-1721931</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">(State or other jurisdiction of <br />
incorporation or organization)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(Commission File Number)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(I.R.S. Employer Identification No.)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration: underline"><span id="xdx_902_edei--EntityAddressAddressLine1_c20221219__20221219_zneVWQqtvqml"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" name="dei:EntityAddressAddressLine1">11411 Southern Highlands Parkway</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressAddressLine2_c20221219__20221219_zNpwN7xoH1mi"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" name="dei:EntityAddressAddressLine2">Suite 240</ix:nonNumeric></span>,
<span id="xdx_901_edei--EntityAddressCityOrTown_c20221219__20221219_zxw6xfqpIGd6"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" name="dei:EntityAddressCityOrTown">Las Vegas</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20221219__20221219_zvVHDLQ7hVPc"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" name="dei:EntityAddressStateOrProvince">NV</ix:nonNumeric></span> <span id="xdx_90F_edei--EntityAddressPostalZipCode_c20221219__20221219_zpMDL2syd711"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" name="dei:EntityAddressPostalZipCode">89141</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration: underline"><span id="xdx_907_edei--CityAreaCode_c20221219__20221219_zTxPmbDQS3B5"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" name="dei:CityAreaCode">(949)</ix:nonNumeric></span> <span id="xdx_906_edei--LocalPhoneNumber_c20221219__20221219_zSzhuDCM8nFj"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" name="dei:LocalPhoneNumber">444-5464</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant's telephone number, including area
code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Wingdings"><span id="xdx_905_edei--WrittenCommunications_c20221219__20221219_zsOPr8b1sNf9"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" format="ixt:booleanfalse" name="dei:WrittenCommunications">o</ix:nonNumeric></span></span>&#160;&#160;&#160;&#160;&#160;Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Wingdings"><span id="xdx_909_edei--SolicitingMaterial_c20221219__20221219_z6yx3tGagwUk"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" format="ixt:booleanfalse" name="dei:SolicitingMaterial">o</ix:nonNumeric></span></span>&#160;&#160;&#160;&#160;&#160;Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Wingdings"><span id="xdx_90F_edei--PreCommencementTenderOffer_c20221219__20221219_zw3CbP0r9cf3"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">o</ix:nonNumeric></span></span>&#160;&#160;&#160;&#160;&#160;Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Wingdings"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20221219__20221219_zPFbVx3xR1Ff"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">o</ix:nonNumeric></span></span>&#160;&#160;&#160;&#160;&#160;Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 34%; text-align: center">Title of each class</td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 15%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Trading</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Symbol(s)</p></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 49%; text-align: center">Name of each exchange on which registered</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: center"><span id="xdx_901_edei--Security12bTitle_c20221219__20221219__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.001ParValueMember_z0NmejoP0pMg"><ix:nonNumeric contextRef="From2022-12-192022-12-19_custom_CommonStock0.001ParValueMember" name="dei:Security12bTitle">Common Stock, $0.001 par value</ix:nonNumeric></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span id="xdx_906_edei--TradingSymbol_c20221219__20221219__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.001ParValueMember_zW4pkmWxAYFf"><ix:nonNumeric contextRef="From2022-12-192022-12-19_custom_CommonStock0.001ParValueMember" name="dei:TradingSymbol">NILE</ix:nonNumeric></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span id="xdx_90F_edei--SecurityExchangeName_c20221219__20221219__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.001ParValueMember_zCwnuQu5pYG3"><ix:nonNumeric contextRef="From2022-12-192022-12-19_custom_CommonStock0.001ParValueMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NYSE</ix:nonNumeric> </span>American</td></tr>
  <tr style="background-color: transparent">
    <td style="vertical-align: top; text-align: center"><span id="xdx_90C_edei--Security12bTitle_c20221219__20221219__us-gaap--StatementClassOfStockAxis__custom--Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember_ztfL7kUIdtU4"><ix:nonNumeric contextRef="From2022-12-192022-12-19_custom_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember" name="dei:Security12bTitle">13.00% Series D Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share</ix:nonNumeric></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span id="xdx_90D_edei--TradingSymbol_c20221219__20221219__us-gaap--StatementClassOfStockAxis__custom--Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember_zKv8io8v3RG3"><ix:nonNumeric contextRef="From2022-12-192022-12-19_custom_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember" name="dei:TradingSymbol">NILE PRD</ix:nonNumeric></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span id="xdx_904_edei--SecurityExchangeName_c20221219__20221219__us-gaap--StatementClassOfStockAxis__custom--Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember_zVl3xHwD0xWf"><ix:nonNumeric contextRef="From2022-12-192022-12-19_custom_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NYSE</ix:nonNumeric> </span>American</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company&#160;<span style="font-family: Wingdings"><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20221219__20221219_zM38S97Tae5d"><ix:nonNumeric contextRef="From2022-12-19to2022-12-19" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">o</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Wingdings">o</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 2px solid; margin-top: 8pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: left; width: 100%"><span style="font-size: 8pt">&#160;</span></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 1.01</b></td><td><b>Entry into a Material Definitive Agreement</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On December 16, 2022
(the &#8220;<b>Closing Date</b>&#8221;), BitNile Holdings, Inc., a Delaware corporation (the &#8220;<b>Company</b>&#8221;) entered into
a Securities Purchase Agreement (the &#8220;<b>SPA</b>&#8221;) with an accredited investor (the &#8220;<b>Investor</b>&#8221;) providing
for the issuance of a secured promissory note with an aggregate principal face amount of $14,700,000 (the &#8220;<b>Financing</b>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Under the SPA, the Company
shall repay, while the Note remains outstanding, (i) eighty percent (80%) of the proceeds it may receive from any financing conducted,
other than at-the-market offerings and (ii) one hundred percent (100%) of the proceeds it may receive from the sale of marketable securities
by Ault Lending, LLC (&#8220;<b>Ault Lending</b>&#8221;), the Company&#8217;s wholly owned subsidiary. In addition, if Third Avenue Apartments,
LLC (&#8220;<b>Third Avenue</b>&#8221;), the Company&#8217;s wholly owned subsidiary, sells the property it owns in St. Peterburg, Florida,
the Company shall use the net proceeds from the sale of such property in excess of $10 million, to repay the Note.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In addition, the Company
agreed to issue 11,605,913 shares of the Company&#8217;s common stock (the &#8220;<b>Registrable Shares</b>&#8221;) to the Investor in
exchange for the cancellation of all outstanding warrants previously issued to the Investor, which warrants were exercisable for 11,605,913
shares of the Company&#8217;s common stock. The Company agreed to file a registration statement on Form S-3 to register the Registrable
Shares and certain other shares owned by the Investor within ten (10) days of the Closing Date. The Company agreed to pay the Investor
liquidated damages of approximately $120,000 per month that the Registrable Shares have not been registered.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Pursuant to the SPA,
the Company, Ault Lending, BitNile, Inc. (&#8220;<b>BitNile</b>&#8221;) and Esousa Group Holdings, LLC, as the collateral agent on behalf
of the Investor (the &#8220;<b>Agent</b>&#8221;) entered into a security agreement (the &#8220;<b>Security Agreement</b>&#8221;), pursuant
to which (i) BitNile granted to the Investor a security interest in 12,000 Bitcoin miners and (ii) Ault Lending granted to the Investor
a security interest in, among other items, substantially all of the Ault Lending&#8217;s deposit accounts, securities accounts, chattel
paper, documents, equipment, general intangibles, instruments and inventory, and all proceeds therefrom (the &#8220;<b>Assets</b>&#8221;),
as set forth in the Security Agreement, except for assets previously granted security interests to other parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Notes are further
secured by a guaranty (the &#8220;<b>Guaranty</b>&#8221;) provided by Ault Lending, BitNile, Ault &amp; Company, Inc. (&#8220;<b>A&amp;C</b>&#8221;),
an affiliate of the Company, as well as by Milton C. Ault, the Company&#8217;s Executive Chairman and the Chief Executive Officer of A&amp;C.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Description of the Secured Promissory Note</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Note has a principal
face amount of $15,700,000 and bears interest at 16% per annum. The maturity date of the Note is March 16, 2023, although if the Company
repays at least $12 million of principal payment on or before the maturity date, the Company may extend the maturity date by forty-five
(45) days by paying a fee of 10% of the outstanding balance owed as of the original maturity date. The Notes contain standard and customary
events of default including, but not limited to, failure to make payments when due under the Note, failure to comply with certain covenants
contained in the Note, or bankruptcy or insolvency of the Company. The Company may prepay any or all outstanding principal and accrued
and unpaid interest at any time without penalty. The purchase price for the Notes was $13.5 million, of which $12 million was paid in
cash and $1.5 million was a non-accountable expense allowance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing descriptions of the Note, the SPA,
the Security Agreement and the Guaranty do not purport to be complete and are qualified in their entirety by reference to their respective
forms which are annexed hereto as&#160;<b><span style="text-decoration: underline">Exhibits 4.1, 10.1, 10.2</span></b> and <b><span style="text-decoration: underline">10.3</span></b>, respectively, to this Current Report
on Form 8-K and are incorporated herein by reference.&#160;&#160;The foregoing does not purport to be a complete description of the rights
and obligations of the parties thereunder and such descriptions are qualified in their entirety by reference to such exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 2.01</b></td><td><b>Completion of Acquisition or Disposition of Assets</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As previously reported in the Current Report on
Form 8-K filed by the Company on November 18, 2022, Circle 8 Newco LLC, a Delaware limited liability company (&#8220;<b>Circle 8 Newco</b>&#8221;),
entered into an Asset Purchase Agreement (the &#8220;<b>Asset Purchase Agreement&#8221;</b>) with Circle 8 Crane Services LLC, a Delaware
limited liability company (&#8220;<b>Circle 8 Crane Services</b>&#8221;) pursuant to which Circle 8 Newco agreed to purchase substantially
all of the assets (the &#8220;<b>Acquired Assets</b>&#8221;) and assume certain specified liabilities of Circle 8 Crane Services (the
&#8220;<b>Circle 8 Transaction</b>&#8221;). Circle 8 Newco is a wholly owned subsidiary of Circle 8 Holdco LLC, a Delaware limited liability
company (&#8220;<b>Circle 8 Holdco</b>&#8221;). Circle 8 Holdco is a subsidiary of Ault Alliance, Inc., a Delaware corporation (&#8220;<b>Ault
Alliance</b>&#8221;) which is a wholly owned subsidiary of the Company. Ault Alliance owns a controlling interest in Circle 8 Holdco.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On December 19, 2022,
the transaction closed and Circle 8 Newco purchased the Acquired Assets. As consideration for the acquisition of the Acquired Assets,
Circle 8 Crane Services received Class D equity interests in Circle 8 Holdco and is eligible to receive cash earnout payments in an aggregate
maximum amount of up to $2,100,000 based on the achievement by Circle 8 Newco of certain EBITDA targets over the three year period following
the completion of the acquisition of the Acquired Assets by Circle 8 Newco. The Company contributed $12 million to Circle 8 Newco, and
an independent third party contributed $4 million, of which approximately $11,650,000 of which was used to pay down a portion of the Circle
8 Crane Services&#8217; senior debt facility at the closing, $3,000,000 of which was used to pay off Circle 8 Crane Services&#8217; subordinated
debt facility in full at the closing and $1,350,000 was used to pay the expenses of Circle 8 Newco and Circle 8 Crane Services. In addition,
Circle 8 Newco assumed a new line of credit issued by Circle 8 Crane Services&#8217; current senior lender.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 2px solid; margin-top: 8pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: left; width: 100%"><span style="font-size: 8pt">&#160;</span></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 2.03</b></td><td><b>Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information contained in Item 1.01 of this Current Report on Form
8-K is incorporated herein by reference to this Item 2.03.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 3.02</b></td><td><b>Unregistered Sales of Equity Securities</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information contained in Item 1.01 of this
Current Report on Form 8-K is incorporated herein by reference to this Item 3.02.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 7.01</b></td><td><b>Regulation FD Disclosure </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On December 19, 2022,
the Company issued a press release announcing the closing of the Financing. On December 19, 2022, the Company issued a press release announcing
the closing of the Circle 8 Transaction. Copies of these press releases are furnished herewith as&#160;<b><span style="text-decoration: underline">Exhibit 99.1</span></b>&#160;and
<b><span style="text-decoration: underline">Exhibit 99.2</span></b> and are incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In accordance with General
Instruction B.2 of Form 8-K, the information under this item shall not be deemed filed for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933,
as amended, except as shall be expressly set forth by specific reference in such a filing. This report will not be deemed an admission
as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Securities and Exchange
Commission encourages registrants to disclose forward-looking information so that investors can better understand the future prospects
of a registrant and make informed investment decisions. This Current Report on Form 8-K and exhibits may contain these types of statements,
which are &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, and which
involve risks, uncertainties and reflect the Registrant&#8217;s judgment as of the date of this Current Report on Form 8-K. Forward-looking
statements may relate to, among other things, operating results and are indicated by words or phrases such as &#8220;expects,&#8221; &#8220;should,&#8221;
&#8220;will,&#8221; and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual
results to differ materially from those anticipated at the date of this Current Report on Form 8-K. Investors are cautioned not to rely
unduly on forward-looking statements when evaluating the information presented within.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item&#160;9.01</b></td><td><b>Financial Statements and Exhibits</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>(d)</b></td><td><b>Exhibits:</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 111px"><b>Exhibit No.&#160;</b></td>
    <td style="white-space: nowrap; width: 44px">&#160;</td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap"><b>Description</b></td></tr>
  <tr>
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="white-space: nowrap">4.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ex4_1.htm">Form of Note</a></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="white-space: nowrap">10.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ex10_1.htm">Form of Securities Purchase Agreement</a></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="white-space: nowrap">10.2</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ex10_2.htm">Form of Security Agreement</a></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="white-space: nowrap">10.3</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ex10_3.htm">Form of Guaranty</a></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="white-space: nowrap">99.1</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ex99_1.htm">Press release regarding the Financing issued by the Company on December 19, 2022</a></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="white-space: nowrap">99.2</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ex99_2.htm">Press release regarding the Circle 8 Transaction issued by the Company on December 19, 2022</a></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="white-space: nowrap">101</td>
    <td>&#160;</td>
    <td style="text-align: justify">Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language).</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="white-space: nowrap">104</td>
    <td>&#160;</td>
    <td style="text-align: justify">Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 2px solid; margin-top: 8pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: left; width: 100%"><span style="font-size: 8pt">&#160;</span></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><b>BITNILE HOLDINGS, INC.</b> </td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 50%">Dated: December 19, 2022</td>
    <td style="border-bottom: Black 1pt solid; width: 15%">/s/ Henry Nisser</td>
    <td style="white-space: nowrap; width: 35%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap">&#160;</td>
    <td colspan="2">Henry Nisser<br /> President and General Counsel</td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">-4-</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 2px solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kdFOgzAUhp9g73BC9G7ZKGYmcjeZLsbNEFgWbzs402a0JacF3SP5lpYyxo02JE1z/v//ftogmAZr/SwqJHh/zDawQ1lX3CJkeERCVaBTJC+vMbg9ww9hLHFl/XEwJtp50HkWM3ZfuIGXtsJgGQOL5uxhHkXAwnjBYLkNJt080eooSlRW8Aq4KiElXZNAy+ncJ+z4t1Zanj1qj2SEVi5uFvbjH4hCFsGbbvmXppOBzSYJJlO/JsGadFN3mMZYLeGpQulYpreOn69SeE2cY8HuZmGYo6thVkkjG3cRosUMS0TJDxWmSDXahlcpdbdDWOZWF6eU055XDYbOzZwm/+SEW5QHJBfPwsg1XV5qe8Qt9BBYwYiBkQNXEFxJ4FFTqDlB29HgxvOgdi9gOuIf/+ReRmrlnX25S9N/yvXygTTkD8Ah/xfeR6qI -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ex4_1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THIS NOTE HAS NOT BEEN REGISTERED WITH THE
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO
AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">BITNILE HOLDINGS, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Original Issuance Discount<BR>
Senior Secured Promissory Note<BR>
due March 16, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note No. 12-16-2022-Note1</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: right; font-size: 10pt">Face Amount: $14,700,000</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">Dated: December&nbsp;16, 2022 (the &ldquo;<B>Issuance Date</B>&rdquo;)</TD>
    <TD STYLE="text-align: right; font-size: 10pt">Purchase Price: $13,500,000</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For value received, BITNILE
HOLDINGS, INC., a Delaware corporation (the &ldquo;<B>Maker</B>&rdquo; or the &ldquo;<B>Company</B>&rdquo;), hereby promises to pay to
the order of _________________ (the &ldquo;<B>Holder</B>&rdquo;), in accordance with the terms hereinafter provided, the principal amount
of Fourteen Million Seven Hundred Thousand Dollars ($14,700,000) (the &ldquo;<B>Principal Amount</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All payments under or pursuant
to this Original Issuance Discount Senior Secured Promissory Note (this &ldquo;<B>Note</B>&rdquo;) shall be made in United States Dollars
in immediately available funds to the Holder at the address of the Holder set forth in the Purchase Agreement (as hereinafter defined)
or at such other place as the Holder may designate from time to time in writing to the Maker or by wire transfer of funds to the Holder&rsquo;s
account, instructions for which are attached hereto as <U>Exhibit&nbsp;A</U>. The Company shall be obligated to make payments to the Investor
as provided herein. The Outstanding Balance of this Note shall be due and payable on March 16, 2023 (the &ldquo;<B>Maturity Date</B>&rdquo;)
or at such earlier time as provided herein; provided, that the Holder, in its sole discretion, may extend the Maturity Date to any date
after the original Maturity Date; and <I>provided, further</I> that to the extent the Maker has paid at least $12,000,000 of the Principal
Amount on or before the Maturity Date, the Maker may extend the Maturity Date by forty-five (45) days beyond the original Maturity Date
by paying a fee equal to 10% of the Outstanding Balance existing as of the Maturity Date to the Holder. In the event that the Maturity
Date shall fall on Saturday or Sunday, such Maturity Date shall be the next succeeding Business Day. All calculations made pursuant to
this Note shall be rounded down to three decimal places.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase
Agreement</U>. This Note has been executed and delivered pursuant to the Securities Purchase Agreement, dated as of December&nbsp;16,
2022 (as the same may be amended from time to time, the &ldquo;<B>Purchase Agreement</B>&rdquo;), by and between the Maker, the Holder
and the other signatories thereto. Capitalized terms used and not otherwise defined herein shall have the meanings set forth for such
terms in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Interest</U>.
This Note shall bear simple interest on the outstanding Principal Amount at the rate of sixteen percent (16%) per annum, based on a 365-day
year. Interest shall commence with the date hereof and shall continue on the outstanding Principal Amount until paid in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Prepayment</U>.
At any time after the Issuance Date, the Maker may repay all or any portion of the Outstanding Balance upon at least ten (10) days&rsquo;
prior written notice of the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delisting
from a Trading Market</U>. If at any time the Class A Common Stock ceases to be listed on a Trading Market, (i) the Holder may deliver
a demand for payment to the Company and, if such a demand is delivered, the Company shall, within three (3) Business Days following receipt
of the demand for payment from the Holder, pay all of the Outstanding Balance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment
on Non-Business Days</U>. Whenever any payment to be made shall be due on a day which is not a Business Day, such payment may be due on
the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer</U>.
This Note may be transferred or sold, subject to the provisions of <U>Section&nbsp;4.9</U> of this Note, or pledged, hypothecated or otherwise
granted as security by the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Replacement</U>.
Upon receipt of a duly executed and notarized written statement from the Holder with respect to the loss, theft or destruction of this
Note (or any replacement hereof), or, in the case of a mutilation of this Note, upon surrender and cancellation of such Note, the Maker
shall issue a new Note, of like tenor and amount, in lieu of such lost, stolen, destroyed or mutilated Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Use
of Proceeds</U>. The Maker shall use the proceeds of this Note as set forth in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Status
of Note and Security Interest</U>. The Maker shall not, and shall not permit any of its Private Subsidiaries to incur, Indebtedness other
than Permitted Indebtedness without the prior written consent of the Holder. Upon any Liquidation Event (as hereinafter defined), the
Holder will be entitled to receive, before any distribution or payment is made upon, or set apart with respect to, any Indebtedness of
the Maker, any Private Subsidiary or any class of capital stock of the Maker or such Private Subsidiary, an amount equal to the Outstanding
Balance, provided, that the Holder shall be treated on a <I>pari passu </I>basis with any other signatories to the Purchase Agreement.
For purposes of this Note, &ldquo;<B>Liquidation Event</B>&rdquo; means a liquidation pursuant to a filing of a petition for bankruptcy
under applicable law or any other insolvency or debtor&rsquo;s relief, an assignment for the benefit of creditors, or a voluntary or involuntary
liquidation, dissolution or winding up of the affairs of the Maker or any Private Subsidiary thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Secured
Note</U>. The full amount of this Note is secured by the Collateral (as defined in the respective Security Documents) identified and described
as security therefor in the Security Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Taxes</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">1.11.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
payments by the Maker to the Holder hereunder will be made free and clear of and without deduction for any and all present or future taxes
in respect of such payments and any deemed payments under applicable laws in respect of this Note. If any taxes are required by law to
be deducted by the Maker from or in respect of any amounts payable to the Holder hereunder (i) the sum payable by the Maker will be increased
as necessary so that, after making all required deductions for such Taxes (including deductions applicable to additional sums payable
under this <U>Section&nbsp;1.11</U>), the Holder will receive an amount equal to the sum it would have received if such deduction had
not been made; (ii) the Maker will make such deductions; and (iii) the Maker will pay the full amount deducted to the relevant taxing
authority in accordance with applicable law and if the Holder so requires, the Maker will promptly furnish to the Holder such written
proof of payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">1.11.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the Maker fails to pay any Taxes when due to the appropriate taxing authority or fails to increase the sum payable as prescribed in <U>Section&nbsp;1.11.1</U>,
the Maker will indemnify the Holder for any incremental taxes, interest or penalties that may become payable by the Holder as a result
of any such failure. This <U>Section&nbsp;1.11</U> shall survive the termination of this Note and the payment of the Principal Amount
and all other obligations payable herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Events
of Default</U>. An &ldquo;<B><U>Event of Default</U></B>&rdquo; under this Note shall mean the occurrence of any of the events defined
in the Purchase Agreement, and any of the additional events described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
default in the payment of (i) the Principal Amount hereunder when due; or (ii) liquidated damages in respect of this Note as and when
the same shall become due and payable (whether on the Maturity Date or by acceleration or otherwise) and any such default is not remedied
within three (3) Business Days from the Event of Default occurring by the Company&rsquo;s failure to comply with this <U>Section&nbsp;2.1(a)</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Maker or any Private Subsidiary or any other Obligor shall fail to observe or perform any other covenant, condition or agreement contained
in this Note or any Transaction Document unless cured, if subject to cure, within ten (10) Business Days from the Event of Default;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;default
shall be made in the performance or observance of any material covenant, condition or agreement contained in the Purchase Agreement or
any other Transaction Document that is not covered by any other provisions of this <U>Section&nbsp;2.1</U> unless cured, if subject to
cure, within ten (10) Business Days from the Event of Default;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
representation or warranty made by the Maker or any of its Private Subsidiaries or any other Obligor herein or in the Purchase Agreement
or any other Transaction Document shall prove to have been false or incorrect or breached in a material respect on the date as of which
made unless cured, if subject to cure, within ten (10) Business Days from the Event of Default;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;unless
otherwise approved in writing in advance by the Holder, the Maker shall announce an intention to pursue or consummate a Change of Control
pursuant to that definition contained in the Purchase Agreement, or the Maker shall enter into any agreement, understanding or arrangement
with respect to any Change of Control;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Maker or any of its Private Subsidiaries or any other Obligor shall (A) default in any payment of any amount or amounts of principal of
or interest (if any) on any Indebtedness (other than the Indebtedness hereunder), the aggregate principal amount of which Indebtedness
is in excess of $100,000 that will permit the holder or holders of such Indebtedness to become due prior to its stated maturity or (B)
default in the observance or performance of any other agreement or condition relating to any such Indebtedness or contained in any instrument
or agreement evidencing, securing or relating thereto, or any other event shall occur or condition exist, the effect of which default
or other event or condition is to cause, or to permit the holder or holders or beneficiary or beneficiaries of such Indebtedness to cause
with the giving of notice if required, such Indebtedness to become due prior to its stated maturity and any such default is not remedied
within ten (10) Business Days from the Event of Default occurring by the Company&rsquo;s failure to comply with this <U>Section&nbsp;2.1(f)</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Maker or any of its Private Subsidiaries or any other Obligor shall: (i) apply for or consent to the appointment of, or the taking of
possession by, a receiver, custodian, trustee or liquidator of itself or of all or a substantial part of its property or assets; (ii)
make a general assignment for the benefit of its creditors; (iii) commence a voluntary case under the United States Bankruptcy Code (as
now or hereafter in effect) or under the comparable laws of any jurisdiction (foreign or domestic); (iv) file a petition seeking to take
advantage of any bankruptcy, insolvency, moratorium, reorganization or other similar law affecting the enforcement of creditors&rsquo;
rights generally; (v) acquiesce in writing to any petition filed against it in an involuntary case under the United States Bankruptcy
Code (as now or hereafter in effect) or under the comparable laws of any jurisdiction (foreign or domestic); (vi) issue a notice of bankruptcy
or winding down of its operations or issue a press release regarding same; or (vii) take any action under the laws of any jurisdiction
(foreign or domestic) analogous to any of the foregoing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
proceeding or case shall be commenced in respect of the Maker or any of its Private Subsidiaries or any other Obligor, without its application
or consent, in any court of competent jurisdiction, seeking: (i) the liquidation, reorganization, moratorium, dissolution, winding up,
or composition or readjustment of its debts; (ii) the appointment of a trustee, receiver, custodian, liquidator or the like of it or of
all or any substantial part of its assets in connection with the liquidation or dissolution of the Maker or any of its Private Subsidiaries
or any other Obligor; or (iii) similar relief in respect of it under any law providing for the relief of debtors, and such proceeding
or case described in clause (i), (ii) or (iii) shall continue undismissed, or unstayed and in effect, for a period of forty-five (45)
days or any order for relief shall be entered in an involuntary case under the United States Bankruptcy Code (as now or hereafter in effect)
or under the comparable laws of any jurisdiction (foreign or domestic) against the Maker or any of its Private Subsidiaries or any other
Obligor or action under the laws of any jurisdiction (foreign or domestic) analogous to any of the foregoing shall be taken with respect
to the Maker or any of its Private Subsidiaries or any other Obligor and shall continue undismissed, or unstayed and in effect for a period
of forty-five (45) days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;one
or more final judgments or orders for the payment of money aggregating in excess of $200,000 (or its equivalent in the relevant currency
of payment) are rendered against one or more of the Company and its Private Subsidiaries or any other Obligor;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Reserved];</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Maker&rsquo;s Class A Common Stock are no longer publicly traded or cease to be listed on the Trading Market or, after the six month anniversary
of the Issuance Date, any Warrant Shares may not be immediately resold under Rule 144 without restriction on the number of shares to be
sold or manner of sale, unless such Warrant Shares have been registered for resale under the 1933 Act and may be sold without restriction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company ceases to be a &ldquo;reporting issuer&rdquo; under the Exchange Act, or applies to do so, in either case without the prior written
consent of the Holder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;there
shall be any SEC or judicial stop trade order or trading suspension stop-order or management cease trade order or any restriction (collectively,
a &ldquo;<B>Restriction</B>&rdquo;) in place with the transfer agent for the Class A Common Stock restricting the trading of such Class
A Common Stock and such Restriction shall not have been lifted within ten (10) Business Days of its imposition;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Class A Common Stock are no longer tradeable through the Depository Trust Company Fast Automated Securities Transfer program;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Reserved];
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
occurrence of a Material Adverse Effect in respect of the Maker, or the Maker and its Private Subsidiaries and any other Obligor taken
as a whole and any such occurrence is not remedied within ten (10) Business Days from the Event of Default occurring by the Company&rsquo;s
failure to comply with this <U>Section&nbsp;2.1(p)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Remedies
Upon an Event of Default</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the occurrence of any Event of Default, interest will be payable on the Note at a rate equal to the greater of: (i) twenty-four percent
(24%) per annum; and (ii) the maximum rate permitted by applicable law (&ldquo;<B>Interest Upon Default Amount</B>&rdquo;). Such interest
will accrue from the first date of the Event of Default on the outstanding Principal Amount, for as long as the Event of Default will
not have been remedied. The Maker must pay this amount of interest on the outstanding Principal Amount to the Investor on a monthly basis
in arrears on the last day of each calendar month following Event of Default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the occurrence of any Event of Default, the Maker shall, as promptly as possible but in any event within one (1) Business Day of such
Event of Default, notify the Holder of the occurrence of such Event of Default, describing the event or factual situation giving rise
to the Event of Default and specifying the relevant subsection or subsections of <U>Section&nbsp;2.1</U> hereof under which such Event
of Default has occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the occurrence and during the continuance of an Event of Default, the Holder may at any time at its option (1) declare that the Interest
Upon Default Amount has become applicable, without presentment, demand, protest or notice, all of which are hereby expressly unconditionally
and irrevocably waived by the Maker and (2) exercise all other rights and remedies available to it under the Transaction Documents; <I>provided,
however</I>, that upon the occurrence of an Event of Default described above, the Holder, in its sole and absolute discretion, may exercise
or otherwise enforce any one or more of the Holder&rsquo;s rights, powers, privileges, remedies and interests under this Note, the Purchase
Agreement, the other Transaction Documents or applicable law. No course of delay on the part of the Holder shall operate as a waiver thereof
or otherwise prejudice the rights of the Holder. No remedy conferred hereby shall be exclusive of any other remedy referred to herein
or now or hereafter available at law, in equity, by statute or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE 3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Covenants</U>.
For so long as any Note is outstanding, without the prior written consent of the Holder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance
with Transaction Documents</U>. The Maker shall, and shall cause its Private Subsidiaries and each other Obligor to, comply with its obligations
under this Note and the other Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment
of Taxes, Etc</U>. The Maker shall, and shall cause each of its Private Subsidiaries and each other Obligor to, promptly pay and discharge,
or cause to be paid and discharged, when due and payable, all lawful taxes, assessments and governmental charges or levies imposed upon
the income, profits, property or business of the Maker and the Private Subsidiaries and each other Obligor, except for such failures to
pay that, individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect; <I>provided,
however</I>, that any such tax, assessment, charge or levy need not be paid if the validity thereof shall currently be contested in good
faith by appropriate proceedings and if the Maker or such Private Subsidiaries and each other Obligor shall have set aside on its books
adequate reserves with respect thereto, and <I>provided, further</I>, that the Maker and such Private Subsidiaries will pay all such taxes,
assessments, charges or levies forthwith upon the commencement of proceedings to foreclose any lien which may have attached as security
therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Corporate
Existence</U>. The Maker shall, and shall cause each of its Private Subsidiaries to, maintain in full force and effect its corporate existence,
rights and franchises and all licenses and other rights to use property owned or possessed by it and reasonably deemed to be necessary
to the conduct of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment
Company Act</U>. The Maker shall conduct its businesses in a manner so that it will not become subject to, or required to be registered
under, the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Sale
of Collateral; Liens</U>. From the date hereof until the full release of the security interest in the Collateral, (i) the Maker and its
Private Subsidiaries shall not sell, lease, transfer or otherwise dispose of any of the Collateral, or attempt or contract to do so, other
than sales of inventory in the ordinary course of business consistent with past practices; and (ii) the Maker and its Private Subsidiaries
shall not, directly or indirectly, create, permit or suffer to exist, and shall defend the Collateral against and take such other action
as is necessary to remove, any lien, security interest or other encumbrance on the Collateral.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Repayment
of This Note</U>. The Company shall make weekly payments to the Investors on a <I>pari passu </I>basis equal to the net proceeds, if any,
generated from the sale of marketable securities by Ault Lending, LLC including, without limitation, the Mullen Securities (as defined
in the Security Agreement). The Company shall make payments to the Investors equal to eighty percent (80%) of the net proceeds generated
from the sale of Capital Stock, but excluding the sale of Capital Stock from at-the-market transactions. Other than as set forth on <U>Schedule&nbsp;5.7</U>
of the Purchase Agreement, the Company has no outstanding Indebtedness (all such Indebtedness set forth on <U>Schedule&nbsp;5.7</U> of
the Purchase Agreement is hereinafter referred to as the &ldquo;<B>Existing Debt</B>&rdquo; and is collectively referred to herein as
the &ldquo;<B>Permitted Indebtedness</B>&rdquo;). The Company shall not make any voluntary cash prepayments on any Indebtedness at any
time while any amounts are owing under the Note other than with respect to the Existing Debt or cash payments the Company is required
to make pursuant to the express terms thereof existing on the date hereof. Neither the Company nor any Private Subsidiary shall incur
any Indebtedness without the express written consent of the Investor. If the Company or any Private Subsidiary issues any Indebtedness
other than the Permitted Indebtedness, after obtaining the written consent of the Investor pursuant to <U>Section&nbsp;1.9</U> of this
Note, including any subordinated Indebtedness or convertible Indebtedness, other than Exempted Securities, then unless otherwise waived
in writing by and at the discretion of the Investor, the Company will immediately utilize no less than sixty-five percent (65%) of the
proceeds of such issuance (or cause such Private Subsidiary to immediately utilize the proceeds of such issuance) to repay the Note. Any
such repayments of the Note as provided herein shall be made to the Investors on a <I>pro rata </I>basis in proportion to their investment
and shall be without premium or penalty to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Sale
of Property</U>. To the extent that the Company sells that certain real property identified on <U>Schedule 5.8(b)</U> of the Purchase
Agreement (the &ldquo;<B>Designated Property</B>&rdquo;), the net proceeds from the sale of the Designated Property in excess of $10,000,000
shall be used by the Company to repay the Notes and such amount shall immediately become due and payable under the Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Set-Off</U>.
This Note shall be subject to the set-off provisions set forth in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE 4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Reserved.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via email
at the email address specified in this <U>Section 4.2</U> prior to 5:00 p.m. (New York time) on a Business Day, (b) the next Business
Day after the date of transmission, if such notice or communication is delivered via email at the email address specified in this <U>Section
4.2</U> on a day that is not a Business Day or later than 5:00 p.m. (New York time) on any date and earlier than 11:59 p.m. (New York
time) on such date, (c) the Business Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service,
or (d) upon actual receipt by the party to whom such notice is required to be given. The addresses for notice shall be as set forth in
the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law</U>. This Agreement shall be governed by and construed in accordance with the Laws of the State of New York, without reference to
principles of conflict of laws or choice of laws. This Note shall not be interpreted or construed with any presumption against the party
causing this Note to be drafted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>.
Article and section headings in this Note are included herein for purposes of convenience of reference only and shall not constitute a
part of this Note for any other purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Remedies,
Characterizations, Other Obligations, Breaches and Injunctive Relief</U>. The remedies provided in this Note shall be cumulative and in
addition to all other remedies available under this Note, at law or in equity (including, without limitation, a decree of specific performance
and/or other injunctive relief), no remedy contained herein shall be deemed a waiver of compliance with the provisions giving rise to
such remedy and nothing herein shall limit the Holder&rsquo;s right to pursue actual damages for any failure by the Maker to comply with
the terms of this Note. Amounts set forth or provided for herein with respect to payments, conversion and the like (and the computation
thereof) shall be the amounts to be received by the holder thereof and shall not, except as expressly provided herein, be subject to any
other obligation of the Maker (or the performance thereof). The Maker acknowledges that a breach by it of its obligations hereunder will
cause irreparable and material harm to the Holder and that the remedy at law for any such breach would be inadequate. Therefore, the Maker
agrees that, in the event of any such breach or threatened breach, the Holder shall be entitled, in addition to all other available rights
and remedies, at law or in equity, to equitable relief, including but not limited to an injunction restraining any such breach or threatened
breach, without the necessity of showing economic loss and without any bond or other security being required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Enforcement
Expenses</U>. The Maker agrees to pay all costs and expenses of enforcement of this Note, including, without limitation, reasonable attorneys&rsquo;
fees and expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Binding
Effect</U>. The obligations of the Maker and the Holder set forth herein shall be binding upon the successors and assigns of each such
party, whether or not such successors or assigns are permitted by the terms herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments;
Waivers</U>. No provision of this Note may be waived or amended except in a written instrument signed by the Company and the Holder. No
waiver of any default with respect to any provision, condition or requirement of this Note shall be deemed to be a continuing waiver in
the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay
or omission of either party to exercise any right hereunder in any manner impair the exercise of any such right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance
with Securities Laws</U>. The Holder of this Note acknowledges that this Note is being acquired solely for the Holder&rsquo;s own account
and not as a nominee for any other party, and for investment, and that the Holder shall not offer, sell or otherwise dispose of this Note
in violation of securities laws. This Note and any note issued in substitution or replacement therefor shall be stamped or imprinted with
a legend in substantially the following form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: justify">&ldquo;THIS NOTE HAS NOT BEEN REGISTERED WITH
THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Jurisdiction;
Venue</U>. Any action, proceeding or claim arising out of, or relating in any way to this Agreement shall be brought and enforced in the
New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York. The Company
and the Holder irrevocably submit to the jurisdiction of such courts, which jurisdiction shall be exclusive, and hereby waive any objection
to such exclusive jurisdiction or that such courts represent an inconvenient forum. The prevailing party in any such action shall be entitled
to recover its reasonable and documented attorneys&rsquo; fees and out- of-pocket expenses relating to such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Parties
in Interest</U>. This Note shall be binding upon, inure to the benefit of and be enforceable by the Maker, the Holder and their respective
successors and permitted assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Failure
or Indulgence Not Waiver</U>. No failure or delay on the part of the Holder in the exercise of any power, right or privilege hereunder
shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further
exercise thereof or of any other right, power or privilege.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Maker
Waivers</U>. Except as otherwise specifically provided herein, the Maker and all others that may become liable for all or any part of
the obligations evidenced by this Note hereby waive presentment, demand, notice of nonpayment, protest and all other demands and notices
in connection with the delivery, acceptance, performance and enforcement of this Note, and do hereby consent to any number of renewals
of extensions of the time or payment hereof and agree that any such renewals or extensions may be made without notice to any such persons
and without affecting their liability herein and do further consent to the release of any person liable hereon, all without affecting
the liability of the other persons, firms or Maker liable for the payment of this Note, AND DO HEREBY WAIVE TRIAL BY JURY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
delay or omission on the part of the Holder in exercising its rights under this Note, or course of conduct relating hereto, shall operate
as a waiver of such rights or any other right of the Holder, nor shall any waiver by the Holder of any such right or rights on any one
occasion be deemed a waiver of the same right or rights on any future occasion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THE
MAKER ACKNOWLEDGES THAT THE TRANSACTION OF WHICH THIS NOTE IS A PART IS A COMMERCIAL TRANSACTION, AND TO THE EXTENT ALLOWED BY APPLICABLE
LAW, HEREBY WAIVES ITS RIGHT TO NOTICE AND HEARING WITH RESPECT TO ANY PREJUDGMENT REMEDY WHICH THE HOLDER OR ITS SUCCESSORS OR ASSIGNS
MAY DESIRE TO USE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>.
Capitalized terms used herein and not defined shall have the meanings set forth in the Purchase Agreement. For the purposes hereof, the
following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Indebtedness</U>&rdquo;
means: (a) all obligations for borrowed money; (b) all obligations evidenced by bonds, debentures, notes, or other similar instruments
and all reimbursement or other obligations in respect of letters of credit, bankers acceptances, current swap agreements, interest rate
hedging agreements, interest rate swaps, or other financial products; (c) all capital lease obligations that exceed $150,000 in the aggregate
in any fiscal year; (d) all obligations or liabilities secured by a lien or encumbrance on any asset of the Maker or any Private Subsidiary,
irrespective of whether such obligation or liability is assumed; (e) all obligations for the deferred purchase price of assets, together
with trade debt and other accounts payable that exceed $150,000 in the aggregate in any fiscal year; (f) all synthetic leases; and (g)
any obligation guaranteeing or intended to guarantee (whether directly or indirectly guaranteed, endorsed, co-made, discounted or sold
with recourse) any of the foregoing obligations of any other person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Market
Capitalization</U>&rdquo; means, as of any date of determination, the product of (a) the number of issued and outstanding Common Shares
as of such date (exclusive of any Common Shares issuable upon the exercise of options or warrants or conversion of any convertible securities),
multiplied by (b) the closing price of the Common Shares on the Trading Market on the date of determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<U>Outstanding
Balance</U>&rdquo; means, at the time of determination, the Principal Amount outstanding plus all accrued but unpaid interest thereon
(if any) after giving effect to any conversions or prepayments pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Pages Follow]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Maker
has caused this Note to be duly executed by its duly authorized officer as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>BITNILE HOLDINGS, INC.</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 36%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD STYLE="padding-left: 9pt">William B. Horne</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD STYLE="padding-left: 9pt">Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ex10_1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES PURCHASE AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(as amended, supplemented, restated and/or modified from time to time, this &ldquo;<B>Agreement</B>&rdquo;) is entered into as of December
16, 2022, by and among BitNile Holdings, Inc., a Delaware corporation (and, unless the context requires otherwise, collectively with the
&ldquo;<B>Subsidiaries</B>&rdquo; referred to below, the &ldquo;<B>Company</B>&rdquo;), and each investor identified on the signature
page hereto (each, including its successors and assigns, the &ldquo;<B>Investor</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">BACKGROUND</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">A.</TD><TD STYLE="text-align: justify">The board of directors (the &ldquo;<B>Board of Directors</B>&rdquo;) of the Company has authorized the
issuance to Investor of the Note (as defined below).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">B.</TD><TD STYLE="text-align: justify">The Investor desires to purchase the Note (as defined below) on the terms and conditions set forth in
this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">C.</TD><TD STYLE="text-align: justify">Concurrently with the execution of this Agreement, the Company, certain of its Subsidiaries and Affiliates
and the Investor will enter into certain security agreements and guarantees, as listed in <U>Exhibit A</U> (the &ldquo;<B>Security Documents</B>&rdquo;),
pursuant to which certain Subsidiaries and Affiliates will guarantee all of the Company&rsquo;s obligations under the Transaction Documents
and the Company and certain of its Subsidiaries will grant a first priority security interest in certain assets to secure the Company&rsquo;s
obligations hereunder and the Subsidiaries&rsquo; obligations under any such guarantee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW THEREFORE, in consideration
of the foregoing recitals and the covenants and agreements set forth herein, and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Company and the Investor hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>1.</B></TD><TD STYLE="text-align: justify"><U>DEFINITIONS</U>. As used in this Agreement, the following terms shall have the following meanings specified
or indicated below, and such meanings shall be equally applicable to the singular and plural forms of such defined terms:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>1933 Act</B>&rdquo;
means the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>1934 Act</B>&rdquo;
means the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Acquisition</B>&rdquo;
means the acquisition by the Company or any direct or indirect Subsidiary of the Company of a majority of the Equity Interests or substantially
all of the assets and business of any Person, whether by direct purchase of Equity Interests, asset purchase, merger, consolidation or
like combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Affiliate</B>&rdquo;
means a Person that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under common control
with, the Person specified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Agreement</B>&rdquo;
has the meaning set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Board of Directors</B>&rdquo;
has the meaning set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Business Day</B>&rdquo;
means any day other than a Saturday, Sunday or any other day on which banks are permitted or required to be closed in New York City.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Capital Stock</B>&rdquo;
means the Common Stock and any other classes of shares in the capital of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Change of Control</B>&rdquo;
means, with respect to the Company, on or after the date of this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40.5pt"></TD><TD STYLE="width: 18pt">(a)</TD><TD STYLE="text-align: justify">a change in the composition of the Board of Directors of the Company at a single shareholder meeting where
a majority of the individuals that were directors of the Company immediately prior to the start of such shareholder meeting are no longer
directors at the conclusion of such meeting, without the prior written consent of a majority in interest of the Investors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40.5pt"></TD><TD STYLE="width: 18pt">(b)</TD><TD STYLE="text-align: justify">a change, without the prior written consent of a majority in interest of the Investors, in the composition
of the Board of Directors of the Company prior to the termination of this Agreement where a majority of the individuals that were directors
as of the date of this Agreement cease to be directors of the Company prior to the termination of this Agreement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40.5pt"></TD><TD STYLE="width: 18pt">(c)</TD><TD STYLE="text-align: justify">other than a shareholder that holds such a position at the date of this Agreement, if a Person comes to
have beneficial ownership, control or direction over more than forty percent (40%) of the voting rights attached to any class of voting
securities of the Company; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 40.5pt"></TD><TD STYLE="width: 18pt">(d)</TD><TD STYLE="text-align: justify">the sale or other disposition by the Company or any of its Subsidiaries in a single transaction, or in
a series of transactions, of all or substantially all of the assets of the Company and its Subsidiaries on a consolidated basis.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Closing</B>&rdquo;
has the meaning set forth in <U>Section 2.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Closing Date</B>&rdquo;
has the meaning set forth in <U>Section 2.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Collateral Agent</B>&rdquo;
means Esousa Group Holdings, LLC as detailed in that certain Security Agreement, executed and delivered on the date hereof and in connection
with the Agreement, by and between the Company and Esousa Group Holdings, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Class B Common Stock</B>&rdquo;
means the Class B Common Stock in the capital of the Company, each of which has $0.001 par value per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Common Stock</B>&rdquo;
means the Class A Common Stock in the capital of the Company, each of which has $0.001 par value per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company</B>&rdquo;
has the meaning set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Equity Interests</B>&rdquo;
means and includes capital stock, membership interests and other similar equity securities, and shall also include equity-linked securities
including, but not limited to, warrants or options to purchase capital stock, membership interests or other equity interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Event</B>&rdquo;
means any event, change, development, effect, condition, circumstance, matter, occurrence or state of facts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Event of Default</B>&rdquo;
has the meaning set forth in <U>Section 7.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Exempted Securities</B>&rdquo;
means (a) Common Stock or preferred shares or rights, warrants or options to purchase Common Stock or preferred shares issued in connection
with any Acquisition where the Company does not receive cash proceeds therefrom, (b) equity securities issued by reason of a dividend,
stock split, split-up or other distribution on Common Stock, (c) Common Stock or rights, warrants or options to purchase Common Stock
issued to employees or directors of, or consultants or advisors to, the Company or any of its Subsidiaries pursuant to a plan, agreement
or arrangement approved by the Board of Directors (&ldquo;<B>Equity Plans</B>&rdquo;), (d) Common Stock or rights, warrants or options
to purchase Common Stock issued to third parties in connection with strategic partnerships approved by the Board of Directors, (e) Common
Stock actually issued upon the exercise of options or warrants or Common Stock actually issued upon the conversion or exchange of any
securities convertible into Common Stock, in each case provided that such issuance is pursuant to the terms of the applicable option,
warrant or convertible security, or (f) Common Stock issued upon the exercise or conversion of options, warrants or convertible securities
outstanding on the date hereof where the Company does not receive cash proceeds therefrom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Funding Amount</B>&rdquo;
means an amount equal to Thirteen Million Five Hundred Thousand Dollars ($13,500,000), consisting of a cash payment of Twelve Million
Dollars ($12,000,000) and a non-reimbursable expense allocation of One Million Five Hundred Thousand Dollars ($1,500,000).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Governmental Entity</B>&rdquo;
means any instrumentality, subdivision, court, administrative agency, department, body, bureau, division, board, committee, panel, commission,
official or other authority of any country, state, province, prefect, municipality, locality or other government or political subdivision
thereof, whether domestic or foreign, or any supranational or multinational organization or authority, or any quasi-governmental, private
body or arbitral body exercising any executive, legislative, judicial, quasi-judicial, regulatory, taxing, importing, administrative or
other governmental or quasi-governmental authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>HSR Act</B>&rdquo;
has the meaning set forth in <U>Section 5.15</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Indebtedness</B>&rdquo;
shall mean (a) all obligations for borrowed money; (b) all obligations evidenced by bonds, debentures, notes, or other similar instruments
and all reimbursement or other obligations in respect of letters of credit, bankers acceptances, current swap agreements, interest rate
hedging agreements, interest rate swaps, or other financial products; (c) all capital lease obligations that exceed $100,000 in the aggregate
in any fiscal year; (d) all obligations or liabilities secured by a lien or encumbrance on any asset of the Company or any Private Subsidiary,
irrespective of whether such obligation or liability is assumed; (e) all obligations for the deferred purchase price of assets, together
with trade debt and other accounts payable that exceed $100,000 in the aggregate in any fiscal year; (f) all synthetic leases; and (g)
any obligation guaranteeing or intended to guarantee (whether directly or indirectly guaranteed, endorsed, co-made, discounted or sold
with recourse) any of the foregoing obligations of any other person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investor</B>&rdquo;
has the meaning set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investor Group</B>&rdquo;
shall mean the Investor plus any other Person with which the Investor is considered to be part of a group under Section 13 of the 1934
Act or with which the Investor otherwise files reports under Sections 13 and/or 16 of the 1934 Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investor Party</B>&rdquo;
has the meaning set forth in <U>Section 5.11(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>IP Rights</B>&rdquo;
has the meaning set forth in <U>Section 3.10</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Law</B>&rdquo; means
any law, rule, regulation, order, judgment or decree, including, without limitation, any federal, and state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Losses</B>&rdquo;
has the meaning set forth in <U>Section 5.11(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Material Adverse
Effect</B>&rdquo; means any material adverse effect on (i) the businesses, properties, assets, prospects, operations, results of operations
or financial condition of the Company, or the Company and the Subsidiaries, taken as a whole, or (ii) the ability of the Company to consummate
the transactions contemplated by this Agreement or to perform its obligations hereunder or under the Note; <I>provided, however</I>, that
none of the following shall be deemed either alone or in combination to constitute, and none of the following shall be taken into account
in determining whether there has been or would be, a Material Adverse Effect: (a) any adverse effect resulting from or arising out of
general economic or financial or capital markets or political conditions in the United States or in any other jurisdiction in which the
Company has operations or conducts business to the extent, and only to the extent, the effects do not disproportionately affect the Company
as compared to other participants in the industries in which the Company operates; (b) any adverse effect resulting from or arising out
of general conditions in the industries in which the Company and the Subsidiaries operate; (c) any adverse effect resulting from any changes
to applicable Law; or (d) any adverse effect resulting from or arising out of any natural disaster or any acts of terrorism, sabotage,
military action or war or any escalation or worsening thereof; <I>provided</I>, <I>further</I>, that any event, occurrence, fact, condition
or change referred to in clauses (a) through (d) immediately above shall be taken into account in determining whether a Material Adverse
Effect has occurred or could reasonably be expected to occur to the extent that such event, occurrence, fact, condition or change has
a disproportionate effect on the Company and/or the Subsidiaries compared to other participants in the industries in which the Company
and the Subsidiaries operate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Money Laundering
Laws</B>&rdquo; has the meaning set forth in <U>Section 3.25</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Note</B>&rdquo;
has the meaning set forth in <U>Section 2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Obligor</B>&rdquo;
means the Company and each of its Subsidiaries that are a signatory to any Transaction Document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>OFAC</B>&rdquo;
has the meaning set forth in <U>Section 3.23</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Permitted Indebtedness</B>&rdquo;
shall have the meaning set forth in <U>Section 5.7</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Person</B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Principal Amount</B>&rdquo;
has the meaning set forth in <U>Section 2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Principal Market</B>&rdquo;
means the NYSE American, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Private Subsidiary</B>&rdquo;
means any Subsidiary of the Company other than a Public Subsidiary, as disclosed on <U>Schedule 3.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Proceedings</B>&rdquo;
has the meaning set forth in <U>Section 3.6</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Prohibited Transaction</B>&rdquo;
means a transaction with a third party or third parties in which the Company acquires any new assets other than in the ordinary course
of business or (ii) acquires any businesses, in both cases other than the contemplated acquisition of the assets from Circle 8 Crane Services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Public Record</B>&rdquo;
has the meaning set forth in <U>Section 3.5(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Public Subsidiary</B>&rdquo;
means any Subsidiary of the Company that has a class of securities registered under Section 12 or 15 of the 1934 Act, or any Subsidiary
of such entity, each as disclosed on <U>Schedule 3.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Register</B>,&rdquo;
&ldquo;<B>Registered</B>&rdquo; and &ldquo;<B>Registration</B>&rdquo; refer to a registration made by preparing and filing a Registration
Statement or similar document in compliance with the 1933 Act, and the declaration or ordering of effectiveness of such Registration Statement
or document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Registration Statement</B>&rdquo;
means any registration statement of the Company filed under the 1933 Act, including amendments and supplements to such Registration Statement,
and including post-effective amendments, all exhibits and all material incorporated by reference in such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>SEC</B>&rdquo; means
the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Security Documents</B>&rdquo;
has the meaning set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Securities Termination
Event</B>&rdquo; means either of the following has occurred:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;trading
in securities generally in the United States has been suspended or limited for a consecutive period of greater than three (3) Business
Days; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">a banking moratorium has been declared by the United States or the New York State authorities and is continuing
for a consecutive period of greater than three (3) Business Days.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Security Agreement</B>&rdquo;
means that certain security agreement, executed and delivered on the date hereof and in connection with the Agreement, by and between
the Company, Esousa Group Holdings, LLC and the other parties named therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Subsidiary</B>&rdquo;
of a Person means a corporation, partnership, joint venture, limited liability company or other business entity of which a majority of
the shares of securities or other interests having ordinary voting power for the election of directors or other governing body (other
than securities or interests having such power only by reason of the happening of a contingency) are at the time beneficially owned, or
the management of which is otherwise controlled, directly, or indirectly through one or more intermediaries, or both, by such Person.
Unless otherwise specified, all references herein to a &ldquo;Subsidiary&rdquo; or to &ldquo;Subsidiaries&rdquo; shall refer to a Subsidiary
or Subsidiaries of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Tax</B>&rdquo; or
&ldquo;<B>Taxes</B>&rdquo; means all federal United States and state, municipal, foreign and other taxes (including, without limitation,
income taxes, sales taxes, excise taxes, value added taxes, capital taxes, property taxes, withholding taxes, payroll taxes and contributions,
and production, severance and similar taxes and assessments) and includes all penalties, interest and fines with respect thereto and all
liabilities for the payment of such amounts as a transferee or successor or under any obligation to indemnify another Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading Day</B>&rdquo;
means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading Market</B>&rdquo;
means whichever of the New York Stock Exchange, NYSE American, or the Nasdaq Stock Market (including the Nasdaq Capital Market), on which
the Common Stock is listed or quoted for trading on the date in question.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Transaction Documents</B>&rdquo;
means this Agreement, the Note, the Security Documents, and any other documents or agreements executed or delivered by any Obligor in
connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>2.</B></TD><TD STYLE="text-align: justify"><U>PURCHASE AND SALE OF THE NOTE</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Purchase
and Sale of the Note</U>. Subject to the terms and conditions set forth herein, at the Closing, the Company shall issue and sell to the
Investors, and the Investors shall purchase from the Company, an original issuance discount senior secured promissory notes in the form
attached hereto as <U>Exhibit B</U> (the &ldquo;<B>Note</B>&rdquo;), in the aggregate principal amount of Fourteen Million Seven Hundred
Thousand Dollars ($14,700,000), subject to adjustment as set forth in the Note (the &ldquo;<B>Principal Amount</B>&rdquo;) in exchange
for the Funding Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Closing</U>.
The closing hereunder, including payment for and delivery of the Note, shall take place remotely via the exchange of documents and signatures,
no later than ten (10) Business Days following the execution and delivery of this Agreement, subject to satisfaction or waiver of the
conditions set forth in <U>Section 6</U>, or at such other time and place as the Company and the Investor agree upon, orally or in writing
(the &ldquo;<B>Closing</B>,&rdquo; and the date of the Closing being the &ldquo;<B>Closing Date</B>&rdquo;). On the Closing Date, (i)
the Investor shall pay the Funding Amount to the Company by wire transfer of immediately available funds in accordance with the Company&rsquo;s
written wire instructions and (ii)&nbsp;the Company shall issue to the Investor a Note in the Principal Amount, duly executed on behalf
of the Company and registered in the name of the Investor or its designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Repayment
of the Note and Prepayment Right</U>. As set forth in this Agreement and in the Note, the Company shall make certain payments to the Investor
as detailed therein. Further, as set forth in the Note, in its sole discretion and upon giving the prior written notice set forth in the
Note, the Company will have the right to pre-pay the entire then-outstanding principal amount of the Note at any time with no penalty
or premium of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Senior
Obligation</U>. As an inducement for the Investors to enter into this Agreement and to purchase the Notes, all obligations of the Obligors
pursuant to the Transaction Documents shall be secured by a security interest in and lien upon certain assets of the Obligors as set forth
in the Security Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>3.</B></TD><TD STYLE="text-align: justify"><U>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</U>. The Company represents and warrants to the Investor
and covenants with the Investor that, except as is set forth in the Disclosure Letter being delivered to the Investor as of the date hereof
and as of the Closing Date, the following representations and warranties are true and correct in all material respects:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Organization
and Qualification</U>. The Company is a corporation duly organized and validly existing in good standing under the Laws of the State of
Delaware and has the requisite corporate power and authority to own its properties and to carry on its business as now being conducted.
The Company is duly qualified to do business and is in good standing in every jurisdiction in which the ownership of its property or the
nature of the business conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified or
be in good standing would not have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Authorization;
Enforcement; Compliance with Other Instruments</U>. The Company and each of its Subsidiaries (as applicable) has the requisite corporate
or limited liability company power, as the case may be, and authority to execute the Transaction Documents to which it is a party, to
issue and sell the Note hereto (in the case of the Company), and to perform its obligations under the Transaction Documents to which it
is a party. The execution and delivery of the Transaction Documents by the Company and its Subsidiaries (as applicable) and the issuance
and sale of the Note by the Company pursuant hereto, have been duly and validly authorized by the Company&rsquo;s Executive Committee
of its Board of Directors and any similar governing body of a Subsidiary and no further consent or authorization is required by the Company,
its Subsidiaries, their respective Boards of Directors or other governing bodies, the Company&rsquo;s stockholders or any other Person
in connection therewith. The Transaction Documents have been duly and validly executed and delivered by the Company and its Subsidiaries
party thereto and constitute valid and binding obligations of the Company and its Subsidiaries (as applicable), enforceable against such
parties in accordance with their respective terms, except as such enforceability may be limited by general principles of equity or applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation or similar Laws relating to, or affecting generally, the enforcement of
creditors&rsquo; rights and remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>No
Conflicts</U>. The execution, delivery and performance of the Transaction Documents by the Company and its Subsidiaries (as applicable)
and the issuance and sale of the Note by the Company hereunder will not (a) conflict with or result in a violation of the Company&rsquo;s
or its Subsidiaries&rsquo; notice of articles, articles or any other constating documents, (b) conflict with, or constitute a default
(or an event which, with notice or lapse of time or both, would become a default) under, or give to others any right of termination, amendment,
acceleration or cancellation of, any agreement to which the Company or any of the Subsidiaries is a party, or require the Company or any
Subsidiary to grant a lien or encumbrance on any of its property or assets under the terms of any other agreement to which it is a party,
or (c) subject to the making of the filings referred to in <U>Section 5</U>, violate in any material respect any Law or any rule or regulation
of the Principal Market applicable to the Company or any of the Subsidiaries or by which any of their properties or assets are bound or
affected. Assuming the accuracy of the Investor&rsquo;s representations in <U>Section 4</U> and subject to the making of the filings referred
to in <U>Section 5</U>, (i) no approval or authorization will be required from any governmental authority or agency, regulatory or self-regulatory
agency or other third party (including the Principal Market) in connection with the issuance of the Note and the other transactions contemplated
by this Agreement and (ii) the issuance of the Note will be exempt from the registration and qualification requirements under the 1933
Act and all applicable state securities Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Capitalization
and Subsidiaries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
authorized Capital Stock of the Company consists of Five Hundred Million shares of Class A Common Stock, Twenty-Five Million shares of
Class B Common Stock and Twenty-Five Million shares of Preferred Stock. As of the close of business on December 15, 2022, 365,525,189
shares of Common Stock, no shares of Class B Common Stock and 300,130 shares of Preferred Stock were issued and outstanding. As of December
15, 2022, (x) an aggregate of 5,810,844 shares of Common Stock are issuable upon exercise of options granted under a stock option plan,
of which 2,538,790 are fully vested and exercisable; (y) an aggregate of 27,560,0021 Common Stock are issuable upon exercise of outstanding
warrants granted by the Company, with exercise prices ranging from $0.45 to $2,000 per share and (Z) an aggregate of 1,505,000 restricted
stock grants are outstanding. No shares of the Company&rsquo;s Capital Stock are subject to preemptive rights or any other similar rights
or any liens or encumbrances suffered or permitted by the Company. The Company&rsquo;s certificate of incorporation and bylaws, each as
amended, on file on the SEC&rsquo;s EDGAR website are true and correct copies of the Company&rsquo;s constating documents as in effect
as of the date hereof. The Company is not in violation of any provision of its certificate of incorporation or bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Schedule
3.4(b)</U> lists each direct and indirect Subsidiary of the Company existing on the date hereof and indicates for each Private Subsidiary
(i) the authorized capital stock or other Equity Interests of such Private Subsidiary as of the date hereof, (ii) the number and kind
of shares or other ownership interests of such Private Subsidiary that are issued and outstanding as of the date hereof, and (iii) the
owner of such shares or other ownership interests. Other than as set forth on <U>Schedule 3.4(b)</U>, no Private Subsidiary has any outstanding
stock options, warrants or other instruments pursuant to which such Private Subsidiary may at any time or under any circumstances be obligated
to issue any shares of its capital stock or other Equity Interests. Each Subsidiary is duly organized and validly existing in good standing
under the laws of its jurisdiction of formation and has all requisite power and authority to own its properties and to carry on its business
as now being conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
the Company nor any Private Subsidiary is bound by any agreement or arrangement pursuant to which it is obligated to register the sale
of any securities under the 1933 Act other than _______________. There are no outstanding securities of the Company or any of the Private
Subsidiaries which contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements
by which the Company or any Private Subsidiary is or may become bound to redeem or purchase any security of the Company or any Private
Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no outstanding securities or instruments
containing anti-dilution or similar provisions that will be triggered by the issuance of the Note. Neither the Company nor any Private
Subsidiary has any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
issuance and sale of the Note on the Closing Date will not obligate the Company to issue shares of Common Stock or other securities to
any other Person and will not result in the adjustment of the exercise, conversion, exchange, or reset price of any outstanding securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Public
Record; Financial Statements</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the date hereof, the Company has filed all reports, schedules, forms, statements and other documents required to be filed by it pursuant
to the reporting requirements of the 1934 Act (all of the foregoing filed prior to the date hereof and all exhibits included therein and
financial statements and schedules thereto and documents incorporated by reference therein being hereinafter referred to as the &ldquo;<B>Public
Record</B>&rdquo;). As of their respective filing dates, all documents filed by the Company in the Public Record complied in all material
respects with the requirements of the 1934 Act, as applicable, and the rules and regulations thereunder, and none of the documents in
the Public Record, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made,
not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of their respective dates, the financial statements of the Company included in the Public Record complied as to form in all material respects
with applicable accounting requirements and the published rules and regulations of the 1934 Act with respect thereto. Such financial statements
have been prepared in accordance with U.S. generally accepted accounting principles (&ldquo;<B>GAAP</B>&rdquo;), and audited by a firm
that is an independent registered public accounting firm subject to the public company accounting oversight board consistently applied,
during the periods involved (except as may be otherwise indicated in such financial statements or the notes thereto, or, in the case of
unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) and fairly present in
all material respects the consolidated financial position of the Company as of the dates thereof and the consolidated results of its operations
and consolidated cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments).
No other written information provided by or on behalf of the Company to the Investor in connection with the Investor&rsquo;s purchase
of the Note which is not included in the Public Record contains any untrue statement of a material fact or omits to state any material
fact necessary to make the statements therein, in the light of the circumstance under which they are or were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as set forth on <U>Schedule 3.5(c)</U>, the Company and each of the Private Subsidiaries maintain a system of internal accounting controls
sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management&rsquo;s general or specific
authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and
to maintain asset accountability, (iii) reasonable controls to safeguard assets are in place and (iv) the recorded accountability for
assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Litigation
and Regulatory Proceedings</U>. Other than as set forth on <U>Schedule 3.6</U>, there are no material actions, causes of action, suits,
claims, proceedings, inquiries or investigations (collectively, &ldquo;<B>Proceedings</B>&rdquo;) before or by any court, public board,
government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of the Company or any of
the Private Subsidiaries, threatened against or affecting the Company or any of the Private Subsidiaries, the Common Stock or any other
class of issued and outstanding shares of the Company&rsquo;s Capital Stock, or any of the Company&rsquo;s or the Private Subsidiaries&rsquo;
officers or directors in their capacities as such and, to the knowledge of the Company, there is no reason to believe that there is any
basis for any such Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>No
Undisclosed Events, Liabilities or Developments</U>. Other than as set forth on <U>Schedule 3.7</U> hereto, no event, development or circumstance
has occurred or exists, or to the knowledge of the Company, is reasonably anticipated to occur or exist that (a) would reasonably be anticipated
to have a Material Adverse Effect or (b) would be required to be disclosed by the Company under applicable securities Laws on a Registration
Statement relating to an issuance and sale by the Company of its Common Stock and which has not been publicly announced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Compliance
with Law</U>. The Company and each of the Private Subsidiaries have conducted and are conducting their respective businesses in compliance
in all material respects with all applicable Laws and are in compliance in all material respects with the rules and regulations of the
Trading Market. Except as disclosed in the Public Record, the Company is not aware of any facts which could reasonably be anticipated
to lead to a delisting of the Common Stock by the Trading Market in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Employee
Relations</U>. Neither the Company nor any Private Subsidiary is involved in any union labor dispute nor, to the knowledge of the Company,
is any such dispute threatened. Neither the Company nor any Private Subsidiary is a party to any collective bargaining agreement. No executive
officer has notified the Company that such officer intends to leave the Company&rsquo;s employ or otherwise terminate such officer&rsquo;s
employment with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Intellectual
Property Rights</U>. The Company and each Private Subsidiary owns or possesses adequate rights or licenses to use all trademarks, trade
names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses, approvals,
governmental authorizations, trade secrets and other intellectual property rights (collectively, &ldquo;<B>IP Rights</B>&rdquo;) necessary
to conduct their respective businesses as now conducted. None of the material IP Rights of the Company or any of the Private Subsidiaries
are expected to expire or terminate within three (3) years from the date of this Agreement. Neither the Company nor any Private Subsidiary
is infringing, misappropriating or otherwise violating any IP Rights of any other Person. No claim has been asserted, and no Proceeding
is pending, against the Company or any Private Subsidiary alleging that the Company or any Private Subsidiary is infringing, misappropriating
or otherwise violating the IP Rights of any other Person, and, to the Company&rsquo;s knowledge, no such claim or Proceeding is threatened,
and the Company is not aware of any facts or circumstances which might give rise to any such claim or Proceeding. The Company and the
Private Subsidiaries have taken commercially reasonable security measures to protect the secrecy, confidentiality and value of all of
their material IP Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Environmental
Laws</U>. Except, in each case, as would not be reasonably anticipated to have a Material Adverse Effect, the Company and the Private
Subsidiaries (a) are in compliance in all material respects with any and all applicable Laws relating to the protection of human health
and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants, (b) have received and hold all permits,
licenses or other approvals required of them under all such Laws to conduct their respective businesses and (c) are in compliance in all
material respects with all terms and conditions of any such permit, license or approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Title
to Assets</U>. The Company and the Private Subsidiaries have good and marketable title to all personal property owned by them which is
material to their respective businesses, in each case free and clear of all liens, encumbrances and defects except those disclosed in
the Public Record or set forth on <U>Schedule 3.12</U>. Any real property and facilities held under lease by the Company or any Private
Subsidiary are held under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with
the use made and proposed to be made of such property and buildings by the Company and the Private Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Insurance</U>.
The Company and each of the Private Subsidiaries are insured by insurers of recognized financial responsibility against such losses and
risks and in such amounts as management of the Company reasonably believes to be prudent and customary in the businesses in which the
Company and the Private Subsidiaries are engaged. Neither the Company nor any of the Private Subsidiaries has been refused any insurance
coverage sought or applied for, and the Company has no reason to believe that it will not be able to renew all existing insurance coverage
as and when such coverage expires or to obtain similar coverage from similar insurers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Regulatory
Permits</U>. The Company and the Private Subsidiaries have in full force and effect all certificates, approvals, authorizations and permits
from all regulatory authorities and agencies necessary to own, lease or operate their respective properties and assets and conduct their
respective businesses, and neither the Company nor any Private Subsidiary has received any notice of Proceedings relating to the revocation
or modification of any such certificate, approval, authorization or permit, except for such certificates, approvals, authorizations or
permits with respect to which the failure to hold would not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>No
Materially Adverse Contracts, Etc</U>. Neither the Company nor any of the Private Subsidiaries is (a) subject to any charter, corporate
or other legal restriction, or any judgment, decree or order which in the judgment of the Company has or is expected in the future to
have a Material Adverse Effect or (b) a party to any contract or agreement which in the judgment of the Company has or would reasonably
be anticipated to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Taxes</U>.
The Company and the Private Subsidiaries each has correctly prepared and duly and timely made or filed, or caused to be made or filed,
all United States federal, and applicable state, local and non-U.S. Tax returns, reports and declarations required by any jurisdiction
to which it is subject and has paid all Taxes and other governmental assessments and charges that are material in amount, required to
be paid by it, regardless of whether such amounts are shown or determined to be due on such returns, reports and declarations, except
those being contested in good faith by appropriate proceedings and for which it has set aside on its books provision reasonably adequate
for the payment of all Taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no
unpaid Taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and, to the knowledge of the Company,
there is no basis for any such claim. Each of the Company and the Private Subsidiaries has collected, withheld and remitted all Taxes
due and payable to the property taxing or other governmental authority. There are no audits, assessments, reassessments, suits, proceedings,
investigations or claims pending against the Company or any of the Private Subsidiaries in respect of Taxes paid or payable, and there
are no matters under discussion with any taxing or governmental authority of any jurisdiction involving the Company or any Private Subsidiary
with, or the subject of any agreement with, any taxing or governmental authority relating to claims for additional Taxes. There are no
agreements, waivers or other arrangements providing for an extension of time with respect to the assessment or reassessment of any Tax
owing by the Company or any subsidiary, the filing of any tax returns by the Company or any Private Subsidiary or the payment of any Tax
by the Company or any Private Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Solvency</U>.
After giving effect to the receipt by the Company of the proceeds from the transactions contemplated by this Agreement (a) the Company&rsquo;s
fair saleable value of its assets exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing
debts and other liabilities (including known contingent liabilities) as they mature; and (b) the current cash flow of the Company, together
with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of
the cash, would be sufficient to pay all amounts on or in respect of its debt when such amounts are required to be paid. The Company does
not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be
payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe that it will
file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Investment
Company</U>. The Company is not, and is not an Affiliate of, an &ldquo;Investment Company&rdquo; within the meaning of the Investment
Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Certain
Transactions</U>. Other than employment or consultant agreements or as disclosed in the Public Record, there are no contracts, transactions,
arrangements or understandings between the Company or any of its Subsidiaries, on the one hand, and any director, officer or employee
thereof on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>No
General Solicitation</U>. Neither the Company, nor any of its Affiliates, nor any person acting on its behalf, has engaged in any form
of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or sale of the Note pursuant
to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Acknowledgment
Regarding the Investor&rsquo;s Purchase of the Note</U>. The Company&rsquo;s Executive Committee of its Board of Directors has approved
the execution of the Transaction Documents and the issuance and sale of the Note, based on its own independent evaluation and determination
that the terms of the Transaction Documents are reasonable and fair to the Company and in the best interests of the Company and its stockholders.
The Company and each of its Subsidiaries (as applicable) are entering into this Agreement and the Security Documents to which they are
party, and the Company is issuing and selling the Note, voluntarily and without economic duress. The Company has had the opportunity to
consider whether or not to retain independent legal counsel of its own choosing to review the Transaction Documents and advise the Company
with respect thereto but has determined not to retain any such independent legal counsel. The Company acknowledges and agrees that the
Investor is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Note and the transactions contemplated
hereby and that neither the Investor nor any person affiliated with the Investor is acting as a financial advisor to, or a fiduciary of,
the Company (or in any similar capacity) with respect to execution of the Transaction Documents or the issuance of the Note or any other
transaction contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>No
Brokers&rsquo;, Finders&rsquo; or Other Advisory Fees or Commissions</U>. No brokers, finders or other similar advisory fees or commissions
will be payable by the Company or any Subsidiary or by any of their respective agents with respect to the issuance of the Note or any
of the other transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>OFAC</U>.
None of the Company nor any of the Private Subsidiaries nor, to the best knowledge of the Company, any Public Subsidiary or director,
officer, agent, employee, affiliate or person acting on behalf of the Company and/or any Subsidiary has been or is currently subject to
any United States sanctions administered by the Office of Foreign Assets Control of the United States Department of the Treasury (&ldquo;<B>OFAC</B>&rdquo;);
and the Company will not directly or indirectly use any proceeds received from the Investor, or lend, contribute or otherwise make available
such proceeds to its Subsidiaries or to any affiliated entity, joint venture partner or other person or entity, to finance any investments
in, or make any payments to, any country or person currently subject to any of the sanctions of the United States administered by OFAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>No
Foreign Corrupt Practices</U>. None of the Company or any of the Private Subsidiaries has, directly or indirectly: (a) made or authorized
any contribution, payment or gift of funds or property to any official, employee or agent of any governmental authority of any jurisdiction
except as otherwise permitted under applicable Law; or (b) made any contribution to any candidate for public office, in either case, where
either the payment or the purpose of such contribution, payment or gift was, is, or would be prohibited under the Foreign Corrupt Practices
Act or the rules and regulations promulgated thereunder or under any other legislation of any relevant jurisdiction covering a similar
subject matter applicable to the Company or its Private Subsidiaries and their respective operations and the Company has instituted and
maintained policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance with
such legislation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Anti-Money
Laundering</U>. The operations of each of the Company and the Private Subsidiaries are and have been conducted at all times in compliance
with all applicable anti-money laundering laws, regulations, rules and guidelines in its jurisdiction of incorporation and in each other
jurisdiction in which such entity, as the case may be, conducts business (collectively, the &ldquo;<B>Money Laundering Laws</B>&rdquo;)
and no action, suit or proceeding by or before any court or governmental authority involving the Company or its Subsidiaries with respect
to any of the Money Laundering Laws is, to the best knowledge of the Company, pending, threatened or contemplated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Disclosure</U>.
The Company confirms that neither it, nor to its knowledge, any other Person acting on its behalf has provided the Investor or its agents
or counsel with any information that the Company believes constitutes material, non-public information. The Company understands and confirms
that the Investor will rely on the foregoing representations and covenants in effecting transactions in securities of the Company. All
disclosures provided to the Investor regarding the Company, its business and the transactions contemplated hereby, furnished by or on
behalf of the Company (including the Company&rsquo;s representations and warranties set forth in this Agreement) are true and correct
in all material respects and do not contain any untrue statement of a material fact or omit to state any material fact necessary in order
to make the statements made therein, in light of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>3.27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Share
Transfer Agent</U>. The Company represents and warrants that the transfer agent used by the Company is Computershare Trust Company, N.A.,
which participates in the Depository Trust Company Fast Automated Securities Transfer program. The Company shall not change its share
transfer agent without the prior written consent of the majority in interest of the Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>4.</B></TD><TD STYLE="text-align: justify"><U>REPRESENTATIONS AND WARRANTIES OF THE INVESTOR</U>. The Investor represents and warrants to the Company
as follows:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Organization
and Qualification</U>. The Investor, if an entity, is a validly existing corporation, limited partnership or limited liability company
and has all requisite corporate, partnership or limited liability company power and authority to invest in the Note pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Authorization;
Enforcement; Compliance with Other Instruments</U>. The Investor has the requisite power and authority to enter into and to perform its
obligations under the Transaction Documents to which it is a party. The execution and delivery by the Investor of the Transaction Documents
to which it is a party have been duly and validly authorized by the Investor&rsquo;s governing body and no further consent or authorization
is required. The Transaction Documents to which it is a party have been duly and validly executed and delivered by the Investor and constitute
valid and binding obligations of the Investor, enforceable against the Investor in accordance with their terms, except as such enforceability
may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar
laws relating to, or affecting generally, the enforcement of creditors&rsquo; rights and remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>No
Conflicts</U>. The execution, delivery and performance of the Transaction Documents to which it is a party by the Investor and the purchase
of the Note by the Investor will not (a) conflict with or result in a violation of the Investor&rsquo;s organizational documents, (b)
conflict with, or constitute a material default (or an event which, with notice or lapse of time or both, would become a material default)
under, or give to others any rights of termination, amendment, acceleration or cancellation of, any material agreement, contract, indenture
mortgage, indebtedness or instrument to which the Investor is a party, or (c) violate any Law applicable to the Investor or by which any
of the Investor&rsquo;s properties or assets are bound or affected. No approval or authorization will be required from any governmental
authority or agency, regulatory or self-regulatory agency or other third party in connection with the purchase of the Note and the other
transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>4.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Investment
Intent; Accredited Investor</U>. The Investor is purchasing the Note for its own account, for investment purposes, and not with a view
towards distribution. The Investor is an &ldquo;accredited investor&rdquo; as such term is defined in Rule 501(a) of Regulation D of the
1933 Act. The Investor has, by reason of its business and financial experience, such knowledge, sophistication and experience in financial
and business matters and in making investment decisions of this type that it is capable of (a) evaluating the merits and risks of an investment
in the Note and making an informed investment decision, (b) protecting its own interests and (c) bearing the economic risk of such investment
for an indefinite period of time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>4.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Opportunity
to Discuss</U>. The Investor has received all materials relating to the business, finance and operations of the Company and the Subsidiaries
as it has requested and has had an opportunity to discuss the business, management and financial affairs of the Company and the Subsidiaries
with the Company&rsquo;s management. In making its investment decision, the Investor has relied solely on its own due diligence performed
on the Company by its own representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>4.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>No
Governmental Review</U>. The Investor understands that no Government Entity has passed on or made any recommendation or endorsement of
the Note or the fairness or suitability of the investment in the Note nor have such authorities passed upon or endorsed the merits of
the offering of the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>4.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>4.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>No
Other Representations</U>. Except for the representations and warranties set forth in this Agreement and in other Transaction Documents,
the Investor makes no other representations or warranties to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>5.</B></TD><TD STYLE="text-align: justify"><U>OTHER AGREEMENTS OF THE PARTIES</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Legends,
etc</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Note may only be disposed of pursuant to an effective Registration Statement, to the Company or pursuant to an available exemption from
or in a transaction not subject to the registration requirements of the 1933 Act, and in compliance with any applicable state securities
laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certificates
evidencing the Note will contain the following legend, so long as is required by this <U>Section 5.1(b)</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">THESE SECURITIES HAVE NOT BEEN REGISTERED
WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THESE SECURITIES
MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company acknowledges and
agrees that the Investor may from time to time pledge, and/or grant a security interest in some or all of the Note, in accordance with
applicable securities laws, pursuant to a bona fide margin agreement in connection with a bona fide margin account and, if required under
the terms of such agreement or account, the Investor may transfer pledged or secured Note to the pledgees or secured parties. Such a pledge
or transfer would not be subject to approval or consent of the Company and no legal opinion of legal counsel to the pledgee, secured party
or pledgor shall be required in connection with the pledge, but such legal opinion may be required in connection with a subsequent transfer
following default by the Investor transferee of the pledge. At the Company&rsquo;s expense, the Company will execute and deliver such
reasonable documentation as a pledgee or secured party of the Note may reasonably request in connection with a pledge or transfer of the
Note including the preparation and filing of any required prospectus supplement under Rule 424(b)(3) of the 1933 Act or other applicable
provision of the 1933 Act to appropriately amend the list of selling stockholders thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Furnishing
of Information</U>. As long as the Investor owns the Note, the Company covenants to timely file (or obtain extensions in respect thereof
and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the 1934
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Integration</U>.
The Company shall not, and shall use its best efforts to ensure that no Affiliate of the Company shall, sell, offer for sale or solicit
offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the 1933 Act) that will be integrated with
the offer or sale of the Note in a manner that would require the registration under the 1933 Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Notification
of Certain Events</U>. The Company shall give prompt written notice to the Investor of (a) the occurrence or non-occurrence of any Event,
the occurrence or non- occurrence of which would render any representation or warranty of the Company contained in this Agreement or any
other Transaction Document, if made on or immediately following the date of such Event, untrue or inaccurate in any material respect,
(b) the occurrence of any Event that, individually or in combination with any other Events, has had or could reasonably be expected to
have a Material Adverse Effect, (c) any failure of the Company to comply with or satisfy any covenant or agreement to be complied with
or satisfied by it hereunder or any Event that would otherwise result in the nonfulfillment of any of the conditions to the Investor&rsquo;s
obligations hereunder, (d) any notice or other communication from any Person alleging that the consent of such Person is or may be required
in connection with the consummation of the transactions contemplated by this Agreement or any other Transaction Document, or (e) any Proceeding
pending or, to the Company&rsquo;s knowledge, threatened against a party relating to the transactions contemplated by this Agreement or
any other Transaction Document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Use
of Proceeds</U>. The Company will use the proceeds from the sale of the Note as provided for herein for certain acquisitions which have
been disclosed to the Investor and general working capital purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Repayment
of Note</U>. The Company shall make weekly payments to the Investors on a <I>pari passu </I>basis equal to the net proceeds, if any, generated
from the sale of marketable securities by Ault Lending, LLC. The Company shall make payments to the Investors equal to eighty percent
(80%) of the net proceeds generated from the sale of Capital Stock, but excluding the sale of Capital Stock from at-the-market transactions.
Other than as set forth on <U>Schedule 5.7</U>, the Company has no outstanding Indebtedness (all such Indebtedness set forth on <U>Schedule
5.7</U> is hereinafter referred to as the &ldquo;<B>Existing Debt</B>&rdquo; and is collectively referred to herein as the &ldquo;<B>Permitted
Indebtedness</B>&rdquo;). The Company shall not make any voluntary cash prepayments on any Indebtedness at any time while any amounts
are owing under the Note other than with respect to the Existing Debt or cash payments the Company is required to make pursuant to the
express terms thereof existing on the date hereof. Neither the Company nor any Private Subsidiary shall incur any Indebtedness without
the express written consent of the Investor. If the Company or any Private Subsidiary issues any Indebtedness other than the Permitted
Indebtedness, after obtaining the written consent of the Investor pursuant to Section 1.9 of the Note, including any subordinated Indebtedness
or convertible Indebtedness, other than Exempted Securities, then unless otherwise waived in writing by and at the discretion of the Investor,
the Company will immediately utilize no less than sixty-five percent (65%) of the proceeds of such issuance (or cause such Private Subsidiary
to immediately utilize the proceeds of such issuance) to repay the Note. Any such repayments of the Note as provided in this <U>Section
5.7</U> shall be made to the Investors on a <I>pro rata </I>basis in proportion to their investment and shall be without premium or penalty
to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Sale
of Property</U>. To the extent that the Company sells that certain real property identified on <U>Schedule 5.8(b)</U> (the &ldquo;<B>Designated
Property</B>&rdquo;), the net proceeds from the sale of the Designated Property in excess of $10,000,000 shall be used by the Company
to repay the Notes and such amount shall immediately become due and payable under the Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Prohibited
Transactions</U>. The Company hereby covenants and agrees not to enter into any Prohibited Transactions without obtaining prior written
consent from the majority in interest of the Investors, until such time as the Note has been repaid in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Securities
Laws Disclosure; Publicity</U>. The Company shall, within one (1) Business Day following the date hereof, file a Current Report on Form
8-K disclosing the material terms of the transactions contemplated hereby and file a copy of this Agreement on EDGAR. The Company shall
not issue any press release nor otherwise make any such public statement regarding the Investor or the Transaction Documents without the
prior written consent of the Investor, except if such disclosure is required by law, in which case the Company shall (a) ensure that such
disclosure is restricted and limited in content and scope to the maximum extent permitted by Law to meet the relevant disclosure requirement
and (b) provide a copy of the proposed disclosure to the Investor for review prior to release and the Company shall incorporate the Investor&rsquo;s
reasonable comments. Notwithstanding anything herein to the contrary, to comply with United States Treasury Regulations Section 1.6011-4(b)(3)(i),
each of the Company and the Investor, and each employee, representative or other agent of the Company or the Investor, may disclose to
any and all persons, without limitation of any kind, the U.S. federal and state income tax treatment, and the U.S. federal and state income
tax structure, of the transactions contemplated hereby and all materials of any kind (including opinions or other tax analyses) that are
provided to such party relating to such tax treatment and tax structure insofar as such treatment and/or structure relates to a U.S. federal
or state income tax strategy provided to such recipient.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Indemnification
of the Investor</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company will indemnify and hold the Investor, its Affiliates and their respective directors, officers, managers, shareholders, members,
partners, employees and agents and permitted successors and assigns (each, an &ldquo;<B>Investor Party</B>&rdquo;) harmless from any and
all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements,
court costs and reasonable attorneys&rsquo; fees and costs of investigation and defense (collectively, &ldquo;<B>Losses</B>&rdquo;) that
any such Investor Party may suffer or incur as a result of or relating to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.8in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
breach or inaccuracy of any representation, warranty, covenant or agreement made by the Company in any Transaction Document;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.8in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
misrepresentation made by the Company in any Transaction Document or in any Public Record document;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.8in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
omission to state any material fact necessary in order to make the statements made in any Public Record, in light of the circumstances
under which they were made, not misleading;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.8in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
proceeding before or by any court, public board, government agency, self-regulatory organization or body based upon, or resulting from
the execution, delivery, performance or enforcement of any of the Transaction Documents or the consummation of the transactions contemplated
thereby, and whether or not the Investor is party thereto by claim, counterclaim, crossclaim, as a defendant or otherwise, or if such
Proceeding is based upon, or results from, any of the items set forth in clauses (i) through (iii) above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to the indemnity contained herein, the Company will reimburse each Investor Party for its reasonable legal and other expenses
(including the cost of any investigation, preparation and travel in connection therewith) incurred in connection therewith, as such expenses
are incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
provisions of this <U>Section 5.11</U> shall survive the termination or expiration of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Non-Public
Information</U>. The Company covenants and agrees that neither it nor any other Person acting on its behalf will provide the Investor
or its agents or counsel with any information that the Company believes constitutes material, non-public information. To the extent the
Company does not comply with this covenant and provides the Investor with material, non-public information, the Company shall publicly
disclose such information within seventy two (72) hours of providing the information to the Investor; <I>provided, however</I>, in the
event that such material non-public information is provided to Investor pursuant to <U>Section 7.2</U>, the Company shall publicly disclose
such information within twenty (20) Business Days of providing the information to the Investor. The Company understands and confirms that
the Investor shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Antitrust
Notification</U>. If the Investor determines, in its sole judgment and upon the advice of counsel, that the issuance of the Note pursuant
to the terms hereof would be subject to the provisions of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the &ldquo;<B>HSR
Act</B>&rdquo;), the Company shall file as soon as practicable after the date on which the Company receives notice from the Investor of
the applicability of the HSR Act and a request to so file with the United States Federal Trade Commission and the United States Department
of Justice the notification and report form required to be filed by it pursuant to the HSR Act in connection with such issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Change
of Prime Broker, Custodian</U>. Each Investor has informed the Company of the names of its prime broker and its share custodian. Each
Investor shall notify the Company of any change in its prime broker or share custodian within three (3) Business Days of such change having
taken effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>5.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Set-Off</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Investor may set off any of its obligations to the Company (whether or not due for payment), against any of the Company&rsquo;s obligations
to the Investor (whether or not due for payment) under this Agreement and/or any other Transaction Document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Investor may do anything necessary to effect any set-off undertaken in accordance with this <U>Section 5.20</U> (including varying the
date for payment of any amount payable by the Investor to the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>6.</B></TD><TD STYLE="text-align: justify"><U>CLOSING CONDITIONS</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Conditions
Precedent to the Obligations of the Investor</U>. The obligation of the Investor to fund the Note at the Closing is subject to the satisfaction
or waiver by the Investor, at or before such Closing, of each of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Required
Documentation</U>. The Company must have delivered to the Investor copies of all resolutions duly adopted by the Company&rsquo;s Executive
Committee of its Board of Directors, or any such other documentation of the Company approving the Agreement, the Transaction Documents
and any of the transactions contemplated hereby or thereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Consents
and Permits</U>. The Company must have obtained and delivered to the Investor copies of all necessary permits, approvals, and registrations
necessary to effect this Agreement, the Transaction Documents and any of the transactions contemplated hereby or thereby, including pursuant
to <U>Section 3.14</U> of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reserved</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Event(s) of Default</U>. No Event of Default shall have occurred and no Event of Default would result from the execution of this Agreement
or any of the Transaction Documents or the transactions contemplated hereby or thereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Warranties</U>. The representations and warranties of the Company contained herein shall be true and correct in all material respects
as of the date when made and as of such Closing as though made on and as of such date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Performance</U>.
The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required
by the Transaction Documents to be performed, satisfied or complied with by it at or prior to such Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Injunction</U>. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions
contemplated by the Transaction Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Suspensions of Trading in Common Stock; Listing</U>. Trading in the Common Stock shall not have been suspended by the SEC or Principal
Market (except for any suspensions of trading of not more than one day on which the Principal Market is open solely to permit dissemination
of material information regarding the Company) at any time since the date of execution of this Agreement, and the Common Stock shall have
been at all times since such date listed for trading on a Trading Market;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>SEC
Reporting</U>. The Company has, during the preceding twelve (12) months, filed with the SEC all reports and other materials required to
be filed by Section 13 or 15(d) of the 1934 Act, as applicable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reserved</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Perfection
of Security Interest; Evidence of Lien Release</U>. The Investor shall have, to the extent possible, perfected certain security interest
granted in the assets and collateral of the Company and its Subsidiaries described in the Security Documents. To the extent that the Investor
has not perfected the security interest granted in the assets and collateral of the Company and its Subsidiaries as described in the Security
Agreement, then, at the expense of the Company, the Company and its Subsidiaries shall immediately take all steps necessary and required
to perfect the Investors&rsquo; security interest in the assets and collateral of the Company and its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Post
Closing Matters Agreement</U>. The Company must have executed and delivered to the Investor the Post Closing Matters Agreement, substantially
in the form set out in <U>Exhibit C</U>; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Funds
Flow Request</U>. The Company shall have delivered to the Investor a flow of funds request, substantially in the form set out in <U>Exhibit
D</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Conditions
Precedent to the Obligations of the Company</U>. The obligation of the Company to issue the Note at the Closing is subject to the satisfaction
or waiver by the Company, at or before such Closing, of each of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Warranties</U>. The representations and warranties of the Investor contained herein shall be true and correct in all material respects
as of the date when made and as of such Closing Date as though made on and as of such date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Performance</U>.
The Investor shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required
by the Transaction Documents to be performed, satisfied or complied with by the Investor at or prior to the Closing; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Injunction</U>. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions
contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>7.</B></TD><TD STYLE="text-align: justify"><U>EVENTS OF DEFAULT</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Events
of Default</U>. The occurrence of any of the following events shall be an &ldquo;<B>Event of Default</B>&rdquo; under this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;an
Event of Default under the Note;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
of the representations or warranties made by the Company, any Private Subsidiary or any of their agents, officers, directors, employees
or representatives in any Transaction Document or public filing being inaccurate, false or misleading in any material respect, as of the
date as of which it is made or deemed to be made, or any certificate or financial or other written statements furnished by or on behalf
of the Company or any Subsidiary to the Investor or any of its representatives, is inaccurate, false or misleading, in any material respect,
as of the date as of which it is made or deemed to be made, or on any Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
failure by the Company to comply with any of its covenants or agreements set forth in this Agreement, including but not limited to those
set forth in <U>Section 5.7</U>, <U>Section 5.13</U>, <U>Section 6.1(k)</U>, and <U>Section 10</U>; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
default or breach, in any material respect, under the Post Closing Matters Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Investor
Right to Investigate an Event of Default</U>. If in the Investor&rsquo;s reasonable opinion, an Event of Default has occurred, or is or
may be continuing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Investor may notify the Company that it wishes to investigate such purported Event of Default;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company shall cooperate with the Investor in such investigation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company shall comply with all reasonable requests made by the Investor to the Company in connection with any investigation by the Investor
and shall (i) provide all information requested by the Investor in relation to the Event of Default to the Investor; provided that the
Investor agrees that any materially price sensitive information and/or non-public information will be subject to confidentiality, and
(ii) provide all such requested information within five (5) Business Days of such request; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company shall pay all reasonable costs incurred by the Investor in connection with any such investigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>7.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Remedies
Upon an Event of Default</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
an Event of Default occurs pursuant to <U>Section 7.1(a)</U>, the Investor shall have such remedies as are set forth in the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
an Event of Default occurs pursuant to <U>Section 7.1(b)</U> or <U>Section 7.1(c)</U> and is not remedied within ten (10) Business Days,
the Investor may declare, by notice to the Company or the applicable Subsidiary, as applicable, effective immediately, all outstanding
obligations by the Company or the applicable Subsidiary, as applicable, under the Transaction Documents to be immediately due and payable
in immediately available funds and the Investor shall have no obligation to consummate any Closing under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
any Event of Default occurs and is not remedied within ten (10) Business Days, the Investor may, by written notice to the Company, terminate
this Agreement effective as of the date set forth in the Investor&rsquo;s notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>8.</B></TD><TD STYLE="text-align: justify"><U>TERMINATION</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>8.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Events
of Termination</U>. This Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;may
be terminated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.8in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
the majority in interest of the Investors on the occurrence or existence of a Securities Termination Event or a Change of Control pursuant
to subsection (c) or (d) contained in that definition;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.8in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
the mutual written consent of the Company and the majority in interest of the Investors, at any time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.8in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
either party, by written notice to the other Parties, effective immediately, if the Closing has not occurred within fifteen (15) Business
Days of the date of this Agreement or such later date as the Company and the majority in interest of the Investors agree in writing, provided
that the right to terminate this Agreement under this <U>Section 8.1(a)(iii)</U> is not available to any party that is in material breach
of or material default under this Agreement or whose failure to fulfill any obligation under this Agreement has been the principal cause
of, or has resulted in the failure of the Closing to occur; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.8in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;by
the majority in interest of the Investors, in accordance with <U>Section 7.3(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>8.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Automatic
Termination</U>. This Agreement will automatically terminate, without further action by the parties, at the time after the Closing that
the Principal Amount outstanding under the Note and any accrued but unpaid interest is reduced to zero (0), whether as a result of prepayment
or repayment by the Company in accordance with the terms of this Agreement and the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>8.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Effect
of Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to <U>Section 8.3(b)</U>, each party&rsquo;s right of termination under <U>Section 8.1</U> is in addition to any other rights it may have
under this Agreement or otherwise, and the exercise of a right of termination will not be an election of remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the Investor terminates this Agreement under <U>Section 8.1(a)(i)</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.8in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Investor may declare, by notice to the Company, all outstanding obligations by the Company under the Transaction Documents to be due and
payable (including, without limitation, the immediate repayment of any Principal Amount outstanding under the Note plus accrued but unpaid
interest) without presentment, demand, protest or any other notice of any kind, all of which are expressly waived by the Company, anything
to the contrary contained in this Agreement or in any other Transaction Document notwithstanding; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.8in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company must within five (5) Business Days of such notice being received, pay to the Investor in immediately available funds the outstanding
Principal Amount for the Note plus all accrued interest thereon (if any), unless the Investor terminates this Agreement as a result of
an Event of Default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.4in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nothing
in this Agreement will be deemed to release any party from any liability for any breach by such party of the terms and provisions of this
Agreement or to impair the right of any party to compel specific performance by any other party of its obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>9.</B></TD><TD STYLE="text-align: justify"><U>RESERVED.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><B>10.</B></TD><TD STYLE="text-align: justify"><U>GENERAL PROVISIONS</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Fees
and Expenses</U>. The Company has paid by wire transfer to the Investor&rsquo;s legal counsel, McDermott Will &amp; Emery LLP (&ldquo;<B>Investor
Counsel</B>&rdquo;), cash in the amount of Seventy-Five Thousand Dollars ($75,000) for legal services. At the Closing, the Company shall
pay any reasonable expenses and disbursements incurred by Investor Counsel in connection with the preparation of the Transaction Documents,
it being understood that Investor Counsel has not rendered any legal advice to the Company in connection with the transactions contemplated
hereby and that the Company has relied for such matters on the advice of its own counsel. Following the Closing, the Company shall reimburse
the Investor for all reasonable fees and disbursements of Investor Counsel in connection with any additional agreements arising pursuant
to the transactions contemplated in this Agreement, including, but not limited to, intercreditor agreements relating to the Note and any
agreements or documentation required with respect to the Investor&rsquo;s exercise of any of its rights hereunder. Except as specified
above, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses
incurred by such party incident to the negotiation, preparation, execution, delivery and performance of the Transaction Documents. The
Company shall pay all stamp and other Taxes and duties levied in connection with the sale of the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.2&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Appointment
of Collateral Agent</U>. The Investor agrees to the appointment of Esousa Group Holdings, LLC, an Investor in the Notes, to act as Collateral
Agent and further each Investor authorizes Esousa Group Holdings, LLC to act as Collateral Agent in accordance with the terms and conditions
detailed in the Security Agreement, executed and delivered on the date hereof, by and between the Company and Esousa Group Holdings, LLC.
The Collateral Agent shall receive a fee of $25,000, as more fully detailed in that certain Fee Letter executed and delivered in connection
with this Agreement and the Security Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Consultation
with Counsel</U>. Each Investor has had the opportunity to seek independent counsel and to consult with counsel in order to review the
Transaction Documents and to advise the Company with respect thereto before executing this Agreement. Each Investor is executing this
Agreement without duress or coercion and without reliance on any representations, warranties or commitments other than those representations,
warranties, and commitments set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via email
at the email address specified in this <U>Section 10.4</U> prior to 5:00 p.m. (New York time) on a Business Day, (b) the next Business
Day after the date of transmission, if such notice or communication is delivered via email at the email address specified in this Section
on a day that is not a Business Day or later than 5:00 p.m. (New York time) on any date and earlier than 11:59 p.m. (New York time) on
such date, (c) the Business Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (d)
upon actual receipt by the party to whom such notice is required to be given. Any and all notices or other communications or deliveries
to be provided by the Company hereunder shall be in writing and delivered personally, by email or facsimile, or sent by a nationally recognized
overnight courier service addressed to each Investor at the email address, facsimile number, or address of the Investor appearing on the
books of the Company, or if no such email address, facsimile number, or address appears on the books of the Company, at the principal
place of business of such Investor set forth on the Investor&rsquo;s signature page attached hereto. The address for such notices and
communications shall be as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">William B. Horne<BR>
Chief Executive Officer<BR>
BitNile Holdings, Inc.<BR>
11411 Southern Highlands Parkway, Suite 240<BR>
Las Vegas, Nevada 89141<BR>
Direct:<BR>
Email:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">With a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Henry Nisser<BR>
President and General Counsel<BR>
BitNile Holdings, Inc.<BR>
100 Park Avenue, 16th Floor<BR>
Suite 1658A<BR>
New York, NY 10017<BR>
Direct:<BR>
Email:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Severability</U>.
If any provision of this Agreement is held by a court of competent jurisdiction to be excessive in scope or otherwise invalid or unenforceable,
such provision shall be adjusted rather than voided, if possible, so that it is enforceable to the maximum extent possible, and the validity
and enforceability of the remaining provisions of this Agreement will not in any way be affected or impaired thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Governing
Law</U>. This Agreement shall be governed by and construed in accordance with the Laws of the State of New York, without reference to
principles of conflict of laws or choice of laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Jurisdiction
and Venue</U>. Any action, proceeding or claim arising out of, or relating in any way to this Agreement shall be brought and enforced
in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York. The Company
and the Investor irrevocably submit to the jurisdiction of such courts, which jurisdiction shall be exclusive, and hereby waive any objection
to such exclusive jurisdiction or that such courts represent an inconvenient forum. The prevailing party in any such action shall be entitled
to recover its reasonable and documented attorneys&rsquo; fees and out-of-pocket expenses relating to such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>WAIVER
OF RIGHT TO JURY TRIAL</U>. THE COMPANY AND THE INVESTOR HEREBY IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW,
ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE OTHER TRANSACTION DOCUMENTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Survival</U>.
The representations, warranties, agreements and covenants contained herein shall survive the Closing and the delivery of the Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.10&nbsp;&nbsp;&nbsp;</B><U>Entire
Agreement</U>. The Transaction Documents, together with the Exhibits and Schedules thereto, contain the entire understanding of the parties
with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written, with respect to such
matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.11&nbsp;&nbsp;&nbsp;</B><U>Amendments;
Waivers</U>. No provision of this Agreement may be waived or amended except in a written instrument signed by the Company and the Investor.
No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing
waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall
any delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.12&nbsp;&nbsp;&nbsp;</B><U>Construction</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the parties to express their
mutual intent, and no rules of strict construction will be applied against any party. This Agreement shall be construed as if drafted
jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship
of any provisions of this Agreement or any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.13&nbsp;&nbsp;&nbsp;</B><U>Successors
and Assigns</U>. This Agreement shall be binding upon, and inure to the benefit of and be enforceable by, the Company and the Investor
and their respective successors and assigns. The Company may not assign this Agreement or any rights or obligations hereunder without
the prior written consent of the Investor. The Investor may assign any or all of its rights under this Agreement to any Person to whom
the Investor assigns or transfers any the Note, provided such transferee agrees in writing to be bound, with respect to the transferred
Note, by the provisions hereof that apply to the &ldquo;Investor&rdquo; and such transferee is an accredited investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.14&nbsp;&nbsp;&nbsp;</B><U>No
Third-Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted
assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.15&nbsp;&nbsp;&nbsp;</B><U>Further
Assurances</U>. Each party hereto shall do and perform, or cause to be done and performed, all such further acts and things, and shall
execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order
to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.16&nbsp;&nbsp;&nbsp;&nbsp;</B><U>Counterparts</U>.
This Agreement may be executed in two identical counterparts, both of which shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the other party. Signature pages delivered by facsimile or
e-mail shall have the same force and effect as an original signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.17&nbsp;&nbsp;&nbsp;</B><U>Specific
Performance</U>. The Company acknowledges that monetary damages alone would not be adequate compensation to the Investor for a breach
by the Company of this Agreement and the Investor may seek an injunction or an order for specific performance from a court of competent
jurisdiction if (a) the Company fails to comply or threatens not to comply with this Agreement or (b) the Investor has reason to believe
that the Company will not comply with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">[Signature Page
Follows]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have executed this Securities Purchase Agreement as of the date first set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>COMPANY:</B></P>
</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BITNILE HOLDINGS, INC.</P>
</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 61%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:</TD>
    <TD>William B. Horne</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">REMAINDER OF PAGE INTENTIONALLY LEFT BLANK<BR>
[SIGNATURE PAGE FOR THE INVESTORS FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>INVESTOR SIGNATURE PAGES TO BITNILE HOLDINGS, INC. SECURITIES PURCHASE
AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IN WITNESS WHEREOF, the undersigned has caused
this Securities Purchase Agreement to be duly executed by its authorized signatory as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Investor:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%">Signature of Authorized Signatory of Investor:</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 45%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name of Authorized Signatory:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title of Authorized Signatory:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Email Address of Authorized Signatory:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Facsimile Number of Authorized Signatory:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Address for Notice to Investor:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Subscription Amount:&#9;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>EIN Number:___________________</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>With a copy (which shall not constitute notice) to:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">30</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>ex10_2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>SECURITY AGREEMENT</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <B>PLEDGE AND SECURITY
AGREEMENT</B>, dated as of December 16, 2022 (this &ldquo;<B><U>Agreement</U></B>&rdquo;), is made by <B>BITNILE HOLDINGS, INC</B>., a
Delaware corporation (the &ldquo;<B><U>Company</U></B>&rdquo;, and collectively with each Person listed as a &ldquo;Grantor&rdquo; on
the signature pages hereto (together with each other Person that executes a joinder agreement and becomes a &ldquo;Grantor&rdquo; hereunder
or otherwise guaranties all or any part of the Secured Obligations, each a &ldquo;<B><U>Grantor</U></B>&rdquo; and, collectively with
the Company, the &ldquo;<B><U>Grantors</U></B>&rdquo;) and <B>ESOUSA GROUP HOLDINGS, LLC</B>, a New York limited liability company (&ldquo;<B>Esousa</B>&rdquo;),
in its capacity as collateral agent for the Secured Parties referred to below (in such capacity, together with its successors and assigns
in such capacity, if any, the &ldquo;<B><U>Collateral Agent</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>RECITALS:</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the Securities Purchase Agreement, dated as of the date hereof (such agreement, as amended, restated, supplemented, modified or otherwise
changed from time to time, including any replacement agreement therefor, being herein referred to as the &ldquo;<B><U>Purchase Agreement</U></B>&rdquo;),
by and among the Company, the investors from time to time party thereto (each a <B><U>&ldquo;Investor</U></B>&rdquo; and collectively,
the &ldquo;<B><U>Investors</U></B>&rdquo;), and the Collateral Agent, the Investors have agreed to purchase certain Senior Secured Promissory
Notes dated on or about the date hereof (each a &ldquo;<B><U>Note</U></B>&rdquo; and collectively, the &ldquo;<B><U>Notes</U></B>&rdquo;)
from the Company.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It
is a condition precedent to the Investors purchasing the Notes from the Company pursuant to the Purchase Agreement that each Grantor grants
to the Collateral Agent, for the benefit of the Secured Parties, a security interest in and lien on all of the Collateral.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Grantors are mutually dependent on each other in the conduct of their respective businesses as an integrated operation, with credit needed
from time to time by each Grantor often being provided through financing obtained by the other Grantors and the ability to obtain such
financing being dependent on the successful operations of all of the Grantors as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor has determined that the execution, delivery and performance of this Agreement directly benefit, and are in the best interest of,
such Grantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the premises and the agreements herein and in order to induce the Collateral Agent and the Investors to purchase the Notes and to provide
other financial accommodations to the Company pursuant to the Purchase Agreement, the Grantors hereby jointly and severally agree with
the Collateral Agent, for the benefit of the Secured Parties, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reference
is hereby made to the Purchase Agreement for a statement of the terms thereof. All capitalized terms used in this Agreement and the recitals
hereto which are defined in the Purchase Agreement or in Article 8 or 9 of the Uniform Commercial Code as in effect from time to time
in the State of New York (the &ldquo;<B>Code</B>&rdquo;) and which are not otherwise defined herein shall have the same meanings herein
as set forth therein; provided that terms used herein which are defined in the Code as in effect in the State of New York on the date
hereof shall continue to have the same meaning notwithstanding any replacement or amendment of such statute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">  </TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following terms shall have the respective meanings provided for in the Code: &ldquo;Accounts&rdquo;, &ldquo;Account Debtor&rdquo;, &ldquo;Cash
Proceeds&rdquo;, &ldquo;Certificate of Title&rdquo;, &ldquo;Chattel Paper&rdquo;, &ldquo;Commercial Tort Claim&rdquo;, &ldquo;Commodity
Account&rdquo;, &ldquo;Commodity Contracts&rdquo;, &ldquo;Deposit Account&rdquo;, &ldquo;Documents&rdquo;, &ldquo;Electronic Chattel
Paper&rdquo;, &ldquo;Equipment&rdquo;, &ldquo;Fixtures&rdquo;, &ldquo;General Intangibles&rdquo;, &ldquo;Goods&rdquo;, &ldquo;Instruments&rdquo;,
&ldquo;Inventory&rdquo;, &ldquo;Investment Property&rdquo;, &ldquo;Letter-of-Credit Rights&rdquo;, &ldquo;Noncash Proceeds&rdquo;, &ldquo;Payment
Intangibles&rdquo;, &ldquo;Proceeds&rdquo;, &ldquo;Promissory Notes&rdquo;, &ldquo;Record&rdquo;, &ldquo;Security Account&rdquo;, &ldquo;Software&rdquo;,
&ldquo;Supporting Obligations&rdquo; and &ldquo;Tangible Chattel Paper&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
used in this Agreement, the following terms shall have the respective meanings indicated below, such meanings to be applicable equally
to both the singular and plural forms of such terms:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Additional Collateral</U></B>&rdquo;
has the meaning specified therefor in <U>Section 4(a)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Copyrights</U></B>&rdquo;
means any and all rights in any published and unpublished works of authorship, including (i) copyrights and moral rights, (ii) copyright
registrations and recordings thereof and all applications in connection therewith including those listed on <U>Schedule II</U> and all
renewals, extensions, restorations and reversions thereof, (iii) income, license fees, royalties, damages, and payments now and hereafter
due or payable under and with respect thereto, including payments under all licenses entered into in connection therewith and damages
and payments for past, present, or future infringements thereof, (iv) the right to sue for past, present, and future infringements thereof,
and (v) all of each Grantor&rsquo;s rights corresponding thereto throughout the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Event of Default</U></B>&rdquo;
has the meaning given to such term in the Purchase Agreement and the Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Existing Issuer</U></B>&rdquo;
has the meaning specified therefor in the definition of the term &ldquo;Pledged Shares&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Intellectual
Property</U></B>&rdquo; means any and all Patents, Copyrights, Trademarks, trade secrets, know-how, inventions (whether or not patentable),
algorithms, software programs (including source code and object code), processes, product designs, industrial designs, blueprints, drawings,
data, customer lists, URLs and domain names, specifications, documentations, reports, catalogs, literature, and any other forms of technology
or proprietary information of any kind, including all rights therein and all applications for registration or registrations thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Licenses</U></B>&rdquo;
means, with respect to any Person (the &ldquo;<B><U>Specified Party</U></B>&rdquo;), (i) any licenses or other similar rights provided
to the Specified Party in or with respect to Intellectual Property owned or controlled by any other Person, and (ii) any licenses or other
similar rights provided to any other Person in or with respect to Intellectual Property owned or controlled by the Specified Party, in
each case, including (A) any software license agreements (other than license agreements for commercially available off-the- shelf software
that is generally available to the public which have been licensed to a Grantor pursuant to end-user licenses), (B) the license agreements
listed on <U>Schedule III</U>, and (C) the right to use any of the licenses or other similar rights described in this definition in connection
with the enforcement of any of the Collateral Agent&rsquo;s and the Investors&rsquo; rights under the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Lien</U></B>&rdquo;
means any lien, encumbrance, claim, charge, pledge, security interest, assignment, hypothecation, deed of trust, mortgage, lease, conditional
sale, retention of title or other preferential arrangement having substantially the same economic effect as any of the foregoing, whether
voluntary, involuntary or imposed by Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Patents</U></B>&rdquo;
means patents and patent applications, including (i) the patents and patent applications listed on Schedule IV, (ii) all continuations,
divisionals, continuations-in-part, re-examinations, reissues, and renewals thereof and improvements thereon, (iii) all income, royalties,
damages and payments now and hereafter due or payable under and with respect thereto, including payments under all licenses entered into
in connection therewith and damages and payments for past, present, or future infringements thereof, (iv) the right to sue for past, present,
and future infringements thereof, and (v) all of each Grantor&rsquo;s rights corresponding thereto throughout the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Permitted Liens</U></B>&rdquo;
mean (1) Liens and security interests securing Indebtedness owed by a Grantor to any other Grantor, provided that such Indebtedness is
subordinate to the Secured Obligations and such Liens are second in priority to the Liens of the Agent; (2) liens for taxes, assessments,
or similar charges either not yet due or being contested in good faith; (3) liens of materialmen, mechanics, warehousemen, or carriers,
or other like liens arising in the ordinary course of business on an arms&rsquo; length basis and securing obligations which are not yet
delinquent; (4) purchase money liens or purchase money security interests upon or in any property acquired or held by a Grantor in the
ordinary course of business to secure Indebtedness outstanding on the date of this Agreement or permitted to be incurred under this Agreement;
(5) Liens which, as of the date of this Agreement, have been disclosed to and approved by the Agent on behalf of the Investors in writing;
and (6) those Liens which in the aggregate constitute an immaterial and insignificant monetary amount with respect to the net value of
the Grantors&rsquo; assets, taken as a whole, in any event not exceeding $25,000in any single instance or $100,000 in the aggregate outstanding
at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Pledged Debt</U></B>&rdquo;
means the indebtedness described in <U>Schedule X</U> and all indebtedness from time to time owned or acquired by a Grantor, the promissory
notes and other Instruments evidencing any or all of such indebtedness, and all interest, cash, Instruments, Investment Property, financial
assets, securities, Equity Interests, other equity interests, stock options and commodity contracts, notes, debentures, bonds, promissory
notes or other evidences of indebtedness and all other property from time to time received, receivable or otherwise distributed in respect
of or in exchange for any or all of such indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Pledged Interests</U></B>&rdquo;
means, collectively, (a) the Pledged Debt, (b) the Pledged Shares and (c) all security entitlements in any and all of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Pledged Issuer</U></B>&rdquo;
has the meaning specified therefor in the definition of the term &ldquo;Pledged Shares&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Pledged Shares</U></B>&rdquo;
means (a) the shares of Equity Interests described in <U>Schedule XI</U>, whether or not evidenced or represented by any stock certificate,
certificated security or other Instrument, issued by the Persons described in such <U>Schedule XI</U> (the &ldquo;<B><U>Existing Issuers</U></B>&rdquo;),
(b) the shares of Equity Interests at any time and from time to time acquired by a Grantor of any and all Persons now or hereafter existing
(such Persons, together with the Existing Issuers, being hereinafter referred to collectively as the &ldquo;<B><U>Pledged Issuers</U></B>&rdquo;
and each individually as a &ldquo;<B><U>Pledged Issuer</U></B>&rdquo;), whether or not evidenced or represented by any stock certificate,
certificated security or other Instrument, and (c) the certificates representing such shares of Equity Interests, all options and other
rights, contractual or otherwise, in respect thereof and all dividends, distributions, cash, Instruments, Investment Property, financial
assets, securities, Equity Interests, other equity interests, stock options and commodity contracts, notes, debentures, bonds, promissory
notes or other evidences of indebtedness and all other property (including without limitation, any stock dividend and any distribution
in connection with a stock split) from time to time received, receivable or otherwise distributed in respect of or in exchange for any
or all of such Equity Interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Post-Closing
Agreement</U></B>&rdquo; means the Post-Closing Agreement of even date herewith between the Agent and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Secured Obligations</U></B>&rdquo;
has the meaning specified therefor in <U>Section 3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Secured Parties</U></B>&rdquo;
means the Agent, for itself and on behalf of the Investors, and the Investors, and each of their successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Titled Collateral</U></B>&rdquo;
means all Collateral for which the title to such Collateral is governed by a Certificate of Title or certificate of ownership, including
without limitation, all motor vehicles (including without limitation, all trucks, trailers, tractors, service vehicles, automobiles and
other mobile equipment) for which the title to such motor vehicles is governed by a Certificate of Title or certificate of ownership.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Trademarks</U></B>&rdquo;
means any and all trademarks, trade names, registered trademarks, trademark applications, service marks, registered service marks, brand
names, certification marks, collective marks, logos, symbols, trade dress, assumed names, fictitious names and service mark applications,
including (i) the trade names, registered trademarks, trademark applications, registered service marks and service mark applications listed
on <U>Schedule V</U>, (ii) all extensions, modifications and renewals thereof, (iii) all income, royalties, damages and payments now and
hereafter due or payable under and with respect thereto, including payments under all licenses entered into in connection therewith and
damages and payments for past or future infringements or dilutions thereof, (iv) the right to sue for past, present and future infringements
and dilutions thereof, (v) the goodwill of each Grantor&rsquo;s business symbolized by the foregoing or connected therewith, and (vi)
all of each Grantor&rsquo;s rights corresponding thereto throughout the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Transaction Documents</U></B>&rdquo;
has the meaning given to such term in the Purchase Agreement and the Notes, and includes this Agreement and any Security Agreement Supplement,
as any of such documents may be amended, restated, supplemented, modified or otherwise changed from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant of
Security Interest</U>. As collateral security for the payment, performance and observance of all of the Secured Obligations, each Grantor
hereby pledges and assigns to the Collateral Agent (and its agents and designees), and grants to the Collateral Agent (and its agents
and designees), for itself and the benefit of the other Secured Parties, a continuing security interest in the following personal property
of such Grantor, wherever located and whether now or hereafter existing and whether now owned or hereafter acquired, (all being collectively
referred to herein as the &ldquo;<B><U>Collateral</U></B>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Twelve
thousand (12,000) Antminers, including: (a) all additions, replacements of and substitutions for all or any part of the foregoing property;
(b) all records and data and embedded software relating to the foregoing property; and (c) all Proceeds including all Cash Proceeds and
Noncash Proceeds (including any insurance proceeds), and products of any and all of the foregoing Collateral thereof (collectively, the
&ldquo;<B>Mining Collateral</B>&rdquo;). The Mining Collateral shall not include any Bitcoin mined from the Mining Collateral. The serial
numbers of the miners that constitute the Mining Collateral are and, in the future, shall be set forth on <U>Schedule XII</U> hereto,
which may be amended from time to time by the Grantors to add additional miners upon prior written notice to the Collateral Agent, and
may be amended from time to time to remove miners upon ten (10) days prior written notice to, and the consent of, the Collateral Agent.
The parties agree that on the date hereof <U>Schedule XII</U> lists eleven thousand eight hundred pieces of Mining Collateral and that
not later than five days after the date hereof, <U>Schedule XII</U> will be updated by the Grantors to include an additional 200 pieces
of Mining Collateral;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to the assets set forth in clause (a) above, a security interest in the following assets of the Grantors (other than Bitnile,
Inc.) except for (A) marketable securities, investments and other property having a value of not more than $10 million held in E*Trade
Securities LLC Account No. 5061-2587, (B) the securities of Mullen Automotive Inc., a Delaware corporation (&ldquo;<B>Mullen</B>&rdquo;),
purchased by Ault Lending, LLC in the Second Closing (as defined in the Mullen Agreement referred to below) for $8,181,819.00 (the &ldquo;<B>Purchased
Securities</B>&rdquo;) pursuant to the Amendment No. 3 to Securities Purchase Agreement, effective November 15, 2022, by and among Mullen,
Ault Lending, LLC and the other purchaser signatories thereto (the &ldquo;<B>Mullen Agreement</B>&rdquo;), (C) any other securities of
Mullen that the Purchased Securities are convertible into or exchangeable or excisable for (collectively with the Purchased Securities,
the &ldquo;<B>Mullen Securities</B>&rdquo;), and (D) all Proceeds from the Mullen Securities (collectively, (A) &ndash; (D) are referred
to as the &ldquo;<B>Excluded Assets</B>&rdquo;), which Excluded Assets are subject to an existing security agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Accounts;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Chattel Paper (whether tangible or electronic);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Commercial Tort Claims, including without limitation, those specified on <U>Schedule IX</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Deposit Accounts, all cash, and all other property from time to time deposited therein or otherwise credited thereto and the monies and
property in the possession or under the control of the Collateral Agent or any Investor or any Affiliate, representative, agent or correspondent
of the Collateral Agent or any Investor;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
General Intangibles (including without limitation, all Payment Intangibles, Intellectual Property and Licenses);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Goods, including without limitation, all Equipment, Fixtures and Inventory;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Instruments (including without limitation, Promissory Notes);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Investment Property;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Letter-of-Credit Rights;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Pledged Interests;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Supporting Obligations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
other tangible and intangible personal property of the Grantors (other than Bitnile, Inc.) (whether or not subject to the Code), including
without limitation, all bank and other accounts and all cash and all investments therein, all proceeds, products, offspring, accessions,
rents, profits, income, benefits, substitutions and replacements of and to any of the property of such Grantor described in the preceding
clauses of this <U>Section 2</U> (including without limitation, any proceeds of insurance thereon and all causes of action, claims and
warranties now or hereafter held by such Grantor in respect of any of the items listed above), and all books, correspondence, files and
other Records, including without limitation, all tapes, disks, cards, Software, data and computer programs in the possession or under
the control of such Grantor or any other Person from time to time acting for such Grantor that at any time evidence or contain information
relating to any of the property described in the preceding clauses of this Section 2 or are otherwise necessary or helpful in the collection
or realization thereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
Proceeds, including all Cash Proceeds and Noncash Proceeds, and products of any and all of the foregoing Collateral;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">in each case howsoever such Grantor&rsquo;s interest
therein may arise or appear (whether by ownership, security interest, claim or otherwise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Security
for Secured Obligations</U>. The security interest created under this Agreement, including under Section 2, in the Collateral constitutes
continuing collateral security for all of the following obligations, whether now existing or hereafter incurred (the &ldquo;<B><U>Secured
Obligations</U></B>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
prompt payment by each Grantor, as and when due and payable (whether by scheduled maturity, required prepayment, acceleration, demand
or otherwise), of all amounts from time to time owing by it in respect of the Purchase Agreement, the Notes and any other Transaction
Documents, including without limitation, (i) all obligations of the Company to pay the &ldquo;Principal Amount&rdquo; under the Notes
and make and fulfill any other repayment obligations as to the principal thereunder, (ii) in the case of a Grantor, all amounts from
time to time owing by such Grantor in respect of its guaranty made pursuant to this Agreement or under any other guaranty to which it
is a party, including without limitation, all obligations guaranteed by such Grantor and (iii) all interest, fees, commissions, charges,
expense reimbursements, indemnifications and all other amounts due or to become due under any Note or other Transaction Document (including
without limitation, all interest, fees, commissions, charges, expense reimbursements, indemnifications and other amounts that accrue
after the commencement of any Insolvency Proceeding of any Grantor, whether or not the payment of such interest, fees, commissions, charges,
expense reimbursements, indemnifications and other amounts are unenforceable or are not allowable, in whole or in part, due to the existence
of such Insolvency Proceeding); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
due performance and observance by each Grantor of all of its other obligations from time to time existing in respect of the Purchase
Agreement, the Notes and any other Transaction Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">provided that, when the Notes
have been indefeasibly paid in full pursuant to their terms, the term &ldquo;Secured Obligations&rdquo; shall not include any of the
foregoing obligations under the Purchase Agreement or any other Transaction Documents, and any remaining obligations under such Transaction
Documents shall no longer be secured hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery
of the Pledged Interests</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)
All promissory notes currently evidencing the Pledged Debt and all certificates currently representing the Pledged Shares shall be delivered
to the Collateral Agent, subject to the Post-Closing Agreement, on or prior to the execution and delivery of this Agreement. All other
promissory notes, certificates and Instruments constituting Pledged Interests from time to time required to be pledged to the Collateral
Agent pursuant to the terms of this Agreement or the Purchase Agreement (the &ldquo;<B><U>Additional Collateral</U></B>&rdquo;) shall
be delivered to the Collateral Agent promptly upon, but in any event within five days of, receipt thereof by or on behalf of any of the
Grantors. All such promissory notes, certificates and Instruments shall be held by or on behalf of the Collateral Agent pursuant hereto
and shall be delivered in suitable form for transfer by delivery or shall be accompanied by duly executed instruments of transfer or
assignment or undated stock powers executed in blank, all in form and substance reasonably satisfactory to the Collateral Agent. If any
Pledged Interest consists of uncertificated securities, unless the immediately following sentence is applicable thereto, such Grantor
shall cause the Collateral Agent (or its designated custodian or nominee) to become the registered holder thereof, or cause each issuer
of such securities to agree, so long as this Agreement is effective, that it will comply with instructions originated by the Collateral
Agent with respect to such securities without further consent by such Grantor. If any Pledged Interest consists of security entitlements,
such Grantor shall transfer such security entitlements to the Collateral Agent (or its custodian, nominee or other designee), or cause
the applicable securities intermediary to agree that it will comply with entitlement orders by the Collateral Agent without further consent
by such Grantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Within
five days of the receipt by a Grantor of any Additional Collateral, a Pledge Amendment, duly executed by such Grantor, in substantially
the form of Exhibit A hereto (a &ldquo;<B><U>Pledge Amendment</U></B>&rdquo;), shall be delivered to the Collateral Agent, in respect
of the Additional Collateral that must be pledged pursuant to this Agreement and the Purchase Agreement. The Pledge Amendment shall from
and after delivery thereof constitute part of <U>Schedules X</U>. Each Grantor hereby authorizes the Collateral Agent to attach each
Pledge Amendment to this Agreement and agrees that all promissory notes, certificates or Instruments listed on any Pledge Amendment delivered
to the Collateral Agent shall for all purposes hereunder constitute Pledged Interests and such Grantor shall be deemed upon delivery
thereof to have made the representations and warranties set forth in <U>Section 5</U> with respect to such Additional Collateral.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
any Grantor shall receive, by virtue of such Grantor&rsquo;s being or having been an owner of any Pledged Interests, any (i) stock certificate
(including without limitation, any certificate representing a stock dividend or distribution in connection with any increase or reduction
of capital, reclassification, merger, consolidation, sale of assets, combination of shares, stock split, spin-off or split-off), promissory
note or other Instrument, (ii) option or right, whether as an addition to, substitution for, or in exchange for, any Pledged Interests,
or otherwise, (iii) dividends payable in cash (except such dividends permitted to be retained by any such Grantor pursuant to <U>Section
7</U>) or in securities or other property or (iv) dividends, distributions, cash, Instruments, Investment Property and other property
in connection with a partial or total liquidation or dissolution or in connection with a reduction of capital, capital surplus or paid-in
surplus, such Grantor shall receive such stock certificate, promissory note, Instrument, option, right, payment or distribution in trust
for the benefit of the Collateral Agent, shall segregate it from such Grantor&rsquo;s other property and shall deliver it forthwith to
the Collateral Agent, in the exact form received, with any necessary indorsement and appropriate stock powers duly executed in blank,
to be held by the Collateral Agent as Pledged Interests and as further collateral security for the Secured Obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Warranties</U>. Each Grantor represents and warrants as of the date of this Agreement or any applicable Security Agreement Supplement
to which it is a party as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Schedule
I</U> sets forth (i) the exact legal name of each Grantor, (ii) the state or jurisdiction of organization of each Grantor, (iii) the
type of organization of each Grantor and (iv) the organizational identification number of each Grantor or states that no such organizational
identification number exists.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as disclosed in the Public Record, there is no pending or, to the knowledge of any Grantor, written notice threatening action, suit,
proceeding or claim before any court or other Governmental Entity or any arbitrator, or any order, judgment or award by any court or
other Governmental Entity or any arbitrator, that may adversely affect the grant by any Grantor, or the perfection, of the security interest
purported to be created hereby in the Collateral, or the exercise by the Collateral Agent of any of its rights or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
Equipment, Fixtures, Inventory and other Goods included within the definition of Collateral now existing are, and all Equipment, Fixtures,
Inventory and other Goods included within the definition of Collateral hereafter existing will be, located at the addresses specified
therefor in <U>Schedule VI</U> (as amended, supplemented or otherwise modified from time to time in accordance with <U>Section 6(b)</U>).
Each Grantor&rsquo;s chief place of business and chief executive office, the place where such Grantor keeps its Records concerning Accounts
included within the definition of Collateral and all originals of all Chattel Paper included within the definition of Collateral are located
at the addresses specified therefor in <U>Schedule VI</U> (as amended, supplemented or otherwise modified from time to time in accordance
with the terms hereof). None of the Accounts included within the definition of Collateral is evidenced by Promissory Notes or other Instruments.
Set forth in <U>Schedule VII</U> is a complete and accurate list, as of the date of this Agreement, of each Deposit Account included within
the definition of Collateral, together with the name and address of each institution at which each such Account is maintained, the account
number for each such Account and a description of the purpose of each such Account. Set forth in <U>Schedule V</U> is (i) a complete and
correct list of each trade name used by each Grantor and (ii) the name of, and each trade name used by, each Person from which such Grantor
has acquired any substantial part of the Collateral within five years of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the Effective Date, (i) <U>Schedule II</U> provides a complete and correct list of all registered Copyrights included within the definition
of Collateral owned by any Grantor, all applications for registration of Copyrights included within the definition of Collateral owned
by any Grantor, and all other Copyrights owned by any Grantor and material to the conduct of the business of any Grantor; (ii) <U>Schedule
III</U> provides a complete and correct list of all Licenses included within the definition of Collateral entered into by any Grantor
pursuant to which (A) any Grantor has provided any license or other rights in Intellectual Property owned or controlled by such Grantor
to any other Person other than non-exclusive software licenses granted in the ordinary course of business or (B) any Person has granted
to any Grantor any license or other rights in Intellectual Property owned or controlled by such Person that is material to the business
of such Grantor; (iii) <U>Schedule IV</U> provides a complete and correct list of all Patents included within the definition of Collateral
owned by any Grantor and all applications for Patents included within the definition of Collateral owned by any Grantor; and (iv) <U>Schedule
V</U> provides a complete and correct list of all registered Trademarks included within the definition of Collateral owned by any Grantor,
all applications for registration of Trademarks included within the definition of Collateral owned by any Grantor, and all other Trademarks
included within the definition of Collateral owned by any Grantor and material to the conduct of the business of any Grantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)
(A) each Grantor owns, or holds licenses in, or otherwise possesses legally enforceable rights in, all Intellectual Property that is reasonably
necessary to the operation of its business as currently conducted, and (B) each Grantor is the sole and exclusive owner of Intellectual
Property (free and clear of any Liens other than Permitted Liens) used by it and has sole and exclusive rights to the use and distribution
therefor or the material covered thereby in connection with the services or products in respect of which such Intellectual Property are
currently being used, sold, licensed or distributed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
for those claims which could not reasonably be expected to result in a Material Adverse Effect and which the applicable Grantor is diligently
pursuing the remedy thereof, no claims with respect to the Intellectual Property rights of any Grantor constituting Collateral are pending
or, to the knowledge of such Grantor, threatened against such Grantor or, to the knowledge of any Grantor, any other Person, (i) alleging
that the manufacture, sale, licensing or use of such Intellectual Property as now manufactured, sold, licensed or used by any Grantor
or any third party infringes on any intellectual property rights of any third party, (ii) against the use by such Grantor or any third
party of any technology, know-how or computer software used in such Grantor&rsquo;s business as currently conducted or (iii) challenging
the ownership by such Grantor, or the validity or effectiveness, of any such Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the knowledge of any Grantor, (i) no Grantor has infringed on any intellectual property rights of any third party and (ii) none of the
Intellectual Property rights of any Grantor constituting Collateral infringes on any intellectual property rights of any third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
registered Copyrights, registered Trademarks, and issued Patents that are owned by any Grantor and necessary in the conduct of its business
are valid, subsisting and enforceable and have at all times been in compliance with all laws, rules, regulations, and orders of any Governmental
Entity applicable thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor has taken reasonable steps to maintain the confidentiality of and otherwise protect and enforce its rights in all trade secrets
owned by such Grantor that are necessary in the business of such Grantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
than software which by the terms of its own license explicitly permits the licensee to distribute the software together with other commercial
programs with no restrictions on such Grantor&rsquo;s ability to charge fees for such distribution and with no restriction on such Grantor&rsquo;s
right to receive payments for transfer of its Intellectual Property, no open source or public library software, including any version
of any software licensed pursuant to any GNU public license, is, in whole or in part, embodied or incorporated, in any manner, in any
Grantor&rsquo;s software products that is licensed or distributed by such Grantor. No open source or public library software licensed
pursuant to any GNU public license which requires any Grantor to license such Grantor&rsquo;s software products to third parties, or any
other license which requires such Grantor to license such Grantor&rsquo;s software products to third parties, is embodied or incorporated,
in any manner, in such Grantor&rsquo;s source code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Pledged Shares have been duly authorized and validly issued and are fully paid and nonassessable and the holders thereof are not entitled
to any preemptive, first refusal or other similar rights. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
promissory notes currently evidencing the Pledged Debt have been, and all other promissory notes from time to time evidencing Pledged
Debt, when executed and delivered, will have been, duly authorized, executed and delivered by the respective makers thereof, and all
such promissory notes are or will be, as the case may be, legal, valid and binding obligations of such makers, enforceable against such
makers in accordance with their respective terms, except as such enforceability may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium or other similar Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Grantors are and will be at all times the sole and exclusive owners of, or otherwise have and will have adequate rights in, the Collateral
free and clear of any Lien, except for Permitted Liens. No effective financing statement or other instrument similar in effect covering
all or any part of the Collateral is on file in any recording or filing office, except such as are securing Permitted Liens as of the
date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
exercise by the Collateral Agent of any of its rights and remedies hereunder will not contravene any Law or any contractual restriction
binding on or otherwise affecting any Grantor or any of its properties and will not result in, or require the creation of, any Lien upon
or with respect to any of its properties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
authorization or approval or other action by, and no notice to or filing with, any Governmental Entity or any other Person (other than
those that have been obtained and are in full force and effect) is required for (i) the due execution, delivery and performance by any
Grantor of this Agreement, (ii) the grant by any Grantor of the security interest purported to be created hereby in the Collateral or
(iii) the exercise by the Collateral Agent of any of its rights and remedies hereunder, except, in the case of this clause (iii), as
may be required in connection with any sale of any Pledged Interests by Laws affecting the offering and sale of securities generally,
except for (A) the filing under the Uniform Commercial Code as in effect in the applicable jurisdiction of the financing statements described
in <U>Schedule VIII</U> and (B) such control account agreements required to perfect the Liens hereunder, as may be subject to Section
6(l) and the Post-Closing Agreement. No authorization or approval or other action by, and no notice to or filing with, any Governmental
Entity or any other Person, is required for the perfection of the security interest purported to be created hereby in the Collateral
(other than those that have been obtained and are in full force and effect), except (A) for the filing under the Uniform Commercial Code
as in effect in the applicable jurisdiction of the financing statements described in <U>Schedule VIII</U>, (B) such control account agreements
required to perfect the Liens hereunder, as may be subject to Section 6(l) and the Post-Closing Agreement, (C) with respect to the perfection
of the security interest created hereby in the United States Intellectual Property and Licenses, for the recording of the appropriate
Assignment for Security, substantially in the form of Exhibit B hereto in the United States Patent and Trademark Office or the United
States Copyright Office, as applicable, (D) with respect to the perfection of the security interest created hereby in Titled Collateral,
for the submission of an appropriate application requesting that the Lien of the Collateral Agent be noted on the Certificate of Title
or certificate of ownership, completed and authenticated by the applicable Grantor, together with the Certificate of Title or certificate
of ownership, with respect to such Titled Collateral, to the appropriate Governmental Entity, (E) with respect to any action that may
be necessary to obtain control of Collateral constituting Deposit Accounts, Electronic Chattel Paper, Investment Property or Letter-of-Credit
Rights, the taking of such actions, and (F) the Collateral Agent&rsquo;s having possession of all Documents, Chattel Paper, Instruments
and cash constituting Collateral (subclauses (A), (B), (C), (D), (E), and (F), each a &ldquo;<B><U>Perfection Requirement</U></B>&rdquo;
and collectively, the &ldquo;<B><U>Perfection Requirements</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement creates a legal, valid and enforceable security interest in favor of the Collateral Agent, for the benefit of the Secured Parties,
in the Collateral, as security for the Secured Obligations. The compliance with the Perfection Requirements result in the perfection
of such security interests. Such security interests are, or in the case of Collateral in which any Grantor obtains rights after the date
hereof, will be, perfected, first priority security interests subject only to Permitted Liens and the Perfection Requirements. Such Perfection
Requirements and all other action necessary or desirable to perfect and protect such security interest have been duly made or taken,
except for (i) the Collateral Agent&rsquo;s having possession of all Instruments, Documents, Chattel Paper and cash constituting Collateral
after the date hereof, (ii) the Collateral Agent&rsquo;s having control of all Deposit Accounts (subject to Section 6(l)), Electronic
Chattel Paper, Investment Property or Letter-of-Credit Rights constituting Collateral after the date hereof, and (iii) the other filings
and recordations and actions described in Section 5(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the date hereof, no Grantor holds any Commercial Tort Claims or is aware of any such pending claims, except for such claims described
in <U>Schedule IX</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With
respect to each Grantor and its Subsidiaries that is a partnership or a limited liability company, each such Person has irrevocably opted
into (and has caused each of its Subsidiaries that is a partnership or a limited liability company, and a Pledged Issuer to opt into)
Article 8 of the Uniform Commercial Code. Such interests are securities for purposes of Article 8 of any relevant Uniform Commercial
Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Covenants
as to the Collateral</U>. So long as any of the Secured Obligations (whether or not due) shall remain unpaid, unless the Collateral Agent
shall otherwise consent in writing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Further
Assurances</U>. Each Grantor will at its expense, at any time and from time to time, promptly execute and deliver all further instruments
and documents and take all further action that may be necessary or desirable or that the Collateral Agent may request in order (i) to
perfect and protect, or maintain the perfection of, the security interest and Lien purported to be created hereby; (ii) to enable the
Collateral Agent to exercise and enforce its rights and remedies hereunder in respect of the Collateral; or (iii) otherwise to effect
the purposes of this Agreement, including without limitation: (A) marking conspicuously all Chattel Paper, Instruments and Licenses and,
at the request of the Collateral Agent, all of its Records pertaining to the Collateral with a legend, in form and substance satisfactory
to the Collateral Agent, indicating that such Chattel Paper, Instrument, License or Collateral is subject to the security interest created
hereby, (B) if any Account shall be evidenced by a Promissory Note or other Instrument or Chattel Paper, delivering and pledging to the
Collateral Agent such Promissory Note, other Instrument or Chattel Paper, duly endorsed and accompanied by executed instruments of transfer
or assignment, all in form and substance satisfactory to the Collateral Agent, (C) executing and filing (to the extent, if any, that
such Grantor&rsquo;s signature is required thereon) or authenticating the filing of, such financing or continuation statements, or amendments
thereto, (D) with respect to Intellectual Property hereafter existing and not covered by an appropriate security interest grant, the
executing and recording in the United States Patent and Trademark Office or the United States Copyright Office, as applicable, appropriate
instruments granting a security interest, as may be necessary or desirable or that the Collateral Agent may reasonably request in order
to perfect and preserve the security interest purported to be created hereby, (E) delivering to the Collateral Agent irrevocable proxies
in respect of the Pledged Interests, (F) furnishing to the Collateral Agent from time to time statements and schedules further identifying
and describing the Collateral and such other reports in connection with the Collateral as the Collateral Agent may reasonably request,
all in reasonable detail, (G) if at any time after the date hereof, any Grantor (other than Bitnile, LLC) acquires or holds any Commercial
Tort Claim with a maximum potential value in excess of $100,000, promptly notifying the Collateral Agent in a writing signed by such
Grantor setting forth a brief description of such Commercial Tort Claim and granting to the Collateral Agent a security interest therein
and in the proceeds thereof, which writing shall incorporate the provisions hereof and shall be in form and substance satisfactory to
the Collateral Agent, (H) upon the acquisition after the date hereof by any Grantor of any Titled Collateral, promptly notifying the
Collateral Agent of such acquisition, setting forth a description of the Titled Collateral acquired and a good faith estimate of the
current value of such Titled Collateral, and if so requested by the Collateral Agent, promptly causing the Collateral Agent to be listed
as the lienholder on such Certificate of Title or certificate of ownership and delivering evidence of the same to the Collateral Agent,
and (I) taking all actions required by Law in any relevant Uniform Commercial Code jurisdiction, or by other Law as applicable in any
foreign jurisdiction. Except in accordance with this Agreement, no Grantor shall take or fail to take any action which would in any manner
impair the validity or enforceability of the Collateral Agent&rsquo;s security interest in and Lien on any Collateral.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Location
of Equipment and Inventory</U>. Each Grantor will keep the Equipment and Inventory (other than Equipment and Inventory sold in the ordinary
course of business in accordance with <U>Section 6(h)</U>) at the locations specified in <U>Schedule VI</U> or, upon not less than 30
days&rsquo; prior written notice to the Collateral Agent accompanied by a new <U>Schedule VI</U> indicating each new location of the
Equipment and Inventory, at such other locations in the continental United States as the Grantors may elect, <U>provided</U> that (i)
all action has been taken to grant to the Collateral Agent a perfected, first priority security interest in such Equipment and Inventory,
and (ii) the Collateral Agent&rsquo;s rights in such Equipment and Inventory, including without limitation, the existence, perfection
and priority of the security interest created hereby in such Equipment and Inventory, are not adversely affected thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Condition
of Equipment</U>. Each Grantor will maintain or cause the Equipment which is necessary or useful in the proper conduct of its business
to be maintained and preserved in good condition, repair and working order and in accordance with any manufacturer&rsquo;s manual, ordinary
wear and tear excepted, and will forthwith, or in the case of any loss or damage to any Equipment promptly after the occurrence thereof,
make or cause to be made all repairs, replacements and other improvements in connection therewith which are necessary or desirable, consistent
with past practice, or which the Collateral Agent may reasonably request to such end. Each Grantor will promptly furnish to the Collateral
Agent a statement describing in reasonable detail any loss or damage in excess of $50,000 to any Equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Taxes,
Etc</U>. Each Grantor jointly and severally agrees to pay promptly when due all property and other taxes, assessments and governmental
charges or levies imposed upon, and all claims (including claims for labor, materials and supplies) against, the Equipment and Inventory,
except to the extent the validity thereof is being contested in good faith by proper proceedings which stay the imposition of any penalty,
fine or Lien resulting from the non-payment thereof and with respect to which adequate reserves in accordance with GAAP have been set
aside for the payment thereof, or otherwise provided in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Insurance</U>.
Each Grantor will, at its own expense, maintain insurance with respect to the Collateral in accordance with the terms of the Purchase
Agreement. Each Grantor will, if so requested by the Collateral Agent, deliver to the Collateral Agent original or duplicate insurance
policies and, as often as the Collateral Agent may reasonably request, a report of a reputable insurance broker with respect to such
insurance. Each Grantor will also, at the request of the Collateral Agent, execute and deliver instruments of assignment of such insurance
policies and cause the respective insurers to acknowledge notice of such assignment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Provisions
Concerning the Accounts and the Licenses</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor will, except as otherwise provided in this subsection (f), continue to collect, at its own expense, all amounts due or to become
due under the Accounts. In connection with such collections, each Grantor may (and, at the Collateral Agent&rsquo;s direction, will)
take such action as such Grantor (or, if applicable, the Collateral Agent) may deem necessary or advisable to enforce collection or performance
of the Accounts; provided, however, that the Collateral Agent shall have the right at any time, upon the occurrence and during the continuance
of an Event of Default, to notify the Account Debtors or obligors under any Accounts of the assignment of such Accounts to the Collateral
Agent and to direct such Account Debtors or obligors to make payment of all amounts due or to become due to such Grantor thereunder directly
to the Collateral Agent or its designated agent and, upon such notification and at the expense of such Grantor and to the extent permitted
by Law, to enforce collection of any such Accounts and to adjust, settle or compromise the amount or payment thereof, in the same manner
and to the same extent as such Grantor might have done. After receipt by any Grantor of a notice from the Collateral Agent that the Collateral
Agent has notified, intends to notify, or has enforced or intends to enforce a Grantor&rsquo;s rights against the Account Debtors or
obligors under any Accounts as referred to in the proviso to the immediately preceding sentence, (A) all amounts and proceeds (including
Instruments) received by such Grantor in respect of the Accounts shall be received in trust for the benefit of the Collateral Agent hereunder,
shall be segregated from other funds of such Grantor and shall be forthwith paid over to the Collateral Agent or its designated agent
in the same form as so received (with any necessary endorsement) to be held as cash collateral and applied as specified in Section 9(d),
and (B) such Grantor will not adjust, settle or compromise the amount or payment of any Account or release wholly or partly any Account
Debtor or obligor thereof or allow any credit or discount thereon. In addition, upon the occurrence and during the continuance of an
Event of Default, the Collateral Agent may (in its sole and absolute discretion) direct any or all of the banks and financial institutions
with which any Grantor either maintains a Deposit Account or a lockbox or deposits the proceeds of any Accounts to send promptly to the
Collateral Agent or its designated agent by wire transfer (to such account as the Collateral Agent shall specify, or in such other manner
as the Collateral Agent shall direct) all or a portion of such securities, cash, investments and other items held by such institution.
Any such securities, cash, investments and other items so received by the Collateral Agent or its designated agent shall (in the sole
and absolute discretion of the Collateral Agent) be held as additional Collateral for the Secured Obligations or distributed in accordance
with <U>Section 9</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the occurrence and during the continuance of any breach or default under any material License by any party thereto other than a Grantor,
(A) the relevant Grantor will, promptly after obtaining knowledge thereof, give the Collateral Agent written notice of the nature and
duration thereof, specifying what action, if any, it has taken and proposes to take with respect thereto, (B) no Grantor will, without
the prior written consent of the Collateral Agent, which consent shall not be unreasonably withheld, delayed or conditioned, declare
or waive any such breach or default or affirmatively consent to the cure thereof or exercise any of its remedies in respect thereof,
and (C) each Grantor will, upon written instructions from the Collateral Agent and at such Grantor&rsquo;s expense, take such action
as the Collateral Agent may reasonably deem necessary or advisable in respect thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor will, at its expense, promptly deliver to the Collateral Agent a copy of each notice or other communication received by it by
which any other party to any material License (A) declares a breach or default by a Grantor of any material term thereunder, (B) terminates
such License or (C) purports to exercise any of its rights or affect any of its obligations thereunder, together with a copy of any reply
by such Grantor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor will exercise promptly and diligently each and every right which it may have under each material License (other than any right
of termination) and will duly perform and observe in all respects all of its obligations under each material License and will take all
action reasonably necessary to maintain the Licenses in full force and effect. No Grantor will, without the prior written consent of
the Collateral Agent, cancel, terminate, amend or otherwise modify in any respect, or waive any provision of, any material License.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Provisions
Concerning the Pledged Interests</U>. Each Grantor will</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;at
the Grantors&rsquo; joint and several expense, promptly deliver to the Collateral Agent a copy of each notice or other communication
received by it in respect of the Pledged Interests;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;at
the Grantors&rsquo; joint and several expense, defend the Collateral Agent&rsquo;s right, title and security interest in and to the Pledged
Interests against the claims of any Person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;not
make or consent to any material amendment or other material modification or waiver with respect to any Pledged Interests or enter into
any agreement or permit to exist any restriction with respect to any Pledged Interests (other than as permitted under the Transaction
Documents); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;not
permit the issuance of (A) any additional shares of any class of Equity Interests of any Pledged Issuer, (B) any securities convertible
voluntarily by the holder thereof or automatically upon the occurrence or non-occurrence of any event or condition into, or exchangeable
for, any such shares of Equity Interests or (C) any warrants, options, contracts or other commitments entitling any Person to purchase
or otherwise acquire any such shares of Equity Interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfers
and Other Liens</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Grantor will sell, assign (by operation of Law or otherwise), lease, license, exchange or otherwise transfer or dispose of any of the
Collateral, without the prior written consent of the Collateral Agent, except for transactions conducted in the ordinary course of business
(which shall not include any real property), including the sale of securities the proceeds of which remain in a Deposit Account or Security
Account subject to a control account agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Grantor will create, suffer to exist or grant any Lien upon or with respect to any Collateral, other than a Permitted Lien.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Intellectual
Property</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the request of the Collateral Agent, in order to facilitate filings with the United States Patent and Trademark Office and the United
States Copyright Office, each Grantor shall execute and deliver to the Collateral Agent one or more Copyright Security Agreements, Trademark
Security Agreements, or Patent Security Agreements to further evidence the Collateral Agent&rsquo;s Lien on such Grantor&rsquo;s Patents,
Trademarks, or Copyrights, and the General Intangibles of such Grantor relating thereto or represented thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor shall have the duty, with respect to Intellectual Property that is necessary in the conduct of such Grantor&rsquo;s business,
to protect and diligently enforce and defend at such Grantor&rsquo;s expense its Intellectual Property, including (A) to diligently enforce
and defend, including, where it is commercially reasonable to, promptly suing for infringement, misappropriation, or dilution and to
recover any and all damages for such infringement, misappropriation, or dilution, and filing for opposition, interference, and cancellation
against conflicting Intellectual Property rights of any Person, (B) to prosecute diligently any material trademark application or service
mark application that is part of the Trademarks pending as of the date hereof or hereafter until the termination of this Agreement, (C)
to prosecute diligently any material patent application that is part of the Patents pending as of the date hereof or hereafter until
the termination of this Agreement, (D) to take all reasonable and necessary action to preserve and maintain all of such Grantor&rsquo;s
Trademarks, Patents, Copyrights, Licenses, and its rights therein, including paying all maintenance fees and filing of applications for
renewal, affidavits of use, and affidavits of noncontestability, and (E) to require all employees, consultants, and contractors of each
Grantor who were involved in the creation or development of such Intellectual Property to sign agreements containing assignment of Intellectual
Property rights and obligations of confidentiality. Each Grantor further agrees not to abandon any Intellectual Property or Intellectual
Property License that is necessary in the conduct of such Grantor&rsquo;s business. Each Grantor hereby agrees to take the steps described
in this Section 6(i)(ii) with respect to all new or acquired Intellectual Property to which it or any of its Subsidiaries is now or later
becomes entitled that is necessary in the conduct of such Grantor&rsquo;s business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Grantors
acknowledge and agree that the Secured Parties shall have no duties with respect to any Intellectual Property or Licenses of any Grantor.
Without limiting the generality of this <U>Section 6(i)(iii)</U>, Grantors acknowledge and agree that no Secured Party shall be under
any obligation to take any steps necessary to preserve rights in the Collateral consisting of Intellectual Property or Licenses against
any other Person, but any Secured Party may do so at its option from and after the occurrence and during the continuance of an Event
of Default, and all expenses incurred in connection therewith (including reasonable fees and expenses of attorneys and other professionals)
shall be for the sole account of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor shall promptly file an application with the United States Copyright Office for any Copyright that has not been registered with
the United States Copyright Office if such Copyright is necessary in connection with the conduct of such Grantor&rsquo;s business. Any
expenses incurred in connection with the foregoing shall be borne by the Grantors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor shall provide the Collateral Agent with a written report of all new Patents or Trademarks that are registered or the subject
of pending applications for registrations, and of all Licenses that are material to the conduct of such Grantor&rsquo;s business, in
each case, which were acquired, registered, or for which applications for registration were filed by any Grantor or entered into during
the prior period and any statement of use or amendment to allege use with respect to intent-to-use trademark applications. In the case
of such registrations or applications therefor, which were acquired by any Grantor, each such Grantor shall file the necessary documents
with the appropriate Governmental Entity identifying the applicable Grantor as the owner (or as a co-owner thereof, if such is the case)
of such Intellectual Property. In each of the foregoing cases, the applicable Grantor shall promptly cause to be prepared, executed,
and delivered to the Collateral Agent supplemental schedules to the applicable Transaction Documents to identify such Patent and Trademark
registrations and applications therefor (with the exception of Trademark applications filed on an intent-to-use basis for which no statement
of use or amendment to allege use has been filed) and Licenses as being subject to the security interests created thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Anything
to the contrary in this Agreement notwithstanding, in no event shall any Grantor, either itself or through any agent, employee, licensee,
or designee, file an application for the registration of any Copyright with the United States Copyright Office or any similar office
or agency in another country without giving the Collateral Agent written notice thereof at least three Business Days prior to such filing
and complying with <U>Section 6(i)(i)</U>. Upon receipt from the United States Copyright Office of notice of registration of any Copyright,
each Grantor shall promptly (but in no event later than three Business Days following such receipt) notify (but without duplication of
any notice required by <U>Section 6(i)(v)</U>) the Collateral Agent of such registration by delivering, or causing to be delivered, to
the Collateral Agent, documentation sufficient for the Collateral Agent to perfect the Collateral Agent&rsquo;s Liens on such Copyright.
If any Grantor acquires from any Person any Copyright registered with the United States Copyright Office or an application to register
any Copyright with the United States Copyright Office, such Grantor shall promptly (but in no event later than five Business Days following
such acquisition) notify the Collateral Agent of such acquisition and deliver, or cause to be delivered, to the Collateral Agent, documentation
sufficient for the Collateral Agent to perfect the Collateral Agent&rsquo;s Liens on such Copyright. In the case of such Copyright registrations
or applications therefor which were acquired by any Grantor, each such Grantor shall promptly (but in no event later than five Business
Days following such acquisition) file the necessary documents with the appropriate Governmental Entity identifying the applicable Grantor
as the owner (or as a co-owner thereof, if such is the case) of such Copyrights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor shall take reasonable steps to maintain the confidentiality of, and otherwise protect and enforce its rights in, the Intellectual
Property that is necessary in the conduct of such Grantor&rsquo;s business, including as applicable (A) protecting the secrecy and confidentiality
of its confidential information and trade secrets by having and enforcing a policy requiring all current employees, consultants, licensees,
vendors and contractors with access to such information to execute appropriate confidentiality agreements; (B) taking actions reasonably
necessary to ensure that no trade secret falls into the public domain; and (C) protecting the secrecy and confidentiality of the source
code of all software programs and applications of which it is the owner or licensee by having and enforcing a policy requiring any licensees
(or sublicensees) of such source code to enter into license agreements with commercially reasonable use and non-disclosure restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Grantor shall enter into any Intellectual Property License to receive any license or rights in any Intellectual Property of any other
Person unless such Grantor has used commercially reasonable efforts to permit the assignment of or grant of a security interest in such
Intellectual Property License (and all rights of Grantor thereunder) to the Collateral Agent (and any transferees of the Collateral Agent).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Deposit,
Commodities and Securities Accounts</U>. Each Grantor shall cause each bank and other financial institution with an account referred
to in Schedule VII to execute and deliver to the Collateral Agent (or its designee), subject to Section 6(l) and the Post-Closing Agreement,
a control agreement, in form and substance satisfactory to the Collateral Agent, duly executed by such Grantor and such bank or financial
institution, or enter into other arrangements in form and substance satisfactory to the Collateral Agent, pursuant to which such institution
shall irrevocably agree, among other things, that (i) it will comply at any time with the instructions originated by the Collateral Agent
(or its designee) to such bank or financial institution directing the disposition of cash, Commodity Contracts, securities, Investment
Property and other items from time to time credited to such account, without further consent of such Grantor, which instructions the
Collateral Agent (or its designee) will not give to such bank or other financial institution in the absence of a continuing Event of
Default and which the Collateral Agent (or its designee) will immediately withdraw if no Event of Default is continuing, (ii) all cash,
Commodity Contracts, securities, Investment Property and other items of such Grantor deposited with such institution shall be subject
to a perfected, first priority security interest in favor of the Collateral Agent (or its designee), (iii) any right of set off (other
than recoupment of standard fees), banker&rsquo;s Lien or other similar Lien, security interest or encumbrance shall be fully waived
as against the Collateral Agent (or its designee), and (iv) upon receipt of written notice from the Collateral Agent during the continuance
of an Event of Default, such bank or financial institution shall promptly send to the Collateral Agent (or its designee) by wire transfer
(to such account as the Collateral Agent (or its designee) shall specify, or in such other manner as the Collateral Agent (or its designee)
shall direct) all such cash, the value of any Commodity Contracts, securities, Investment Property and other items held by it, provided,
however, that arrangements will be made to allow any derivative contracts to be fulfilled. Without the prior written consent of the Collateral
Agent, no Grantor shall make or maintain any Deposit Account, Commodity Account or Securities Account except for the accounts set forth
in Schedule VII. The provisions of this Section 6(j) shall not apply to Excluded Accounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Titled
Collateral</U>. At the request of the Collateral Agent, each Grantor shall (a) cause all Collateral, now owned or hereafter acquired
by any Grantor, which under applicable Law are required to be registered and has a value in excess of $25,000, to be properly registered
in the name of such Grantor, (b) cause all Titled Collateral with a value in excess of $25,000, to be properly titled in the name of
such Grantor, and if requested by the Collateral Agent, with the Collateral Agent&rsquo;s Lien noted thereon and (c) if requested by
the Collateral Agent, promptly deliver to the Collateral Agent (or its custodian) originals of all such Certificates of Title or certificates
of ownership for such Titled Collateral a value in excess of $25,000, with the Collateral Agent&rsquo;s Lien noted thereon, and take
such other actions as may be reasonably required by the Collateral Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Control</U>.
Each Grantor hereby agrees to take any or all action that may be necessary or desirable or that the Collateral Agent may request in order
for the Collateral Agent to obtain control in accordance with Sections 9-104, 9-105, 9-106, and 9-107 of the Code with respect to the
following Collateral: (i) Deposit Accounts, (ii) Securities Accounts (other than solely containing Excluded Assets), (iii) Electronic
Chattel Paper, (iv) Investment Property and (v) Letter-of-Credit Rights. Each Grantor hereby acknowledges and agrees that any agent or
designee of the Collateral Agent shall be deemed to be a &ldquo;secured party&rdquo; with respect to the Collateral under the control
of such agent or designee for all purposes. Notwithstanding anything in this Agreement to the contrary, so long as no Event of Default
has occurred and is then continuing, the Grantors shall not be required to maintain a control account agreement for the benefit of the
Agent in respect of any Deposit Account that contains $25,000, individually, or $100,000, in the aggregate, or less in cash at any time;
provided that any Deposit Account may contain in excess of $25,000/$100,000 for a period not to exceed two Business Days, so long as
Grantors are making diligent efforts to transfer such cash or securities to a Deposit Account that is subject to a control account agreement,
or obtain a deposit account control agreement covering such Deposit Account or Security Account within such applicable period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Records;
Inspection and Reporting</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor shall keep adequate records concerning the Accounts, Chattel Paper and Pledged Interests. Each Grantor shall permit the Collateral
Agent, or any agents or representatives thereof or such professionals or other Persons as the Collateral Agent may designate (A) to examine
and make copies of and abstracts from such Grantor&rsquo;s books and records, (B) to visit and inspect its properties, (C) to verify
materials, leases, notes, Accounts, Inventory and other assets of such Grantor from time to time, (D) to conduct audits, appraisals and
valuations or examinations at the locations of such Grantor and (E) to discuss such Grantor&rsquo;s affairs, finances and accounts with
any of its directors, officers, managerial employees, independent accountants or any of its other representatives, and otherwise as provided
in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Grantor shall, without the prior written consent of the Collateral Agent, which consent shall not be unreasonably withheld, delayed or
conditioned, change (A) its name, identity or organizational structure, (B) its jurisdiction of incorporation or organization as set
forth in <U>Schedule I</U> or (C) its chief executive office as set forth in Schedule VI. Each Grantor shall promptly notify the Collateral
Agent upon obtaining an organizational identification number, if on the date hereof such Grantor did not have such identification number.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Voting
Rights, Dividends, Etc. in Respect of the Pledged Interests</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;So
long as no Event of Default shall have occurred and be continuing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;each
Grantor may exercise any and all voting and other consensual rights pertaining to any Pledged Interests for any purpose not inconsistent
with the terms of this Agreement, the Purchase Agreement, the Notes or the other Transaction Documents; <U>provided</U>, <U>however</U>,
that (A) each Grantor will give the Collateral Agent at least five Business Days&rsquo; notice of the manner in which it intends to exercise,
or the reasons for refraining from exercising, any such right that could reasonably be expected to adversely affect in any material respect
the value, liquidity or marketability of any Collateral or the creation, perfection and priority of the Collateral Agent&rsquo;s Lien;
and (B) none of the Grantors will exercise or refrain from exercising any such right, as the case may be, if the Collateral Agent gives
a Grantor notice that, in the Collateral Agent&rsquo;s reasonable judgment, such action (or inaction) could reasonably be expected to
adversely affect in any material respect the value, liquidity or marketability of any Collateral or the creation, perfection and priority
of the Collateral Agent&rsquo;s Lien; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;each
of the Grantors may receive and retain any and all dividends, interest or other distributions paid in respect of the Pledged Interests
to the extent permitted by the Transaction Documents; <U>provided</U>, <U>however</U>, that any and all (A) dividends and interest paid
or payable other than in cash in respect of, and Instruments and other property received, receivable or otherwise distributed in respect
of or in exchange for, any Pledged Interests and (B) cash paid, payable or otherwise distributed in redemption of, or in exchange for,
any Pledged Interests, together with any dividend, interest or other distribution or payment which at the time of such payment was not
permitted by the Transaction Documents, shall be, and shall forthwith be delivered to the Collateral Agent, to hold as, Pledged Interests
and shall, if received by any of the Grantors, be received in trust for the benefit of the Collateral Agent, shall be segregated from
the other property or funds of the Grantors, and shall be forthwith delivered to the Collateral Agent in the exact form received with
any necessary indorsement and appropriate stock powers duly executed in blank, to be held by the Collateral Agent as Pledged Interests
and as further collateral security for the Secured Obligations; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Collateral Agent will execute and deliver (or cause to be executed and delivered) to a Grantor all such proxies and other instruments
as such Grantor may reasonably request for the purpose of enabling such Grantor to exercise the voting and other rights which it is entitled
to exercise pursuant to <U>Section 7(a)(i)</U> and to receive the dividends, interest or other distributions which it is authorized to
receive and retain pursuant to <U>Section 7(a)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the occurrence and during the continuance of an Event of Default:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
rights of each Grantor to exercise the voting and other consensual rights which it would otherwise be entitled to exercise pursuant to
<U>Section 7(a)(i)</U>, and to receive the dividends, distributions, interest and other payments that it would otherwise be authorized
to receive and retain pursuant to <U>Section 7(a)(ii)</U>, shall cease, and all such rights shall thereupon become vested in the Collateral
Agent, which shall thereupon have the sole right (but not the obligation) to exercise such voting and other consensual rights and to
receive and hold as Pledged Interests such dividends, distributions and interest payments;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Collateral Agent is authorized to notify each debtor with respect to the Pledged Debt to make payment directly to the Collateral Agent
(or its designee) and may collect any and all moneys due or to become due to any Grantor in respect of the Pledged Debt, and each of
the Grantors hereby authorizes each such debtor to make such payment directly to the Collateral Agent (or its designee) without any duty
of inquiry;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;without
limiting the generality of the foregoing, the Collateral Agent may at its option exercise any and all rights of conversion, exchange,
subscription or any other rights, privileges or options pertaining to any of the Pledged Interests as if it were the absolute owner thereof,
including without limitation, the right to exchange, in its discretion, any and all of the Pledged Interests upon the merger, consolidation,
reorganization, recapitalization or other adjustment of any Pledged Issuer, or upon the exercise by any Pledged Issuer of any right,
privilege or option pertaining to any Pledged Interests, and, in connection therewith, to deposit and deliver any and all of the Pledged
Interests with any committee, depository, transfer agent, registrar or other designated agent upon such terms and conditions as it may
determine; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;all
dividends, distributions, interest and other payments that are received by any of the Grantors contrary to the provisions of <U>Section
7(b)(i)</U> shall be received in trust for the benefit of the Collateral Agent, shall be segregated from other funds of the Grantors,
and shall be forthwith paid over to the Collateral Agent as Pledged Interests in the exact form received with any necessary indorsement
and appropriate stock powers duly executed in blank, to be held by the Collateral Agent as Pledged Interests and as further collateral
security for the Secured Obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Additional
Provisions Concerning the Collateral</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the maximum extent permitted by applicable Law, and for the purpose of taking any action that the Collateral Agent may deem necessary
or advisable to accomplish the purposes of this Agreement, each Grantor hereby (i) authorizes the Collateral Agent to execute any such
agreements, instruments or other documents in such Grantor&rsquo;s name and to file such agreements, instruments or other documents in
such Grantor&rsquo;s name and in any appropriate filing office, (ii) authorizes the Collateral Agent at any time and from time to time
to file, one or more financing or continuation statements and amendments thereto, relating to the Collateral (including without limitation,
any such financing statements that (A) describe the Collateral as &ldquo;all assets&rdquo; or &ldquo;all personal property&rdquo; (or
words of similar effect) or that describe or identify the Collateral by type or in any other manner as the Collateral Agent may determine,
regardless of whether any particular asset of such Grantor falls within the scope of Article 9 of the Uniform Commercial Code or whether
any particular asset of such Grantor constitutes part of the Collateral, and (B) contain any other information required by Part 5 of
Article 9 of the Code for the sufficiency or filing office acceptance of any financing statement, continuation statement or amendment,
including without limitation, whether such Grantor is an organization, the type of organization and any organizational identification
number issued to such Grantor) and (iii) ratifies such authorization to the extent that the Collateral Agent has filed any such financing
statements, continuation statements, or amendments thereto, prior to the date hereof. A photocopy or other reproduction of this Agreement
or any financing statement covering the Collateral or any part thereof shall be sufficient as a financing statement where permitted by
Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor hereby irrevocably appoints the Collateral Agent as its attorney-in-fact and proxy, with full authority in the place and stead
of such Grantor and in the name of such Grantor or otherwise, from time to time in the Collateral Agent&rsquo;s discretion, to take any
action and to execute any instrument that the Collateral Agent may deem necessary or advisable to accomplish the purposes of this Agreement,
including without limitation, (i) to obtain and adjust insurance required to be paid to the Collateral Agent, (ii) to ask, demand, collect,
sue for, recover, compound, receive and give acquittance and receipts for moneys due and to become due under or in respect of any Collateral,
(iii) to receive, endorse, and collect any drafts or other Instruments, Documents and Chattel Paper in connection with clause (i) or
(ii) above, (iv) to receive, indorse and collect all Instruments made payable to such Grantor representing any dividend, interest payment
or other distribution in respect of any Pledged Interests and to give full discharge for the same, (v) to file any claims or take any
action or institute any proceedings which the Collateral Agent may deem necessary or desirable for the collection of any Collateral or
otherwise to enforce the rights of each Secured Party with respect to any Collateral, (vi) to execute assignments, licenses and other
documents to enforce the rights of each Secured Party with respect to any Collateral, (vii) to pay or discharge taxes or Liens levied
or placed upon or threatened against the Collateral, the legality or validity thereof and the amounts necessary to discharge the same
to be determined by the Collateral Agent in its sole discretion, and such payments made by the Collateral Agent to become Secured Obligations
of such Grantor to the Collateral Agent, due and payable immediately upon demand, and (viii) to sign and endorse any invoices, freight
or express bills, bills of lading, storage or warehouse receipts, assignments, verifications and notices in connection with Accounts,
Chattel Paper and other documents relating to the Collateral. This power is coupled with an interest and is irrevocable until the date
on which all of the Secured Obligations have been indefeasibly paid in full in cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the purpose of enabling the Collateral Agent to exercise rights and remedies hereunder, at such time as the Collateral Agent shall be
lawfully entitled to exercise such rights and remedies, and for no other purpose, each Grantor hereby (i) grants to the Collateral Agent
an irrevocable, non-exclusive license (exercisable without payment of royalty or other compensation to any Grantor) to use, assign, license
or sublicense any Intellectual Property now or hereafter owned by any Grantor, wherever the same may be located, including in such license
reasonable access to all media in which any of the licensed items may be recorded or stored and to all computer programs used for the
compilation or printout thereof; and (ii) assigns to the Collateral Agent, to the extent assignable, all of its rights to any Intellectual
Property now or hereafter licensed or used by any Grantor. Notwithstanding anything contained herein to the contrary, but subject to
the provisions of the Purchase Agreement that limit the right of a Grantor to dispose of its property and <U>Section 6(i)</U>, so long
as no Event of Default shall have occurred and be continuing, each Grantor may exploit, use, enjoy, protect, license, sublicense, assign,
sell, dispose of or take other actions with respect to the Intellectual Property in the ordinary course of its business. In furtherance
of the foregoing, unless an Event of Default shall have occurred and be continuing, the Collateral Agent shall from time to time, upon
the request of a Grantor, execute and deliver any instruments, certificates or other documents, in the form so requested, which such
Grantor shall have certified are appropriate (in such Grantor&rsquo;s judgment) to allow it to take any action permitted above (including
relinquishment of the license provided pursuant to this clause (c) as to any Intellectual Property). Further, upon the date on which
all of the Secured Obligations have been indefeasibly paid in full in cash, the Collateral Agent (subject to Section 14(e)) shall release
and reassign to the Grantors all of the Collateral Agent&rsquo;s right, title and interest in and to the Intellectual Property, and the
Licenses, all without recourse, representation or warranty whatsoever and at the Grantors&rsquo; sole expense. The exercise of rights
and remedies hereunder by the Collateral Agent shall not terminate the rights of the holders of any licenses or sublicenses theretofore
granted by any Grantor in accordance with the second sentence of this clause (c). Each Grantor hereby releases the Collateral Agent from
any claims, causes of action and demands at any time arising out of or with respect to any actions taken or omitted to be taken by the
Collateral Agent under the powers of attorney granted herein other than actions taken or omitted to be taken through the Collateral Agent&rsquo;s
gross negligence or willful misconduct, as determined by a final determination of a court of competent jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
any Grantor fails to perform any agreement or obligation contained herein, the Collateral Agent may itself perform, or cause performance
of, such agreement or obligation, in the name of such Grantor or the Collateral Agent, and the expenses of the Collateral Agent incurred
in connection therewith shall be jointly and severally payable by the Grantors pursuant to Section 10 and shall be secured by the Collateral.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
powers conferred on the Collateral Agent hereunder are solely to protect its interest in the Collateral and shall not impose any duty
upon it to exercise any such powers. Other than the exercise of reasonable care to assure the safe custody of any Collateral in its possession
and the accounting for moneys actually received by it hereunder, the Collateral Agent shall have no duty as to any Collateral or as to
the taking of any necessary steps to preserve rights against other parties or any other rights pertaining to any Collateral and shall
be relieved of all responsibility for any Collateral in its possession upon surrendering it or tendering surrender of it to any of the
Grantors (or whomsoever shall be lawfully entitled to receive the same or as a court of competent jurisdiction shall direct). The Collateral
Agent shall be deemed to have exercised reasonable care in the custody and preservation of any Collateral in its possession if such Collateral
is accorded treatment substantially equal to that which the Collateral Agent accords its own property, it being understood that the Collateral
Agent shall not have responsibility for ascertaining or taking action with respect to calls, conversions, exchanges, maturities, tenders
or other matters relating to any Collateral, whether or not the Collateral Agent has or is deemed to have knowledge of such matters.
The Collateral Agent shall not be liable or responsible for any loss or damage to any of the Collateral, or for any diminution in the
value thereof, by reason of the act or omission of any warehouseman, carrier, forwarding agency, consignee or other agent or bailee selected
by the Collateral Agent in good faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Anything
herein to the contrary notwithstanding (i) each Grantor shall remain liable under the Licenses and otherwise in respect of the Collateral
to the extent set forth therein to perform all of its obligations thereunder to the same extent as if this Agreement had not been executed,
(ii) the exercise by the Collateral Agent of any of its rights hereunder shall not release any Grantor from any of its obligations under
the Licenses or otherwise in respect of the Collateral, and (iii) the Collateral Agent shall not have any obligation or liability by
reason of this Agreement under the Licenses or otherwise in respect of the Collateral, nor shall the Collateral Agent be obligated to
perform any of the obligations or duties of any Grantor thereunder or to take any action to collect or enforce any claim for payment
assigned hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Collateral Agent may at any time in its discretion (i) without notice to any Grantor, transfer or register in the name of the Collateral
Agent or any of its nominees any or all of the Pledged Interests, and (ii) exchange certificates or Instruments constituting Pledged
Interests for certificates or Instruments of smaller or larger denominations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Remedies
Upon Default</U>. If any Event of Default shall have occurred and be continuing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Collateral Agent may exercise in respect of the Collateral, in addition to any other rights and remedies provided for herein or otherwise
available to it, all of the rights and remedies of a secured party upon default under the Code (whether or not the Code applies to the
affected Collateral), and also may (i) take absolute control of the Collateral, including without limitation, transfer into the Collateral
Agent&rsquo;s name or into the name of its nominee or nominees (to the extent the Collateral Agent has not theretofore done so) and thereafter
receive, for the benefit of each Secured Party, all payments made thereon, give all consents, waivers and ratifications in respect thereof
and otherwise act with respect thereto as though it were the outright owner thereof, (ii) require each Grantor to, and each Grantor hereby
agrees that it will at its expense and upon request of the Collateral Agent forthwith, assemble all or part of the Collateral as directed
by the Collateral Agent and make it available to the Collateral Agent at a place or places to be designated by the Collateral Agent that
is reasonably convenient to both parties, and the Collateral Agent may enter into and occupy any premises owned or leased by any Grantor
where the Collateral or any part thereof is located or assembled for a reasonable period in order to effectuate the Collateral Agent&rsquo;s
rights and remedies hereunder or under Law, without obligation to any Grantor in respect of such occupation, and (iii) without notice
except as specified below and without any obligation to prepare or process the Collateral for sale, (A) sell the Collateral or any part
thereof in one or more parcels at public or private sale, at any of the Collateral Agent&rsquo;s offices, at any exchange or broker&rsquo;s
board or elsewhere, for cash, on credit or for future delivery, and at such price or prices and upon such other terms as the Collateral
Agent may deem commercially reasonable or (B) lease, license or otherwise dispose of the Collateral or any part thereof upon such terms
as the Collateral Agent may deem commercially reasonable. Each Grantor agrees that, to the extent notice of sale or any other disposition
of the Collateral shall be required by Law, at least ten (10) days&rsquo; prior notice to the applicable Grantor of the time and place
of any public sale or the time after which any private sale or other disposition of the Collateral is to be made shall constitute reasonable
notification. The Collateral Agent shall not be obligated to make any sale or other disposition of Collateral regardless of notice of
sale having been given. The Collateral Agent may adjourn any public or private sale from time to time by announcement at the time and
place fixed therefor, and such sale may, without further notice, be made at the time and place to which it was so adjourned. Each Grantor
hereby waives any claims against each Secured Party arising by reason of the fact that the price at which the Collateral may have been
sold at a private sale was less than the price which might have been obtained at a public sale or was less than the aggregate amount
of the Secured Obligations, even if the Collateral Agent accepts the first offer received and does not offer the Collateral to more than
one offeree, and waives all rights that such Grantor may have to require that all or any part of the Collateral be marshaled upon any
sale (public or private) thereof. Each Grantor hereby acknowledges that (i) any such sale of the Collateral by the Collateral Agent shall
be made without warranty, (ii) the Collateral Agent may specifically disclaim any warranties of title, possession, quiet enjoyment or
the like, (iii) the Collateral Agent may bid (which bid may be, in whole or in part, in the form of cancellation of indebtedness), if
permitted by Law, for the purchase, lease, license or other disposition of the Collateral or any portion thereof for the account of the
Collateral Agent (on behalf of itself and each Secured Party) and (iv) such actions set forth in clauses (i), (ii) and (iii) above shall
not adversely affect the commercial reasonableness of any such sale of the Collateral. In addition to the foregoing, (i) upon written
notice to any Grantor from the Collateral Agent after and during the continuance of an Event of Default, such Grantor shall cease any
use of the Intellectual Property or any trademark, patent or copyright similar thereto for any purpose described in such notice; (ii)
the Collateral Agent may, at any time and from time to time after and during the continuance of an Event of Default, upon ten (10) days&rsquo;
prior notice to any Grantor, license, whether general, special or otherwise, and whether on an exclusive or non-exclusive basis, any
of the Intellectual Property, throughout the universe for such term or terms, on such conditions, and in such manner, as the Collateral
Agent shall in its sole discretion determine; and (iii) the Collateral Agent may, at any time, pursuant to the authority granted in <U>Section
8</U> (such authority being effective upon the occurrence and during the continuance of an Event of Default), execute and deliver on
behalf of a Grantor, one or more instruments of assignment of the Intellectual Property (or any application or registration thereof),
in form suitable for filing, recording or registration in any country.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event that the Collateral Agent determines to exercise its right to sell all or any part of the Pledged Interests pursuant to <U>Section
9(a)</U>, each Grantor will, at such Grantor&rsquo;s expense and upon request by the Collateral Agent: (i) execute and deliver, and cause
each issuer of such Pledged Interests and the directors and officers thereof to execute and deliver, all such instruments and documents,
and do or cause to be done all such other acts and things, as may be necessary or, in the opinion of the Collateral Agent, advisable
to register such Pledged Interests under the provisions of the Securities Act, and to cause the registration statement relating thereto
to become effective and to remain effective for such period as prospectuses are required by Law to be furnished, and to make all amendments
and supplements thereto and to the related prospectus which, in the reasonable opinion of the Collateral Agent, are necessary or advisable,
all in conformity with the requirements of the Securities Act and the rules and regulations of the SEC applicable thereto, (ii) cause
each issuer of such Pledged Interests to qualify such Pledged Interests under the state securities or &ldquo;Blue Sky&rdquo; Laws of
each jurisdiction, provided, that, such issuer shall not be required to qualify generally to do business in any jurisdiction where it
is not then so qualified, subject the issuer to any material tax in any such jurisdiction where it is not then so subject or file a general
consent to service of process in any such jurisdiction; and to use commercially reasonable efforts to obtain all necessary governmental
approvals for the sale of the Pledged Interests, as reasonably requested by the Collateral Agent, (iii) cause each Pledged Issuer to
make available to its securityholders, as soon as practicable, an earnings statement which will satisfy the provisions of Section 11(a)
of the Securities Act, and (iv) do or cause to be done all such other acts and things as may be reasonably necessary to make such sale
of such Pledged Interests valid and binding and in compliance with applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
the provisions of <U>Section 9(b)</U>, each Grantor recognizes that the Collateral Agent may deem it impracticable to effect a public
sale of all or any part of the Pledged Shares or any other securities constituting Pledged Interests and that the Collateral Agent may,
therefore, determine to make one or more private sales of any such securities to a restricted group of purchasers who will be obligated
to agree, among other things, to acquire such securities for their own account, for investment and not with a view to the distribution
or resale thereof. Each Grantor acknowledges that any such private sale may be at prices and on terms less favorable to the seller than
the prices and other terms which might have been obtained at a public sale and, notwithstanding the foregoing, agrees that if such private
sales are made in a commercially reasonable manner, then the Collateral Agent shall have no obligation to delay the sale of any such
securities for the period of time necessary to permit the issuer of such securities to register such securities for public sale under
the Securities Act. Each Grantor further acknowledges and agrees that any offer to sell such securities which has been (i) publicly advertised
on a bona fide basis in a newspaper or other publication of general circulation in the financial community of New York, New York (to
the extent that such an offer may be so advertised without prior registration under the Securities Act) or (ii) made privately in the
manner described above to not less than fifteen bona fide offerees shall be deemed to involve a &ldquo;public disposition&rdquo; for
the purposes of Section 9-610(c) of the Code (or any successor or similar, applicable statutory provision) as then in effect in the State
of New York, notwithstanding that such sale may not constitute a &ldquo;public offering&rdquo; under the Securities Act, and that the
Collateral Agent may, in such event, bid for the purchase of such securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
cash held by the Collateral Agent (or its agent or designee) as Collateral and all Cash Proceeds received by the Collateral Agent (or
its agent or designee) in respect of any sale of or collection from, or other realization upon, all or any part of the Collateral may,
in the discretion of the Collateral Agent, be held by the Collateral Agent (or its agent or designee) as collateral for, or then or at
any time thereafter applied (after payment of any amounts payable to the Collateral Agent pursuant to <U>Section 10</U>) in whole or
in part by the Collateral Agent against, all or any part of the Secured Obligations in such order as the Collateral Agent shall elect,
consistent with the provisions of the Purchase Agreement. Any surplus of such cash or Cash Proceeds held by the Collateral Agent (or
its agent or designee) and remaining after the date on which all of the Secured Obligations have been indefeasibly paid in full in cash,
shall be paid over to whomsoever shall be lawfully entitled to receive the same or as a court of competent jurisdiction shall direct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event that the proceeds of any such sale, collection or realization are insufficient to pay all amounts to which each Secured Party
is legally entitled, the Grantors shall be jointly and severally liable for the deficiency, together with interest thereon at the highest
rate specified in any applicable Transaction Document for interest on overdue principal thereof or such other rate as shall be fixed
by applicable Law, together with the costs of collection and the reasonable fees, costs, expenses and other client charges of any attorneys
employed by the Collateral Agent to collect such deficiency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor hereby acknowledges that if the Collateral Agent complies with any applicable Law in connection with a disposition of the Collateral,
such compliance will not adversely affect the commercial reasonableness of any sale or other disposition of the Collateral.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Collateral Agent shall not be required to marshal any present or future collateral security (including but not limited to, this Agreement
and the Collateral) for, or other assurances of payment of, the Secured Obligations or any of them or to resort to such collateral security
or other assurances of payment in any particular order, and all of the Collateral Agent&rsquo;s rights hereunder and in respect of such
collateral security and other assurances of payment shall be cumulative and in addition to all other rights, however existing or arising.
To the extent that any Grantor lawfully may, such Grantor hereby agrees that it will not invoke any Law relating to the marshalling of
collateral which might cause delay in or impede the enforcement of the Collateral Agent&rsquo;s rights under this Agreement or under
any other instrument creating or evidencing any of the Secured Obligations or under which any of the Secured Obligations is outstanding
or by which any of the Secured Obligations is secured or payment thereof is otherwise assured, and, to the extent that it lawfully may,
each Grantor hereby irrevocably waives the benefits of all such Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor irrevocably and unconditionally:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;consents
to the appointment of pre-judgment or post-judgment receiver with all of the same powers that would otherwise be available to the Grantors,
including but not limited to the power to (A) hold, manage, control or dispose of the Collateral wherever located, (B) take any action
with respect to the Collateral to the maximum extent permitted by Law and (C) conduct a public or private sale of any or all of the Grantors&rsquo;
right, title and interest in and to such Collateral, including any disposition of the Collateral to the Secured Parties in exchange for
cancellation of all or a portion of the Obligations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;consents
that any such receiver can be appointed without a hearing or prior notice to the Grantors, provided, however, that the Collateral Agent
shall provide prompt notice to the Grantors after such appointment;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;agrees
not to oppose or otherwise interfere (directly or indirectly) with any effort by Collateral Agent to seek the appointment of a receiver;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;waives
any right to demand that a bond be posted in connection with the appointment of any such receiver, provided, however, that in the event
that no bond is posted, the Collateral Agent shall be responsible for ; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnity
and Expenses</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor jointly and severally agrees to defend, protect, indemnify and hold harmless the Collateral Agent and each other Indemnitee from
and against any and all claims, losses, damages, liabilities, obligations, penalties, fees, reasonable costs and expenses (including
without limitation, reasonable attorneys&rsquo; fees, costs, expenses and disbursements) incurred by the Collateral Agent or such Indemnitee
to the extent that they arise out of or otherwise result from or relate to or are in connection with this Agreement (including without
limitation, enforcement of this Agreement), except claims, losses or liabilities resulting solely and directly from the Collateral Agent&rsquo;s
or such Indemnitee&rsquo;s gross negligence or willful misconduct, as determined by a final judgment of a court of competent jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor jointly and severally agrees to pay to the Collateral Agent upon demand the amount of any and all costs and expenses, including
the reasonable fees, costs, expenses and disbursements of counsel for the Collateral Agent and of any experts and agents (including without
limitation, any collateral trustee which may act as agent of the Collateral Agent), which the Collateral Agent may incur in connection
with (i) the preparation, negotiation, execution, delivery, recordation, administration, amendment, waiver or other modification or termination
of this Agreement, (ii) the custody, preservation, use or operation of, or the sale of, collection from, or other realization upon, any
Collateral, (iii) the exercise or enforcement of any of the rights of the Collateral Agent hereunder, or (iv) the failure by any Grantor
to perform or observe any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices,
Etc</U>. All notices and other communications provided for hereunder shall be given in accordance with the notice provision of the Purchase
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Security
Interest Absolute</U>; Joint and Several Obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
rights of the Secured Parties, all Liens and all obligations of each of the Grantors hereunder shall be absolute and unconditional irrespective
of (i) any lack of validity or enforceability of the Purchase Agreement or the Notes, (ii) any change in the time, manner or place of
payment of, or in any other term in respect of, all or any of the Secured Obligations, or any other amendment or waiver of or consent
to any departure from the Purchase Agreement or the Notes, (iii) any exchange or release of, or non-perfection of any Lien on any Collateral,
or any release or amendment or waiver of or consent to departure from any guaranty, for all or any of the Secured Obligations, or (iv)
any other circumstance that might otherwise constitute a defense available to, or a discharge of, any of the Grantors in respect of the
Secured Obligations. All authorizations and agencies contained herein with respect to any of the Collateral are irrevocable and powers
coupled with an interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor hereby waives (i) promptness and diligence, and (ii) any requirement that the Collateral Agent or any Secured Party protect,
secure, perfect or insure any security interest or other lien on any property subject thereto or exhaust any right or take any action
against any Grantor or any other Person or any collateral.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
of the obligations of the Grantors hereunder are joint and several. The Collateral Agent may, in its sole and absolute discretion, enforce
the provisions hereof against any of the Grantors and shall not be required to proceed against all Grantors jointly or seek payment from
the Grantors ratably. In addition, the Collateral Agent may, in its sole and absolute discretion, select the Collateral of any one or
more of the Grantors for sale or application to the Secured Obligations, without regard to the ownership of such Collateral, and shall
not be required to make such selection ratably from the Collateral owned by all of the Grantors. The release or discharge of any Grantor
by the Collateral Agent shall not release or discharge any other Grantor from the obligations of such Person hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>The
Collateral Agent</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<U>Reserved</U>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Powers
and Duties</U>. Each Investor irrevocably authorizes the Collateral Agent to take such action on such Investor&rsquo;s behalf and to
exercise such powers, rights and remedies hereunder as are specifically delegated or granted to the Collateral Agent by the terms hereof
and the other Transaction Documents, together with such powers, rights and remedies as are reasonably incidental thereto. The Collateral
Agent shall have only those duties and responsibilities that are expressly specified herein or any other Transaction Documents. The Collateral
Agent may exercise such powers, rights and remedies and perform such duties by or through its agents or employees. The Collateral Agent
shall not have, by reason hereof or any of the other Transaction Documents, a fiduciary relationship in respect of, or any fiduciary
duties to, any Investor or any other Person; and nothing herein, expressed or implied, is intended to or shall be so construed as to
impose upon the Collateral Agent any obligations in respect hereof except as expressly set forth herein. The powers conferred on the
Collateral Agent hereunder are solely to protect its interest in the Collateral and shall not impose any duty upon it to exercise any
such powers. Except for the exercise of reasonable care in the accounting for moneys actually received by it hereunder, the Collateral
Agent shall have no duty as to any Collateral or as to the taking of any necessary steps to preserve rights against prior parties or
any other rights pertaining to any Collateral. The Collateral Agent shall be deemed to have exercised reasonable care in the custody
and preservation of Collateral in its possession if such Collateral is accorded treatment substantially equal to that which the Collateral
Agent accords its own property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>General
Immunity</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Responsibility for Certain Matters</U>. The Collateral Agent shall not be responsible to any Investor for the execution, effectiveness,
genuineness, validity, enforceability, collectability or sufficiency hereof or for any representations, warranties, recitals or statements
made herein or made in any written or oral statements or in any financial or other statements, instruments, reports or certificates or
any other documents furnished or made by the Collateral Agent to the Investors or by or on behalf of any Grantor to the Collateral Agent
and the transactions contemplated hereby or for the financial condition or business affairs of the Grantor, or any other Person liable
for the payment of any Secured Obligations, nor shall the Collateral Agent be required to ascertain or inquire as to the performance
or observance of any of the terms, conditions, provisions, covenants or agreements contained in any of the Transaction Documents or as
to the existence or possible existence of any Event of Default or to make any disclosures with respect to the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exculpatory
Provisions</U>. Neither the Collateral Agent nor any of its officers, partners, directors, employees, attorneys or agents shall be liable
to the Investors for any action taken or omitted by the Collateral Agent under or in connection with any of the Transaction Documents
except to the extent caused by the Collateral Agent&rsquo;s gross negligence or willful misconduct, as determined by a final, non-appealable
judgment of a court of competent jurisdiction. The Collateral Agent shall be entitled to refrain from any act or the taking of any action
(including the failure to take an action) in connection herewith or any of the other Transaction Documents or from the exercise of any
power, discretion or authority vested in it hereunder unless and until the Collateral Agent shall have received instructions in respect
thereof from the Investors and, upon receipt of such instructions from the Investors, the Collateral Agent shall be entitled to act or
(where so instructed) refrain from acting, or to exercise such power, discretion or authority, in accordance with such instructions,
including for the avoidance of doubt refraining from any action that, in its opinion or the opinion of its counsel, may be in violation
of the automatic stay under any debtor relief Laws. Without prejudice to the generality of the foregoing, (A) the Collateral Agent shall
be entitled to rely, and shall be fully protected in relying, upon any communication, instrument or document believed by it to be genuine
and correct and to have been signed or sent by the proper Person, and shall be entitled to rely and shall be protected in relying on
opinions and judgments of attorneys (who may be attorneys for a Grantor), accountants, experts and other professional advisors selected
by it; and (B) no Investor shall have any right of action whatsoever against the Collateral Agent as a result of the Collateral Agent
acting or (where so instructed) refraining from acting hereunder or any of the other Transaction Documents in accordance with the instructions
of the Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delegation
of Duties</U>. The Collateral Agent may perform any and all of its duties and exercise its rights and powers under this Agreement by
or through any one or more sub-agents appointed by the Collateral Agent. The Collateral Agent and any such sub-agent may perform any
and all of its duties and exercise its rights and powers by or through their respective Affiliates. The exculpatory, indemnification
and other provisions of this Section 13 shall apply to any of the Affiliates of the Collateral Agent. All of the rights, benefits, and
privileges (including the exculpatory and indemnification provisions) of this Section 13 shall apply to any such sub-agent and to the
Affiliates of any such sub-agent, and shall apply to their respective activities as sub-agent as if such sub-agent and Affiliates were
named herein. Notwithstanding anything herein to the contrary, with respect to each sub-agent appointed by the Collateral Agent, (i)
such sub-agent shall be a third party beneficiary under this Agreement with respect to all such rights, benefits and privileges (including
exculpatory rights and rights to indemnification) and shall have all of the rights and benefits of a third party beneficiary, including
an independent right of action to enforce such rights, benefits and privileges (including exculpatory rights and rights to indemnification)
directly, without the consent or joinder of any other Person, against the Grantors and the Investors, (ii) such rights, benefits and
privileges (including exculpatory rights and rights to indemnification) shall not be modified or amended without the consent of such
sub-agent, and (iii) such sub-agent shall only have obligations to the Collateral Agent and not to the Grantors, any Investor or any
other Person and no Grantor, Investor, or any other Person shall have any rights, directly or indirectly, as a third party beneficiary
or otherwise, against such sub-agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Agent
Entitled to Act as Investor</U>. The agency hereby created shall in no way impair or affect any of the rights and powers of, or impose
any duties or obligations upon, Esousa in its individual capacity as an Investor. With respect to its financial advances to the Company,
the Collateral Agent shall have the same rights and powers hereunder as any other Investor and may exercise the same as if it were not
performing the duties and functions delegated to it hereunder, and the term &ldquo;Investor&rdquo; shall, unless the context clearly
otherwise indicates, include the Collateral Agent in its individual capacity. The Collateral Agent and its Affiliates may accept deposits
from, lend money to, own securities of, and generally engage in any kind of banking, trust, financial advisory or other business with
any Grantor or any of its Affiliates as if it were not performing the duties specified herein, and may accept fees and other consideration
from such Grantor for services in connection herewith and otherwise without having to account for the same to Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Investors&rsquo;
Representations, Warranties and Acknowledgment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Investor represents and warrants that it has made its own independent investigation of the financial condition and affairs of the Company
and that it has made and shall continue to make its own appraisal of the creditworthiness of the Company. The Collateral Agent shall
not have any duty or responsibility, either initially or on a continuing basis, to make any such investigation or any such appraisal
on behalf of the Investors or to provide any Investor with any credit or other information with respect thereto, whether coming into
its possession before the execution of this Agreement or at any time or times thereafter, and the Collateral Agent shall not have any
responsibility with respect to the accuracy of or the completeness of any information produced by the Company and subsequently provided
to the Investors by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Investor, by delivering its signature page to this Agreement, shall be deemed to have acknowledged receipt of, and consented to and approved,
each collateral document in existence on the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Right
to Indemnity</U>. Each Investor, according to its pro rata amount of Notes, severally agrees to indemnify the Collateral Agent, to the
extent that the Collateral Agent shall not have been reimbursed by the Grantors, for and against any and all liabilities, obligations,
losses, damages, penalties, actions, judgments, suits, costs, expenses (including counsel fees and disbursements) or disbursements of
any kind or nature whatsoever which may be imposed on, incurred by or asserted against the Collateral Agent in exercising its powers,
rights and remedies or performing its duties hereunder, or otherwise in its capacity as the Collateral Agent in any way relating to or
arising out of this Agreement; <U>provided</U>, no Investor shall be liable for any portion of such liabilities, obligations, losses,
damages, penalties, actions, judgments, suits, costs, expenses or disbursements resulting from the Collateral Agent&rsquo;s gross negligence
or willful misconduct, as determined by a final, non-appealable judgment of a court of competent jurisdiction. If any indemnity furnished
to the Collateral Agent for any purpose shall, in the opinion of the Collateral Agent, be insufficient or become impaired, the Collateral
Agent may call for additional indemnity and cease, or not commence, to do the acts indemnified against until such additional indemnity
is furnished.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Successor
Collateral Agent</U>. The Collateral Agent may resign at any time by giving prior written notice thereof to Investors and the Grantors,
and the Collateral Agent may be removed at any time with or without cause by an instrument or concurrent instruments in writing delivered
to the Grantors and the Collateral Agent signed by the Investors. The Collateral Agent shall have the right to appoint a financial institution
as Collateral Agent hereunder, subject to the reasonable satisfaction of the Grantors and the Investors and the Collateral Agent&rsquo;s
resignation shall become effective on the earliest of (i) 30 days after delivery of the notice of resignation (regardless of whether
a successor has been appointed or not), (ii) the acceptance of such successor Collateral Agent by the Grantors and the Investors or (iii)
such other date, if any, agreed to by the Investors. Upon any such notice of resignation or any such removal, the Investors shall have
the right, upon five Business Days&rsquo; notice to the Collateral Agent, to appoint a successor Collateral Agent. Until a successor
Collateral Agent is so appointed by the Investors or the Collateral Agent, any collateral security held by Collateral Agent on behalf
of the Investors under the Collateral Documents shall continue to be held by the retiring Collateral Agent as nominee until such time
as a successor Collateral Agent is appointed. Upon the acceptance of any appointment as Collateral Agent hereunder by a successor Collateral
Agent, that successor Collateral Agent shall thereupon succeed to and become vested with all the rights, powers, privileges and duties
of the retiring or removed Collateral Agent under this Agreements, and the retiring or removed Collateral Agent under this Agreement
shall promptly (i) transfer to such successor Collateral Agent all sums and all of its right, title and interest in and to all other
items of Collateral held hereunder, together with all records and other documents necessary or appropriate in connection with the performance
of the duties of the successor Collateral Agent under this Agreements, and (ii) execute and deliver to such successor Collateral Agent
or otherwise authorize the filing of such amendments to financing statements, and take such other actions, as may be necessary or appropriate
in connection with the assignment to such successor Collateral Agent of the security interests created hereunder, whereupon such retiring
or removed Collateral Agent shall be discharged from its duties and obligations under this Agreement. After any retiring or removed Collateral
Agent&rsquo;s resignation or removal hereunder as the Collateral Agent, the provisions of this Agreement, shall inure to its benefit
as to any actions taken or omitted to be taken by it under this Agreement while it was the Collateral Agent hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Withholding
Taxes</U>. To the extent required by any applicable law, the Collateral Agent may withhold from any payment to any Investor an amount
equivalent to any applicable withholding tax attributable to the amount paid to that Investor. If the Internal Revenue Service or any
other Governmental Entity asserts a claim that the Collateral Agent did not properly withhold tax from amounts paid to or for the account
of any Investor because the appropriate form was not delivered or was not properly executed or because such Investor failed to notify
the Collateral Agent of a change in circumstance which rendered the exemption from, or reduction of, withholding tax ineffective or for
any other reason, or if the Collateral Agent reasonably determines that a payment was made to a particular Investor pursuant to this
Agreement without deduction of applicable withholding tax from such payment, such Investor (and not the other Investors) shall indemnify
the Collateral Agent fully for all amounts paid, directly or indirectly, by the Collateral Agent as tax or otherwise, including any penalties
or interest and together with all expenses (including legal expenses, allocated internal costs and out-of-pocket expenses) incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Collateral
Agent May File Bankruptcy Disclosure and Proofs of Claim</U>. In case of the pendency of any proceeding under any debtor relief Laws
relative to the Grantors, the Collateral Agent (irrespective of whether the principal of any Secured Obligation shall then be due and
payable as herein expressed or by declaration or otherwise and irrespective of whether the Collateral Agent shall have made any demand
on the Grantors) shall be entitled and empowered (but not obligated) by intervention in such proceeding or otherwise:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
file a verified statement pursuant to rule 2019 of the Federal Rules of Bankruptcy Procedure that, in its sole opinion, complies with
such rule&rsquo;s disclosure requirements for entities representing more than one creditor;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
file and prove a claim for the whole amount of the principal and interest owing and unpaid in respect of the Secured Obligations that
are owing and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Investors and
the Collateral Agent (including any claim for the reasonable compensation, expenses, disbursements and advances of the Collateral Agent
and its respective agents and counsel and all other amounts due the Collateral Agent hereunder) allowed in such judicial proceeding;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
collect and receive any monies or other property payable or deliverable on any such claims and to distribute the same; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">and any custodian, receiver, assignee, trustee,
liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Investor to make such
payments to the Collateral Agent and, in the event that the Collateral Agent shall consent to the making of such payments directly to
the Investors, to pay to the Collateral Agent any amount due for the reasonable compensation, expenses, disbursements and advances of
the Collateral Agent and its agents and counsel, and any other amounts due the Collateral Agent hereunder. To the extent that the payment
of any such compensation, expenses, disbursements and advances of the Collateral Agent, its agents and counsel, and any other amounts
due the Collateral Agent hereunder out of the estate in any such proceeding, shall be denied for any reason, payment of the same shall
be secured by a Lien on, and shall be paid out of, any and all distributions, dividends, money, securities and other properties that
the Investors may be entitled to receive in such proceeding whether in liquidation or under any plan of reorganization or arrangement
or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nothing contained herein shall be deemed to authorize
the Collateral Agent to authorize or consent to or accept or adopt on behalf of any Investor any plan of reorganization, arrangement,
adjustment or composition affecting the Secured Obligations or the rights of any Investor or to authorize the Collateral Agent to vote
in respect of the claim of any Investor in any such proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
amendment of any provision of this Agreement (including any Schedule attached hereto) shall be effective unless it is in writing and
signed by each Grantor affected thereby and the Collateral Agent, and no waiver of any provision of this Agreement, and no consent to
any departure by any Grantor therefrom, shall be effective unless it is in writing and signed by the Collateral Agent, and then such
waiver or consent shall be effective only in the specific instance and for the specific purpose for which given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
failure on the part of the Secured Parties to exercise, and no delay in exercising, any right hereunder or under any other Transaction
Document shall operate as a waiver thereof; nor shall any single or partial exercise of any such right preclude any other or further
exercise thereof or the exercise of any other right. The rights and remedies of the Secured Parties provided herein and in the other
Transaction Documents are cumulative and are in addition to, and not exclusive of, any rights or remedies provided by Law. The rights
of the Secured Parties under any Transaction Document against any party thereto are not conditional or contingent on any attempt by such
Person to exercise any of its rights under any other Transaction Document against such party or against any other Person, including but
not limited to, any Grantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement shall create a continuing security interest in the Collateral and shall (i) remain in full force and effect, subject to paragraph
(e) below, until the date on which all of the Secured Obligations have been indefeasibly paid in full in cash and (ii) be binding on
each Grantor and all other Persons who become bound as debtor to this Agreement in accordance with Section 9-203(d) of the Code, and
shall inure, together with all rights and remedies of the Secured Parties hereunder, to the benefit of the Secured Parties and their
respective successors, transferees and assigns. Without limiting the generality of clause (ii) of the immediately preceding sentence,
the Secured Parties may assign or otherwise transfer their respective rights and obligations under this Agreement and any other Transaction
Document to any other Person pursuant to the terms of the Purchase Agreement, and such other Person shall thereupon become vested with
all of the benefits in respect thereof granted to the Secured Parties herein or otherwise. Upon any such assignment or transfer, all
references in this Agreement to any Secured Party shall mean the assignee of any such Secured Party. None of the rights or obligations
of any Grantor hereunder may be assigned or otherwise transferred without the prior written consent of the Collateral Agent, and any
such assignment or transfer shall be null and void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the date on which all of the Secured Obligations have been indefeasibly paid in full in cash, (i) subject to paragraph (e) below, this
Agreement and the security interests and licenses created hereby shall terminate and all rights to the Collateral shall revert to the
respective Grantor that granted such security interests hereunder and (ii) the Collateral Agent will, upon the Grantors&rsquo; request
and at the Grantors&rsquo; expense, without any representation, warranty or recourse whatsoever, (A) return to the Grantors (or whomsoever
shall be lawfully entitled to receive the same or as a court of competent jurisdiction shall direct) such of the Collateral as shall
not have been sold or otherwise disposed of or applied pursuant to the terms hereof and (B) execute and deliver to the Grantors such
documents as the Grantors shall reasonably request to evidence such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement shall remain in full force and effect and continue to be effective should any petition be filed by or against any Grantor for
liquidation or reorganization, should any Grantor become insolvent or make an assignment for the benefit of any creditor or creditors
or should a receiver or trustee be appointed for all or any significant part of any Grantor&rsquo;s assets, and shall continue to be
effective or be reinstated, as the case may be, if at any time payment or performance of the Secured Obligations, or any part thereof,
is, pursuant to applicable Law, rescinded or reduced in amount, or must otherwise be restored or returned by any obligee of the Secured
Obligations, whether as a &ldquo;voidable preference,&rdquo; &ldquo;fraudulent conveyance,&rdquo; or otherwise, all as though such payment
or performance had not been made. In the event that any payment, or any part thereof, is rescinded, reduced, restored or returned, the
Secured Obligations shall be reinstated and deemed reduced only by such amount paid and not so rescinded, reduced, restored or returned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the execution and delivery, or authentication, by any Person of a security agreement supplement in substantially the form of <U>Exhibit
C</U> hereto (each a &ldquo;<B><U>Security Agreement Supplement</U></B>&rdquo;), (i) such Person shall be referred to as an &ldquo;<B><U>Additional
Grantor</U></B>&rdquo; and shall be and become a Grantor, and each reference in this Agreement to &ldquo;Grantor&rdquo; shall also mean
and be a reference to such Additional Grantor, and each reference in this Agreement and the other Transaction Documents to &ldquo;Collateral&rdquo;
shall also mean and be a reference to the Collateral of such Additional Grantor, and (ii) the supplemental <U>Schedules I-XI</U> attached
to each Security Agreement Supplement shall be incorporated into and become a part of and supplement <U>Schedules I-XI</U>, respectively,
hereto, and the Collateral Agent may attach such Schedules as supplements to such Schedules, and each reference to such Schedules shall
mean and be a reference to such Schedules, as supplemented pursuant hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>THIS
AGREEMENT SHALL BE GOVERNED BY, CONSTRUED AND INTERPRETED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, EXCEPT AS REQUIRED BY
MANDATORY PROVISIONS OF LAW AND EXCEPT TO THE EXTENT THAT THE VALIDITY AND PERFECTION OR THE PERFECTION AND THE EFFECT OF PERFECTION
OR NON-PERFECTION OF THE SECURITY INTEREST CREATED HEREBY, OR REMEDIES HEREUNDER, IN RESPECT OF ANY PARTICULAR COLLATERAL ARE GOVERNED
BY THE LAW OF A JURISDICTION OTHER THAN THE STATE OF NEW YORK.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>EACH
GRANTOR HEREBY IRREVOCABLY CONSENTS TO AND WAIVES ANY RIGHT TO OBJECT TO OR OTHERWISE CONTEST THE APPOINTMENT OF A RECEIVER AFTER THE
OCCURRENCE OF AN EVENT OF DEFAULT. EACH GRANTOR (i) GRANTS SUCH WAIVER AND CONSENTS KNOWINGLY AFTER HAVING DISCUSSED THE IMPLICATIONS
THEREOF WITH COUNSEL, (ii) ACKNOWLEDGES THAT (A) THE UNCONTESTED RIGHT TO HAVE A RECEIVER APPOINTED FOR THE FOREGOING PURPOSES IS CONSIDERED
ESSENTIAL BY THE SECURED PARTIES IN CONNECTION WITH THE ENFORCEMENT OF THEIR RIGHTS AND REMEDIES HEREUNDER AND UNDER THE OTHER DOCUMENTS
EXECUTED IN CONNECTION HEREWITH, AND </B>(<B>B) THE AVAILABILITY OF SUCH APPOINTMENT AS A REMEDY UNDER THE FOREGOING CIRCUMSTANCES WAS
A MATERIAL FACTOR IN INDUCING THE SECURED PARTIES TO MAKE (AND COMMIT TO MAKE) THE LOAN TO THE COMPANY, AND (iii) AGREES TO ENTER INTO
ANY AND ALL STIPULATIONS IN ANY LEGAL ACTIONS, OR AGREEMENTS OR OTHER INSTRUMENTS IN CONNECTION WITH THE FOREGOING AND TO COOPERATE FULLY
WITH THE AGENTS OR INVESTORS IN CONNECTION WITH THE ASSUMPTION AND EXERCISE OF CONTROL BY THE RECEIVER OVER ALL OR ANY PORTION OF THE
COLLATERAL.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to and without limitation of any of the foregoing, this Agreement shall be deemed to be a Transaction Document and shall otherwise
be subject to all of terms and conditions contained in Sections 11.5 and 11.6 of the Purchase Agreement, <I>mutatis mutandi</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Grantor irrevocably and unconditionally waives any right it may have to claim or recover in any legal action, suit or proceeding with
respect to this Agreement any special, exemplary, punitive or consequential damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
provision of this Agreement which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to
the extent of such prohibition or unenforceability without invalidating the remaining portions hereof or thereof or affecting the validity
or enforceability of such provision in any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section
headings herein are included for convenience of reference only and shall not constitute a part of this Agreement for any other purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement may be executed in any number of counterparts and by the different parties hereto on separate counterparts, each of which shall
be deemed an original, but all of such counterparts taken together shall constitute one and the same agreement. Delivery of an executed
counterpart of this Agreement by facsimile or electronic mail shall be equally effective as delivery of an original executed counterpart.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF THIS PAGE INTENTIONALLY LEFT
BLANK]</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, each Grantor
has caused this Agreement to be executed and delivered by its officer thereunto duly authorized, as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><U>GRANTORS</U>:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>BITNILE HOLDINGS, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 3%">By:&nbsp;&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 47%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"></TD>
    <TD STYLE="text-align: justify">Name: Milton C. Ault, III</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"></TD>
    <TD STYLE="text-align: justify">Title: Executive Chairman</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>BITNILE, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">By:&nbsp;&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"></TD>
    <TD STYLE="text-align: justify">Name: William B. Horne</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"></TD>
    <TD STYLE="text-align: justify">Title: Chief Executive Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>AULT LENDING, LLC</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">By:&nbsp;&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"></TD>
    <TD STYLE="text-align: justify">Name:&nbsp;&nbsp;David J. Katzoff</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"></TD>
    <TD STYLE="text-align: justify">&nbsp;Title:&nbsp;&nbsp;Manager </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ACCEPTED BY:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ESOUSA GROUP HOLDINGS, LLC</B>, as Collateral
Agent</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%; text-align: justify">By: </TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 43%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Name:</TD>
    <TD STYLE="text-align: justify">Michael Wachs</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">Managing Member</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>5
<FILENAME>ex10_3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">GUARANTY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <B>GUARANTY </B>dated
as of December 16, 2022 (as amended, supplemented or otherwise modified from time to time, this &#8220;<B><U>Guarant</U>y</B>&#8221;)
is made by the undersigned (together with each other Person that executes a joinder agreement and becomes a &#8220;Guarantor&#8221; hereunder,
each a &#8220;<B><U>Guarantor</U></B>&#8221;, and collectively, the &#8220;<B><U>Guarantors</U></B>&#8221;), in favor of the Agent (as
defined below) for the benefit of the Investors (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>RECITALS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BitNile
Holdings, Inc., a Delaware corporation (the &#8220;<B><U>Compan</U>y</B>&#8221;), each party listed as a &#8220;Investor&#8221; in the
Purchase Agreement referenced below (together with their respective successors and assigns, each a &#8220;<B><U>Investor</U></B>&#8221;),
and Esousa Group Holdings LLC, a New York limited liability company, as agent for the Investors (the &#8220;<B>Ag<U>ent</U></B>&#8221;)
and as an Investor, are parties to that certain Securities Purchase Agreement of even date herewith (as amended, supplemented or otherwise
modified from time to time, the &#8220;<B>Purchase Agreement</B>&#8221;), pursuant to which, among other things, the Company shall issue
certain Senior Secured Promissory Notes (as amended, supplemented or otherwise modified from time to time, and as replaced or refinanced
from time to time, the &#8220;<B><U>Notes</U></B>&#8221;) to the Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Notes are secured by that certain Security Agreement dated as of the date hereof (as amended, supplemented or otherwise modified from
time to time, the &#8220;<B><U>Security Agreement</U></B>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally,
the Investors have requested, and the Guarantors have agreed, that the Guarantors shall execute and deliver to the Investors, a guaranty
guaranteeing all of the obligations of the Company under the Purchase Agreement, the Notes and the other Transaction Documents until the
Notes have been indefeasibly paid in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the Security Agreement, the Guarantors have granted to Agent, as agent for the Investors, a security interest in and lien on their
assets to secure their respective obligations under this Guaranty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">E.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
Guarantor has determined that the execution, delivery and performance of this Guaranty directly benefits, and is in the best interest
of, such Guarantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in
consideration of the premises and the agreements herein and for other consideration, the sufficiency of which is hereby acknowledged,
each Guarantor hereby agrees with each Investor as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Section
1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>Definitions</U>. </B>Reference is hereby made to the Purchase Agreement, the Notes and the other Transaction Documents
for a statement of the terms thereof. All terms used in this Guaranty, which are defined in the Purchase Agreement and not otherwise defined
herein, shall have the same meanings herein as set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Section
2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>Guaranty</U>. </B>The Guarantors hereby unconditionally and irrevocably, guaranty the punctual payment, as and
when due and payable, by stated maturity or otherwise (after giving effect to any applicable grace or cure periods), of the Obligations
and any other amounts now or hereafter owing by the Company in respect of the Purchase Agreement, the Notes and the other Transaction
Documents (such obligations, to the extent not paid by the Company, being the &#8220;<B><U>Guaranteed Obligations</U></B>&#8221;; <U>provided
that</U>, when the Notes have been indefeasibly paid in full pursuant to their terms, the term &#8220;Guaranteed Obligations&#8221; shall
not include any of the foregoing obligations under the Purchase Agreement or any other Transaction Documents, and any remaining obligations
under such Transaction Documents shall no longer be guaranteed hereby). Without limiting the generality of the foregoing, each Guarantor&#8217;s
liability hereunder shall extend to all amounts that constitute part of the Guaranteed Obligations and would be owed by the Company to
the Investors under the Purchase Agreement and the Notes but for the fact that they are unenforceable or not allowable due to the existence
of any proceeding commenced by or against the Company or any Guarantor under any provision of the Bankruptcy Code (Title 11 of the United
States Code) or under any other bankruptcy or insolvency law, assignments for the benefit of creditors, formal or informal moratoria,
compositions, or extensions generally with creditors, or proceedings seeking reorganization, arrangement, or other similar relief, and
all fees, commissions, expense reimbursements, indemnifications and all other amounts due or to become due under any of the Transaction
Documents, and any and all expenses (including reasonable counsel fees and expenses) reasonably incurred by the Investors or the Agent
in enforcing any rights under this Guaranty, involving the Company, any other Grantor under the Security Agreement or any Guarantor hereunder
(the &#8220;<B><U>Transaction Parties</U></B>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Section
3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>Guaranty Absolute; Continuing Guaranty; Assignments</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>The
Guarantors guaranty that the Guaranteed Obligations will be paid strictly in accordance with the terms of the Transaction Documents, regardless
of any Law now or hereafter in effect in any jurisdiction affecting any of such terms or the rights of the Investors with respect thereto.
The obligations of each Guarantor under this Guaranty are independent of the Guaranteed Obligations, and a separate action or actions
may be brought and prosecuted against any Guarantor to enforce such obligations, irrespective of whether any action is brought against
any other Transaction Party or whether any Transaction Party is joined in any such action or actions. The liability of any Guarantor under
this Guaranty shall be irrevocable, absolute and unconditional irrespective of, and each Guarantor hereby irrevocably waives, to the extent
permitted by law, any defenses it may now or hereafter have in any way relating to, any or all of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>any
lack of validity or enforceability of any Transaction Document or any agreement or instrument relating thereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>any
change in the time, manner or place of payment of, or in any other term of, all or any of the Guaranteed Obligations, or any other amendment
or waiver of or any consent to departure from any Transaction Document, including without limitation, any increase in the Guaranteed Obligations
resulting from the extension of additional credit to any Transaction Party or otherwise;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>any
taking, exchange, release or non-perfection of any collateral with respect to the Guaranteed Obligations, or any taking, release or amendment
or waiver of or consent to departure from any other guaranty, for all or any of the Guaranteed Obligations; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>any
change, restructuring or termination of the corporate, limited liability company or partnership structure or existence of any Transaction
Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Guaranty shall continue
to be effective or be reinstated, as the case may be, if at any time any payment of any of the Guaranteed Obligations is rescinded or
must otherwise be returned by any Investor or any other Person upon the insolvency, bankruptcy or reorganization of any Transaction Party
or otherwise, all as though such payment had not been made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>This
Guaranty is a continuing guaranty and shall (i) remain in full force and effect until the indefeasible payment in full in cash of all
Guaranteed Obligations (together with any matured indemnification obligations as of the date of such payment, but excluding any inchoate
or unmatured contingent indemnification obligations) and (ii) be binding upon each Guarantor and its respective successors and assigns.
This Guaranty shall inure to the benefit of and be enforceable by the Agent, on behalf of the Investors and their respective successors,
and permitted pledgees, transferees and assigns. Without limiting the generality of the foregoing sentence, the Agent and any Investor
may pledge, assign or otherwise transfer all or any portion of its rights and obligations under and subject to the terms of any Transaction
Document to any other Person, and such other Person shall thereupon become vested with all the benefits in respect thereof granted to
the Agent and such Investor herein or otherwise, in each case as provided in the Transaction Documents. Notwithstanding the foregoing
and for the avoidance of doubt, this Guaranty will expire and each Guarantor will be automatically released from its obligation hereunder
without any further action by any Person upon the indefeasible payment in full in cash of all Guaranteed Obligations (together with any
matured indemnification obligations as of the date of such payment, but excluding any inchoate or unmatured contingent indemnification
obligations).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Section
4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>Waivers</U>. </B>To the extent permitted by applicable Law, each Guarantor hereby waives promptness, diligence,
notice of acceptance and any other notice with respect to any of the Guaranteed Obligations and this Guaranty and any requirement that
the Agent exhaust any right or take any action against any Transaction Party or any other Person or any Collateral (as defined in the
Security Agreement). In furtherance of the foregoing, each Guarantor acknowledges that this Guaranty is a guarantee of payment and note
of collection. Each Guarantor further acknowledges that it will receive direct and indirect benefits from the financing arrangements contemplated
herein and that the waiver set forth in this <U>Section 4</U> is knowingly made in contemplation of such benefits. The Guarantors hereby
waive any right to revoke this Guaranty, and acknowledge that this Guaranty is continuing in nature and applies to all Guaranteed Obligations,
whether existing now or in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Section
5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>Subrogation</U>. </B>No Guarantor may exercise any rights that it may now or hereafter acquire against any Transaction
Party or any other Guarantor that arise from the existence, payment, performance or enforcement of any Guarantor&#8217;s obligations under
this Guaranty, including without limitation, any right of subrogation, reimbursement, exoneration, contribution or indemnification and
any right to participate in any claim or remedy of the Investors or the Agent against any Transaction Party or any other guarantor or
any Collateral, whether or not such claim, remedy or right arises in equity or under contract, statute or common law, including without
limitation, the right to take or receive from any Transaction Party or any other guarantor, directly or indirectly, in cash or other property
or by set-off or in any other manner, payment or security solely on account of such claim, remedy or right, unless and until the indefeasible
payment in full in cash of all Guaranteed Obligations (together with any matured indemnification obligations as of the date of such payment,
but excluding any inchoate or unmatured contingent indemnification obligations). If any amount shall be paid to a Guarantor in violation
of the immediately preceding sentence at any time prior to the later of the payment in full in cash of the Guaranteed Obligations, such
amount shall be held in trust for the benefit of the Investors and shall forthwith be paid ratably to the Investors to be credited and
applied to the Guaranteed Obligations, whether matured or unmatured, in accordance with the terms of the Transaction Documents, or to
be held as collateral for any Guaranteed Obligations thereafter arising. If (a) any Guarantor shall make payment to the Investors of all
or any part of the Guaranteed Obligations, and (b) the Investors receive the indefeasible payment in full in cash of all Guaranteed Obligations
(together with any matured indemnification obligations as of the date of such payment, but excluding any inchoate or unmatured contingent
indemnification obligations), the Agent and the Investors will, at such Guarantor&#8217;s request and expense, promptly execute and deliver
to such Guarantor appropriate documents, without recourse and without representation or warranty, necessary to evidence the transfer by
subrogation to such Guarantor of an interest in the Guaranteed Obligations resulting from such payment by such Guarantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Section
6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>Representations, Warranties and Covenants</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Each
Guarantor hereby represents and warrants as of the date first written above as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Each
Guarantor is (A) an individual with full capacity, who has knowledge and a complete understanding of the terms set forth in this Guaranty
and each other Transaction Document to which Guarantor is a party, and has had the opportunity to consult with counsel regarding the terms,
conditions, liabilities and obligations under this Guaranty; or (B)(1) a corporation, limited liability company or limited partnership
duly organized, validly existing and in good standing under the Laws of the jurisdiction of its organization as set forth on the signature
pages hereto, (2) has all requisite corporate, limited liability company or limited partnership power and authority to conduct its business
as now conducted and as presently contemplated and to execute and deliver this Guaranty and each other Transaction Document to which the
Guarantor is a party, and to consummate the transactions contemplated hereby and thereby and (3) is duly qualified to do business and
is in good standing in each jurisdiction in which the character of the properties owned or leased by it or in which the conduct of its
business makes such qualification necessary except where the failure to be so qualified would not reasonably be expected to result in
a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>The
execution, delivery and performance by each Guarantor of this Guaranty and each other Transaction Document to which such Guarantor is
a party (A) in the case of a Guarantor that is an entity, have been duly authorized by all necessary corporate, limited liability company
or limited partnership action, (B) in the case of a Guarantor that is an entity, do not and will not contravene its Organization Documents,
or any applicable Law or any material contractual restriction binding on the Guarantor or its properties and will not result in or require
the creation of any Lien (other than pursuant to any Transaction Document) upon or with respect to any of its properties, and (C) do not
and will not result in any default, noncompliance, suspension, revocation, impairment, forfeiture or nonrenewal of any material agreement,
permit, license, authorization or approval applicable to it or its operations or any of its properties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>No
authorization or approval or other action by, and no notice to or filing with, any Governmental Authority is required in connection with
the due execution, delivery and performance by the Guarantor of this Guaranty or any of the other Transaction Documents to which the Guarantor
is a party, other than expressly provided for in any of the Transaction Documents and the filing of any financing statements or similar
matters needed in connection with the perfection of the Liens granted under the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Each
of this Guaranty and the other Transaction Documents to which the Guarantor is or will be a party, when delivered, will be, a legal, valid
and binding obligation of the Guarantor, enforceable against the Guarantor in accordance with its terms, except as may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, suretyship or other similar Laws and equitable principles (regardless
of whether enforcement is sought in equity or at law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>There
is no pending or, to the knowledge of the Guarantor, threatened in writing action, suit or proceeding against the Guarantor or to which
any of the properties of the Guarantor is subject, before any court or other Governmental Authority or any arbitrator that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>if
adversely determined, could reasonably be expected to have a Material Adverse Effect or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>relates
to this Guaranty or any of the other Transaction Documents to which the Guarantor is a party or any transactions contemplated hereby or
thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>The
Guarantor (A) has read and understands the terms and conditions of the Purchase Agreement, the Notes and the other Transaction Documents,
and (B) now has and will continue to have independent means of obtaining information concerning the affairs, financial condition and business
of the Company and the other Transaction Parties, and has no need of, or right to obtain from the Agent or any Investor, any credit or
other information concerning the affairs, financial condition or business of the Company or the other Transaction Parties that may come
under the control of the Agent or any Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Section
7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>Right of Set-off</U>. </B>Upon the occurrence and during the continuance of any Event of Default, the Agent may,
and is hereby authorized to, at any time and from time to time, without notice to the Guarantors (any such notice being expressly waived
by each Guarantor) and to the fullest extent permitted by law, set-off and apply any and all deposits (general or special, time or demand,
provisional or final) at any time held and other indebtedness at any time owing by any Investor to or for the credit or the account of
any Guarantor against any and all obligations of the Guarantors now or hereafter existing under this Guaranty or any other Transaction
Documents, irrespective of whether or not Agent shall have made any demand under this Guaranty or any other Transaction Document and although
such obligations may be contingent or unmatured. Agent agrees to notify in writing the relevant Guarantor promptly after any such set-off
and application made by such Investor, provided that the failure to give such notice shall not affect the validity of such set-off and
application. The rights of the Agent under this <U>Section 7</U> are in addition to other rights and remedies (including without limitation,
other rights of set-off) which the Agent or any Investor may have under this Guaranty or any other Transaction Document in law or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Section
8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>Notices, Etc</U>. </B>All notices and other communications provided for hereunder shall be in writing and shall
be mailed (by overnight mail or by certified mail, postage prepaid and return receipt requested), telecopied or delivered, if to any Guarantor,
to the address for such Guarantor set forth on the signature page hereto, or if to any Investor, to it at its respective address set forth
in the Purchase Agreement; or as to any Person at such other address as shall be designated by such Person in a written notice to such
other Person complying as to delivery with the terms of this <U>Section 8</U>. All such notices and other communications shall be effective
(i) if mailed (by certified mail, postage prepaid and return receipt requested), when received or three Business Days after deposited
in the mails, whichever occurs first; (ii) if telecopied, when transmitted and confirmation is received, provided same is on a Business
Day and, if not, on the next Business Day; or (iii) if delivered by hand, upon delivery, provided same is on a Business Day and, if not,
on the next Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Section
9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>CONSENT TO JURISDICTION</U>; <U>SERVICE OF PROCESS AND VENUE</U></B>. ANY LEGAL ACTION OR PROCEEDING WITH RESPECT
TO THIS GUARANTY OR ANY OTHER TRANSACTION DOCUMENT MAY BE BROUGHT IN THE COURTS OF THE STATE OF NEW YORK IN THE COUNTY OF NEW YORK OR
OF THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, AND, BY EXECUTION AND DELIVERY OF THIS AGREEMENT, EACH GUARANTOR
HEREBY IRREVOCABLY ACCEPTS IN RESPECT OF ITS PROPERTY, GENERALLY AND UNCONDITIONALLY, THE JURISDICTION OF THE AFORESAID COURTS. NOTHING
HEREIN SHALL AFFECT THE RIGHT OF THE INVESTORS TO SERVICE OF PROCESS IN ANY OTHER MANNER PERMITTED BY LAW OR TO COMMENCE LEGAL PROCEEDINGS
OR OTHERWISE PROCEED AGAINST EACH GUARANTOR IN ANY OTHER JURISDICTION. ANY GUARANTOR HEREBY EXPRESSLY AND IRREVOCABLY WAIVES, TO THE FULLEST
EXTENT PERMITTED BY LAW, ANY OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE TO THE JURISDICTION OR LAYING OF VENUE OF ANY SUCH LITIGATION
BROUGHT IN ANY SUCH COURT REFERRED TO ABOVE AND ANY CLAIM THAT ANY SUCH LITIGATION HAS BEEN BROUGHT IN AN INCONVENIENT FORUM. TO THE EXTENT
THAT ANY GUARANTOR HAS OR HEREAFTER MAY ACQUIRE ANY IMMUNITY FROM JURISDICTION OF ANY COURT OR FROM ANY LEGAL PROCESS (WHETHER THROUGH
SERVICE OR NOTICE, ATTACHMENT PRIOR TO JUDGMENT, ATTACHMENT IN AID OF EXECUTION OR OTHERWISE) WITH RESPECT TO ITSELF OR ITS PROPERTY,
EACH GUARANTOR HEREBY IRREVOCABLY WAIVES SUCH IMMUNITY IN RESPECT OF ITS OBLIGATIONS UNDER THIS GUARANTY AND THE OTHER TRANSACTION DOCUMENTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Section
10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>WAIVER OF JURY TRIAL, ETC</U>. </B>EACH GUARANTOR HEREBY WAIVES ANY RIGHT TO A TRIAL BY JURY IN ANY ACTION, PROCEEDING
OR COUNTERCLAIM CONCERNING ANY RIGHTS UNDER THIS GUARANTY OR THE OTHER TRANSACTION DOCUMENTS, OR UNDER ANY AMENDMENT, WAIVER, CONSENT,
INSTRUMENT, DOCUMENT OR OTHER AGREEMENT DELIVERED OR WHICH IN THE FUTURE MAY BE DELIVERED IN CONNECTION HEREWITH OR THEREWITH, OR ARISING
FROM ANY FINANCING RELATIONSHIP EXISTING IN CONNECTION WITH THIS GUARANTY OR THE OTHER TRANSACTION DOCUMENTS, AND AGREES THAT ANY SUCH
ACTION, PROCEEDING OR COUNTERCLAIM SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY. EACH GUARANTOR CERTIFIES THAT NO OFFICER, REPRESENTATIVE,
AGENT OR ATTORNEY OF ANY INVESTOR HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT ANY INVESTOR WOULD NOT, IN THE EVENT OF ANY ACTION, PROCEEDING
OR COUNTERCLAIM, SEEK TO ENFORCE THE FOREGOING WAIVERS. EACH GUARANTOR HEREBY ACKNOWLEDGES THAT THIS PROVISION IS A MATERIAL INDUCEMENT
FOR THE INVESTORS ENTERING INTO THE OTHER TRANSACTION DOCUMENTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Section
11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>Taxes</U>. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>All
payments made by any Guarantor hereunder or under any other Transaction Document shall be made in accordance with the terms of the respective
Transaction Document and shall be made without set-off, counterclaim, deduction or other defense. All such payments shall be made free
and clear of and without deduction for any present or future Taxes, deductions, charges or withholdings and all liabilities with respect
thereto, other than Excluded Taxes. If any Guarantor shall be required to deduct or to withhold any Taxes from or in respect of any amount
payable hereunder or under any other Transaction Document:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>the
amount so payable shall be increased to the extent necessary so that after making all required deductions and withholdings (including
Taxes on amounts payable to any Investor pursuant to this sentence) each Investor receives an amount equal to the sum it would have received
had no such deduction or withholding been made,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>such
Guarantor shall make such deduction or withholding,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>such
Guarantor shall pay the full amount deducted or withheld to the relevant taxation authority in accordance with applicable law, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>as
promptly as possible thereafter, such Guarantor shall send the Agent an official receipt (or, if an official receipt is not available,
such other documentation as shall be satisfactory to the Agent, as the case may be) showing payment. In addition, each Guarantor agrees
to pay any Other Taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Each
Guarantor hereby indemnifies and agrees to hold the Agent and each Investor (each an &#8220;<B><U>Indemnified Part</U>y</B>&#8221;) harmless
from and against Taxes or Other Taxes (including, without limitation, any Taxes or Other Taxes imposed by any jurisdiction on amounts
payable under this <U>Section 11</U>, but excluding Excluded Taxes) paid by any Indemnified Party as a result of any payment made hereunder
or from the execution, delivery, registration or enforcement of, or otherwise with respect to, this Agreement or any other Transaction
Document, and any liability (including penalties, interest and expenses for nonpayment, late payment or otherwise) arising therefrom or
with respect thereto, whether or not such Taxes or Other Taxes were correctly or legally asserted, except to the extent that such Taxes
or Other Taxes are determined by a court of competent jurisdiction by a final and nonappealable judgment to have resulted from the gross
negligence or willful misconduct of such Indemnified Party. This indemnification shall be paid within 30 days from the date on which the
Agent makes written demand therefor, which demand shall identify the nature and amount of such Taxes or Other Taxes and shall include
a certification as to the amount of any such Taxes or Other Taxes by the Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>If
any Guarantor fails to perform any of its obligations under this <U>Section 11</U>, such Guarantor shall indemnify the Agent and each
Investor for any taxes, interest or penalties that may become payable as a result of any such failure. The obligations of the Guarantors
under this <U>Section 11</U> shall survive the termination of this Guaranty and the payment of the Guaranteed Obligations and all other
amounts payable hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
Investor that is entitled to an exemption from or reduction of withholding tax with respect to payments made under any Transaction Document
shall deliver to the Company, at the time or times reasonably requested by the Company, such properly completed and executed documentation
reasonably requested by the Company as will permit such payments to be made without withholding or at a reduced rate of withholding. In
addition, any Investor, if reasonably requested by the Company, shall deliver such other documentation prescribed by applicable law or
reasonably requested by the Company as will enable the Company to determine whether or not such Investor is subject to backup withholding
or information reporting requirements. Notwithstanding anything to the contrary in the preceding two sentences, the completion, execution
and submission of such documentation shall not be required if in the Investor&#8217;s reasonable judgment such completion, execution or
submission would subject such Investor to any material unreimbursed cost or expense or would materially prejudice the legal or commercial
position of such, Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>If
any party determines, in its sole discretion exercised in good faith, that it has received a refund of any taxes as to which it has been
indemnified pursuant to this <U>Section 11</U> (including by the payment of additional amounts pursuant to this <U>Section 11</U>), it
shall pay to the indemnifying party an amount equal to such refund (but only to the extent of indemnity payments made under this <U>Section
11</U> with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including Taxes) of such indemnified
party and without interest (other than any interest paid by the relevant governmental refunding party with respect to such refund). Such
indemnifying party, upon the request of such indemnified party, shall repay to such indemnified party the amount paid over pursuant to
this paragraph (e) (plus any penalties, interest or other charges imposed by the relevant governmental refunding party) in the event that
such indemnified party is required to repay such refund to such governmental refunding party. Notwithstanding anything to the contrary
in this paragraph (e), in no event will the indemnified party be required to pay any amount to an indemnifying party pursuant to this
paragraph (e) the payment of which would place the indemnified party in a less favorable net after-tax position than the indemnified party
would have been in if the tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed
and the indemnification payments or additional amounts with respect to such tax had never been paid. This paragraph shall not be construed
to require any indemnified party to make available its tax returns (or any other information that it deems confidential) to the indemnifying
party or any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Section
12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>Miscellaneous</U>. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Each
Guarantor will make each payment hereunder in Dollars and in immediately available funds to each Investor, at such address specified by
such Investor from time to time by notice to the Guarantors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>No
amendment or waiver of any provision of this Guaranty and no consent to any departure by any Guarantor therefrom shall in any event be
effective unless the same shall be in writing and signed by each Guarantor and the Agent, on behalf of the Investors, and then such waiver
or consent shall be effective only in the specific instance and for the specific purpose for which given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>No
failure on the part of the Agent or any Investor to exercise, and no delay in exercising, any right hereunder or under any other Transaction
Document shall operate as a waiver thereof, nor shall any single or partial exercise of any right hereunder or under any Transaction Document
preclude any other or further exercise thereof or the exercise of any other right. The rights and remedies of the Agent and the Investors
provided herein and in the other Transaction Documents are cumulative and are in addition to, and not exclusive of, any rights or remedies
provided by Law. The rights of the Agent and the Investors under any Transaction Document against any party thereto are not conditional
or contingent on any attempt by the Agent or any Investor to exercise any of their respective rights under any other Transaction Document
against such party or against any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
provision of this Guaranty that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the
extent of such prohibition or unenforceability without invalidating the remaining portions hereof or affecting the validity or enforceability
of such provision in any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>This
Guaranty shall (i) be binding on each Guarantor and Investor and their respective successors and assigns, and (ii) inure, together with
all rights and remedies of the Agent and the Investors hereunder, to the benefit of the Agent and the Investors and their respective successors,
transferees and assigns. Without limiting the generality of clause (ii) of the immediately preceding sentence, the Agent and any Investor
may assign or otherwise transfer its rights and obligations under the Purchase Agreement, the Notes or any other Transaction Document
to any other Person in accordance with the terms thereof, and such other Person shall thereupon become vested with all of the benefits
in respect thereof granted to the Agent or such Investor, as the case may be, herein or otherwise. None of the rights or obligations of
any Guarantor hereunder may be assigned or otherwise transferred without the prior written consent of the Agent on behalf of the Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Any
subsidiary (whether by acquisition or formation) of any Guarantor shall execute and deliver to the Agent and the Investors a joinder to
this Guaranty in form and substance reasonably satisfactory to the Agent and the Investors. Upon the execution and delivery of such a
joinder by any such subsidiary, such subsidiary shall become a Guarantor hereunder with the same force and effect as if originally named
a Guarantor herein. The execution and delivery of any agreement or instrument adding an additional Guarantor as a party to this Guaranty
shall not require the consent of any Guarantor hereunder. The rights and obligations of each Guarantor hereunder shall remain in full
force and effect notwithstanding the addition of any new Guarantor hereunder, as though such new Guarantor had originally been named a
Guarantor hereunder on the date of this Guaranty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>This
Guaranty reflects the entire understanding of the transactions contemplated hereby and shall not be contradicted or qualified by any other
agreement, oral or written, entered into before the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Section
headings herein are included for convenience of reference only and shall not constitute a part of this Agreement for any other purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>This
Guaranty may be executed by each party hereto on a separate counterpart, each of which when so executed and delivered shall be an original,
but all of which together shall constitute one agreement. Delivery of an executed counterpart by facsimile or other method of electronic
transmission shall be equally effective as delivery of an original executed counterpart.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>THIS
GUARANTY SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAW OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS MADE AND TO BE
PERFORMED THEREIN WITHOUT REGARD TO CONFLICT OF LAW PRINCIPLES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Section
13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>Receipt of Payments</U>. </B>Without limiting the obligations of the Guarantors under <U>Section 2</U> of this
Guaranty, if the Agent or any Investor receives from or on behalf of any Guarantor any amount under this Guaranty or any other Transaction
Document in a currency other than the currency in which the Guaranteed Obligations are denominated (the &#8220;<B>Obligation Currency</B>&#8221;),
including without limitation, by way of enforcement upon Collateral, the Agent and each Investor is hereby authorized to, and at its sole
discretion may, convert such currency into the Obligation Currency for application to the Guaranteed Obligations in accordance with the
Transaction Documents. The Guaranteed Obligations shall be satisfied only to the extent of the amount of the Obligation Currency received
by the Agent or any Investor from such conversion of the Guaranteed Obligations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Section
14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>Currency; Judgment</U>. </B>Without limiting and in addition to <U>Section 13</U> of this Guaranty, if for the
purposes of obtaining judgment in any court in any jurisdiction with respect to this Guaranty it becomes necessary to convert into the
currency of such jurisdiction (herein called the &#8220;<B><U>Jud</U>g<U>ment Currenc</U>y</B>&#8221;) any amount due hereunder in any
currency other than the Judgment Currency, then conversion shall be made at the Exchange Rate prevailing on the Business Day before the
day on which (a) the date of actual payment of the amount due, in case of any proceeding in the courts of any jurisdictions that could
give effect to such conversion being made on such date, or (b) judgment is given in the case of any proceeding in the courts of any other
jurisdiction. In the event that there is a change in the Exchange Rate prevailing between the Business Day before the day on which the
judgment is given and the date of payment of the amount due, the Guarantors will, on the date of payment, pay such additional amounts
(if any) as may be necessary to ensure that the amount paid on such date is the amount in the Judgment Currency which when converted at
the exchange rate prevailing on the date of payment is the amount then due under this Guaranty. Any additional amount due from the Guarantors
under this <U>Section 14</U> will be due as a separate debt and shall not be affected by judgment being obtained for any other sums due
under or in respect of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[The remainder of this page intentionally left
blank]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, each Guarantor
has caused this Guaranty to be executed by its respective duly authorized officer, as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><B>GUARANTORS:</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 5%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 25%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><B>AULT AND COMPANY, INC.</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"></TD>
    <TD>Name: Milton Ault</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"></TD>
    <TD>Title: Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><B>BITNILE, INC.</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"></TD>
    <TD>Name: William Horne</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"></TD>
    <TD>Title:&nbsp;&nbsp;Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><B>AULT LENDING, LLC</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"></TD>
    <TD>Name: David Katzoff</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"></TD>
    <TD>Title: Manager</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><B>Todd Ault, individually</B></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notices to all Guarantors:<BR>
11411 Southern Highlands Parkway, Suite 240, Las Vegas, NV 89141<BR>
Attn: Milton C. Ault, III<BR>
Email.:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 Park Avenue, Suite 1658A, New York, NY 10017<BR>
Attn: Henry Nisser<BR>
Email.:</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page to Guaranty)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="bitnile_logo.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>BitNile Holdings Obtains $14.7 Million in Secured
Debt Financing to Support Private Equity Investment </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Las
Vegas, NV, December 19, 2022 &ndash;</FONT> BitNile
Holdings, Inc.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #151B22">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(NYSE
American: NILE), a diversified holding company (&ldquo;<B>BitNile</B>&rdquo; or the &ldquo;<B>Company</B>&rdquo;) announced today that
it borrowed $14.7 million of principal amount of a secured promissory note (the &ldquo;<B>Note</B>&rdquo;) from an accredited investor
and shareholder. The Note matures on March 16, 2023, although if the Company repays at least $12 million of principal payment on or before
the maturity date, the Company may extend the maturity date by 45 days by paying a fee of 10% of the outstanding balance owed as of the
original maturity date. The Note is secured by certain assets of the Company and various subsidiaries. The purchase price for the Note
was $13.5 million, of which $12 million was paid in cash and $1.5 million was a non-accountable expense allowance. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Loans are guaranteed
by Ault Lending, LLC, a subsidiary of the Company (&ldquo;<B>Ault Lending</B>&rdquo;), Ault &amp; Company, Inc., an affiliate of the Company,
as well as Milton C. Ault, III, the Company&rsquo;s Executive Chairman and the Chief Executive Officer of Ault &amp; Company, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The proceeds from the
Note will be used for one of the Company&rsquo;s first private equity related investments, the previously announced agreement to purchase
<FONT STYLE="color: #151B22">substantially all of the operating assets of Circle 8 Crane Services LLC (&ldquo;<B>Circle 8</B>&rdquo;),
which is expected to close later today. The Company&rsquo;s investments in private equity and commercial real estate are led by<BR>
Christopher K. Wu, the President of the Company&rsquo;s subsidiary, Ault Alliance, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #151B22">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #151B22">The Company&rsquo;s
Founder and Executive Chairman, Milton &ldquo;Todd&rdquo; Ault, III said &ldquo;Chris Wu and I are very pleased to close this financing
related to what I believe will be a transformational acquisition of the crane operations of Circle 8, an expected key component of our
initiatives in energy and infrastructure. We expect to repay the Note from funds from Ault Lending and proceeds from certain real estate
transactions.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more information on BitNile and its subsidiaries,
BitNile recommends that stockholders, investors, and any other interested parties read BitNile&rsquo;s public filings and press releases
available under the Investor Relations section at www.BitNile.com or available at www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE"><B>About BitNile Holdings,
Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">BitNile Holdings, Inc.
is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact.
Through its wholly and majority-owned subsidiaries and strategic investments, BitNile owns and operates a data center at which it mines
Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, defense/aerospace,
industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. In addition, BitNile extends credit to
select entrepreneurial businesses through a licensed lending subsidiary. BitNile&rsquo;s headquarters are located at 11411 Southern Highlands
Parkway, Suite 240, Las Vegas, NV 89141; www.BitNile.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE"><B>Forward-Looking
Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">This press release
contains &ldquo;forward-looking statements&rdquo; within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, and
Section&nbsp;21E of the Securities Exchange Act of 1934, as amended.&nbsp;These forward-looking statements generally include statements
that are predictive in nature and depend upon or refer to future events or conditions, and include words such as &ldquo;believes,&rdquo;
&ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;projects,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expects,&rdquo; &ldquo;intends,&rdquo;
&ldquo;strategy,&rdquo; &ldquo;future,&rdquo; &ldquo;opportunity,&rdquo; &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo;
&ldquo;could,&rdquo; &ldquo;potential,&rdquo; or similar expressions. Statements that are not historical facts are forward-looking statements.
Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking statements
speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information
or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various
factors.&nbsp;More information, including potential risk factors, that could affect the Company&rsquo;s business and financial results
are included in the Company&rsquo;s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company&rsquo;s
Forms 10-K, 10-Q and 8-K. All filings are available at&nbsp;www.sec.gov
and on the Company&rsquo;s website at www.BitNile.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>BitNile Holdings Investor Contact: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IR@BitNile.com
or 1-888-753-2235</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>7
<FILENAME>ex99_2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><IMG SRC="bitnile_logo.jpg" ALT="">&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>BitNile Holdings&rsquo; Subsidiary Announces
the Closing of its Acquisition of the Assets of Circle 8 Crane Services </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Las Vegas, NV, December
19, 2022 &ndash; <FONT STYLE="color: Black">BitNile Holdings, Inc</FONT><FONT STYLE="color: blue">.</FONT><FONT STYLE="color: #151B22">&nbsp;</FONT>(NYSE
American: NILE), a diversified holding company (&ldquo;<B>BitNile</B>&rdquo; or the &ldquo;<B>Company</B>&rdquo;) announced today <FONT STYLE="color: #151B22">that
Circle 8 Newco LLC, a newly formed indirect subsidiary of Ault Alliance, Inc.&nbsp;(&ldquo;<B>Ault Alliance</B>&rdquo;), a wholly owned
subsidiary of the Company, has closed on its acquisition of substantially all of the operating assets of Circle 8 Crane Services LLC
(&ldquo;<B>Circle 8</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #151B22">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #151B22">Circle
8 was a crane rental and lifting solutions provider founded in 2007 and headquartered in Corpus Christi, TX with multiple locations throughout
the South Central region of the U.S. It maintained a large modern fleet of mobile cranes for its customers&rsquo; heavy lifting needs.
In particular, Circle 8 provided crane operators, engineering, custom rigging and transportation services for oilfield, construction,
commercial and infrastructure markets. Circle 8 maintained an industry leading safety record.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #151B22">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #151B22">The Company&rsquo;s
Founder and Executive Chairman, Milton &ldquo;Todd&rdquo; Ault, III said &ldquo;We are very pleased to consummate this strategic acquisition.
We believe the Circle 8 acquisition provides a significant growth platform and furthers our strategy of investing in private equity opportunities
that provide operating cash flow. As previously disclosed, based on current market conditions, we believe that the assets of Circle 8
we acquired are on track to generate in excess of $40 million of annual revenue in 2023.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #151B22">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #151B22">Ault
Alliance&rsquo;s President, Christopher K. Wu said, &ldquo;Todd and I are excited to close this private equity investment and look forward
to supporting the expected growth of our crane operations.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more information on BitNile and its subsidiaries,
BitNile recommends that stockholders, investors, and any other interested parties read BitNile&rsquo;s public filings and press releases
available under the Investor Relations section at www.BitNile.com or available at <FONT STYLE="color: Black">www.sec.gov</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE"><B>About BitNile Holdings,
Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">BitNile Holdings, Inc.
is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact.
Through its wholly and majority-owned subsidiaries and strategic investments, BitNile owns and operates a data center at which it mines
Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, defense/aerospace,
industrial, crane rental, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. In addition, BitNile extends
credit to select entrepreneurial businesses through a licensed lending subsidiary. BitNile&rsquo;s headquarters are located at 11411 Southern
Highlands Parkway, Suite 240, Las Vegas, NV 89141; www.BitNile.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE"><B>Forward-Looking
Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">This press release
contains &ldquo;forward-looking statements&rdquo; within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, and
Section&nbsp;21E of the Securities Exchange Act of 1934, as amended.&nbsp;These forward-looking statements generally include statements
that are predictive in nature and depend upon or refer to future events or conditions, and include words such as &ldquo;believes,&rdquo;
&ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;projects,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expects,&rdquo; &ldquo;intends,&rdquo;
&ldquo;strategy,&rdquo; &ldquo;future,&rdquo; &ldquo;opportunity,&rdquo; &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo;
&ldquo;could,&rdquo; &ldquo;potential,&rdquo; or similar expressions. Statements that are not historical facts are forward-looking statements.
Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking
statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light
of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as
a result of various factors.&nbsp;More information, including potential risk factors, that could affect the Company&rsquo;s business
and financial results are included in the Company&rsquo;s filings with the U.S. Securities and Exchange Commission, including, but not
limited to, the Company&rsquo;s Forms 10-K, 10-Q and 8-K. All filings are available at&nbsp;<FONT STYLE="color: Black">www.sec.gov</FONT>
and on the Company&rsquo;s website at www.BitNile.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>BitNile Holdings Investor Contact: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IR@BitNile.com or 1-888-753-2235</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>nile-20221219.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9KhZs7xRiXgen8uNYnZcWaCPmaP9yZ5wqekxtG1zHQkaPyEmoWcf3S/zD+gGcfwP -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:NILE="http://NILE/20221219" elementFormDefault="qualified" targetNamespace="http://NILE/20221219">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://NILE/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="nile-20221219_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="nile-20221219_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="nile-20221219_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="NILE_CommonStock0.001ParValueMember" name="CommonStock0.001ParValueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NILE_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember" name="Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>nile-20221219_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://NILE/role/Cover" xlink:href="nile-20221219.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://NILE/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="nile-20221219.xsd#NILE_CommonStock0.001ParValueMember" xlink:label="loc_NILECommonStock0.001ParValueMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NILECommonStock0.001ParValueMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="nile-20221219.xsd#NILE_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember" xlink:label="loc_NILESec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NILESec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>nile-20221219_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="nile-20221219.xsd#NILE_CommonStock0.001ParValueMember" xlink:label="NILE_CommonStock0.001ParValueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NILE_CommonStock0.001ParValueMember" xlink:to="NILE_CommonStock0.001ParValueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NILE_CommonStock0.001ParValueMember_lbl" xml:lang="en-US">Common Stock, $0.001 par value</link:label>
      <link:loc xlink:type="locator" xlink:href="nile-20221219.xsd#NILE_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember" xlink:label="NILE_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NILE_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember" xlink:to="NILE_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NILE_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember_lbl" xml:lang="en-US">13.00% Series D Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>nile-20221219_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://NILE/role/Cover" xlink:href="nile-20221219.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://NILE/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="nile-20221219.xsd#NILE_CommonStock0.001ParValueMember" xlink:label="loc_NILECommonStock0.001ParValueMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NILECommonStock0.001ParValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nile-20221219.xsd#NILE_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember" xlink:label="loc_NILESec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NILESec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>bitnile_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bitnile_logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,"XU /_; $,  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( #$
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M::?='R#K^@_M_?\ !MS^WO;W^G7,MYHU^TQTC5A'?I\'?VIO@[%J$37.FZE
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MF*TB>&PMHHY)$0-,X,CDL37S/_Q#$?\ !(K_ *(SX_\ _#O^-O\ Y-K@PO\
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M& 5DUH7"7(BC*8,I@6^MXF91^X1-Z5^P>(G@2_''A7_5['^)4>!>&JU23QF
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M/(([U_CL?L7_  -M?C-_P4;_ &;/@K\)=5N_%^AZU^TQ\//[!\02V<EK-?\
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*BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504621165824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 19, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 19,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12711<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BITNILE HOLDINGS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000896493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-1721931<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11411 Southern Highlands Parkway<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Las Vegas<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">89141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(949)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">444-5464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NILE_CommonStock0.001ParValueMember', window );">Common Stock, $0.001 par value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NILE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NILE_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember', window );">13.00% Series D Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">13.00% Series D Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NILE PRD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NILE_CommonStock0.001ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NILE_CommonStock0.001ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NILE_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NILE_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>b12192208k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:NILE="http://NILE/20221219"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nile-20221219.xsd" xlink:type="simple"/>
    <context id="From2022-12-19to2022-12-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000896493</identifier>
        </entity>
        <period>
            <startDate>2022-12-19</startDate>
            <endDate>2022-12-19</endDate>
        </period>
    </context>
    <context id="From2022-12-192022-12-19_custom_CommonStock0.001ParValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000896493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NILE:CommonStock0.001ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-19</startDate>
            <endDate>2022-12-19</endDate>
        </period>
    </context>
    <context id="From2022-12-192022-12-19_custom_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000896493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NILE:Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-19</startDate>
            <endDate>2022-12-19</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-12-19to2022-12-19">0000896493</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-12-19to2022-12-19">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-12-19to2022-12-19">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-12-19to2022-12-19">2022-12-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-12-19to2022-12-19">BITNILE HOLDINGS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-12-19to2022-12-19">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-12-19to2022-12-19">001-12711</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-12-19to2022-12-19">94-1721931</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-12-19to2022-12-19">11411 Southern Highlands Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-12-19to2022-12-19">Suite 240</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-12-19to2022-12-19">Las Vegas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-12-19to2022-12-19">NV</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-12-19to2022-12-19">89141</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-12-19to2022-12-19">(949)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-12-19to2022-12-19">444-5464</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-12-19to2022-12-19">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-12-19to2022-12-19">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-12-19to2022-12-19">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-12-19to2022-12-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-12-192022-12-19_custom_CommonStock0.001ParValueMember">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-12-192022-12-19_custom_CommonStock0.001ParValueMember">NILE</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-12-192022-12-19_custom_CommonStock0.001ParValueMember">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-12-192022-12-19_custom_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember">13.00% Series D Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-12-192022-12-19_custom_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember">NILE PRD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-12-192022-12-19_custom_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-12-19to2022-12-19">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
MT8.356<@,$7(!   *10  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R]
MF&UOXC@0Q[^*Q3UH5VI+G%(*>Q2II>T6;9>BPG5U]\XD UA-XISME/+M;YQ"
MTO;"A.Z+XP7$2>;/SS/VC.W>2NE'LP2P[#F.$G/66%J;?FDV3;"$6)@CE4*"
M3^9*Q\)B4R^:)M4@PMPHCIJ^Y[6;L9!)H]_+[XUUOZ<R&\D$QIJ9+(Z%7E]
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M2_R==S Y8\0#.I3OW/1W!R;Q&-#C%<K<9":)-5U>B/%*0:S;%4S.Y68R#/;
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M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ T8.35660>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
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M+GAM;%!+ 0(4 Q0    ( -&#DU4:"@K>[0   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( -&#DU697)PC$ 8
M )PG   3              "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ T8.356<@,$7(!   *10  !@              ("!# @  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( -&#DU7@]#J)J@(
M # ,   -              "  0H-  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  %<4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="b12192208k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://NILE/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="b12192208k.htm">b12192208k.htm</File>
    <File>ex10_1.htm</File>
    <File>ex10_2.htm</File>
    <File>ex10_3.htm</File>
    <File>ex4_1.htm</File>
    <File>ex99_1.htm</File>
    <File>ex99_2.htm</File>
    <File>nile-20221219.xsd</File>
    <File>nile-20221219_def.xml</File>
    <File>nile-20221219_lab.xml</File>
    <File>nile-20221219_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "b12192208k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 26
   },
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "nile-20221219_def.xml"
     ]
    },
    "inline": {
     "local": [
      "b12192208k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "nile-20221219_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nile-20221219_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "nile-20221219.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 65,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "NILE",
   "nsuri": "http://NILE/20221219",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "b12192208k.htm",
      "contextRef": "From2022-12-19to2022-12-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://NILE/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "b12192208k.htm",
      "contextRef": "From2022-12-19to2022-12-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "NILE_CommonStock0.001ParValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, $0.001 par value"
       }
      }
     },
     "localname": "CommonStock0.001ParValueMember",
     "nsuri": "http://NILE/20221219",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "NILE_Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "13.00% Series D Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share"
       }
      }
     },
     "localname": "Sec13.00SeriesDCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember",
     "nsuri": "http://NILE/20221219",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://NILE/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001214659-22-015103-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001214659-22-015103-xbrl.zip
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M#'1S/RQLZ\RQWQH#::EG6I*!J:9[DM,RK<>@1<+RCS:E(.0$:+&D4*,9$=C
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M)]9C_$8U4L2A9A@@RBJ(85;R.[0S29'2*"TX[594DPF>/^:97%(Q#N(\H0Y
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M+#TBZI%.]Q('TZ&<413#F)H ?3F3\*BPX"1SNWEXS68>:)>W@!NPUC[.J2Z
MSC^=MX\II$U1+]2F$=,@*!WA$-W5RAKX8$DE-F.=.ZVP5HGGPDD<#1U$46+5
MFU@=45"E4(TDWH4?9EVW*YQ'I-/ Q'_%V=0A?SG5CJ!^4T0/S1JB[)HL$\'S
M.Y-N+X@RWRE6YTO_ UI%U<HP$MR#-8UP--'*E]RMAIK;2W4E9\HM\U_*[#CE
MA.,UC9V\6E%L,..[Q8QJFW<< \ZN%1BWK:Z6Y7,#O&&&FE)EQ%+I8815,[QF
MPVB62:,O52<J(V-4-B^LLS+>3MLTD$S'$Y7&T]\TYC6C\6''2U;5BSYUU_T"
M23HXYLB]\!NJ&N!E;<M1(+-70G1AM>:6C/@S+2T-?:EICNDU[U*DV'5UN<9'
MYY(QR\-MS'*M8I:'VYCE-F;Y/6RGU6OLF*L(#1B=\VXF(!E8R0Z, EFF7F^,
MIB\#;O%O"G9L'FF,$2;&U>C="#&/J54EUC(,IJ$>>P>_/-EG7D+N$;/&Q_6*
MJ[5ZA=@1;(X D4-6<]!F<;!5E<1P/.3HHC:.+A_Q4G6"K=3:MEV,L3G;,U.]
M,PS9]C J[Q#@T.Y3-WN?"^LO LQO*-@12$MV5<[NZ\HNK"K657.E,)6I^VE&
M\ D;(S*'JY=B8%+BO5"N@*,$ABTW?YR;A_#M1 0NCM[GA?G35$B21ZKG#L7I
MB#3-)V-08#$J!(9\*\1^IMA?"FLH%$>0WP<A*0"B>]YI/R\N=2FL=SRW56.&
M3"8$IZMS2M<H;)TZ@8V1D]6ATKV1,M[Y%+ZDB+(&]]<I[2X4N;TUM0W%85IW
M:6*/(R+E+R/M K\EFD?XX5AS5=PP"6V>W5)Y\8W5-EF]KKTY\E)]CGV,AD:A
M$EKJ:V-Q64;HH >Z/XX*E O^0]=2Z(:V"T:3NU1*PMM8;Q$K4#=R7V".W?9.
MC0OAU\0UCY@.Q$[-1^[=UQ9:T&L8FE9N8DM[4AS 0!4JF&^SH2:$&46OD;H+
MMQ1EX'(HE[.(DD0)%:_&;98@_U$>2WH(MW!6P4+ MLXFH(Q"K(THFO[F32"-
M5Z<8GZ]2=HNII0!F#W*=!D$JWZQDF!OATNSUYO0HNL<P-,UCB1&0FXQ9Y^F^
MVQBVZ6+)@Z.+BDC,,"7,46-Z]885)SJL)(P[/AVDGSO0&D!,[UV-S((U+'3E
M3[=C*"L+=6C#"8QI.,VR2;0P$D^&%9WHS9O 60Y?H4@L\]; JM,*=T$37)R"
MH4HQ!*4#X=*#K&L9I8 L&JR6#T+QM@"GM!P$1^2$-_PIK$;2.\YWV['L<)PC
ML#HTJ G9;7SNDH>1!'5;V_JZ!$+6=+E!1IZLS=%*J]<-H/7R-L\^@R"(//K8
M%2 T/^-<LNW;XP6?>>\B!J*2KJ%\BN)1@+W'#_-14$(GO: 6/E"/&<MC1N8Q
MN*$Y)*MB9.WQ>3>V+WGD-I)KA%"VP/CN$1S-(WM/S^EFE'IS9&EUR/OYN]Z1
MI CLXM55X#<V908IZ_F42)2F86_*E0;MQ&@J"Y_%P->NC&^./ &,NL9V.SLQ
MG*D_-^5/P\OYK)08?3*S,$3<_<0%5Q0@>I+F#D%%*7IO$?=S&C@.X%V61[!@
M4M;#6*=,MWIPGWF,:!"G;\I53J6/,YN,G)?)5"N_:A9Z:@0[SZ6"J>J?*FFZ
MI',+&O6K,SM*?Y!N  T7<IN!/!Y6/.FFS)68D8/; $Z'(18QJ>H325MD34N+
M0?"T)D9U8?DF&DA_9&!K>5@CCF%ZG)&4;13>S++8Z-C*#<A73UHMDM( %2HI
M,)_M,W?X9_EB3B$6I/482H5TT3-+C-HDP!9\L_*MBU@7!URN-3Y5EHR@/]Y&
MT-<J@OYX&T'?1M"_AUFQ>@D/FJA*"QYE.:8?P7A 93V*M-W9-#>6JPSSYZBX
MEP0W4!A)TZV:5;G69(07T[ 2!$6,2?>.*Z3#RG(+AJ5T *:^$52I;!'&X%JP
ME.5Q2-V.Z<1AU*EI)=]@83P-[EXI2+#4@+H?HP'"&%HF%  A^]C,8FN*:W;9
MJ>2J_CN&7%F.IC4C]&.58Y6IKBQ=/'UWN"HQ$V-JS #,(_6HTE^%SYTK%=U.
M;Z3?WL[Q!P^<5,FU:4G$C\WLQM0:WQT7;A_Z/$JB6PSX.Z@PJL(C1UGY.FC+
ML G 0#1[+6I1*I0^,"O:RR#9/',]&],*I+5"$4%V<5D)&2-69,>JR=.40L/R
M7+*S* +DA5$!LRG<,%0[Z'N&1M.)MLV<LB;&LE21?:/ZG6H-I"G+Q;ZS9G6-
MK9L5#[?52QIZV)/S(QQ?,V3/(-$#"3*!7FN50?:B5<&DN&B,G%;]C2R.3D;M
ME#0=-0;.-J)-:A\ZP:%ZB1XI@3Y\>V?YUH:[KF+DJTSY!6W-TDV+.!405HP
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MU5U:G5J,7_]L_^#@D6 ,=^)=+'E:T!##2)#NVFOZ_[EL"!9 \3IJPF*SO/9
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M&?YN7B[A]YZW7@)^3!(#Q/1-K9&&I2FN;L.'+>Y7NR)G,$/KJ,@.MTC'!>S
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MC!:%APVD:XJ.^Q=I6OL6)=.FVIH6Q<8X'P]A,T9((4:I/DU)'[8[&S_X!#W
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MRH?Y 'Y'[M>HG;)#0/B,@B:(C["9<G$2+/</&Y#NMN3):A@;O6[+II4T FR
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MXWTE#.9O,,WFLJB6VG) ]2-T%7-)ZXO'$F'Z^ER"AJ97NE>*"^C%!78+DQ!
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M#TF4^-YQ2)/D/BCPST$S<URG:N0%VX!RH-[#K4&VW>"R2!0WPZ@5W,EU"<;
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M*Z5*NUI*T6O:\1[0A@A584T8?+FJ5!Y04HB42_6==^G9BW.% A ?IL1/O K
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M7"G35DC?@7X,^#CLG3*FZ#"Z5D0_<NFQQAT=::H-0XD45E&ZG[V]=(%!LO/
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MJ"6MF$[,@"^PY"4H>'EJM_J&<X:DA2+)H3J>/U,Y8Q;D-ZCHM9MN"I20Z$O
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MOS*["'_N86#$Y(0NQPF[;$RHEJY#=GKRW5DAR>^1SQ^=^X'Y8IBV/.GNG[#
MOF>4W_BR%&(\U,]/3Z@#I:_M0F^>8(:[=!(,:"22PM[/MO/61D25:-^GE=7*
M0?W?D '.49=%$]+@)": %[A_WJ??:Y>01HY4).&&L&QQWD!KUF6=MIHT&TZ)
M&:6@G*"/)B;#9(N.6!/><+4*-$Z?S#7/KM$18;S1WOF!M30 D5EC%XHTHBP+
M&I2OKD<PS?"Y5S$E>%!05)1<]V2$<:64R(TIT[O<M'797;J%[RJ[[7"7>WY8
MJ4JR ?W'4T!+""RD9=,(W,*\F-T]?A6L:_G&!6G=!'5FSDGOG(R(>E:I-'G\
M#AJD5_'&2^*W<KNIG(9*+C:5(@[EF>=/K=.V5WY<,F0/.CDP.PBU1V+J&[<3
M;0>MORNY&D*6_1-BM=^\\_S8L((=^4:I%S9;(?<!\5Q<XGSRN*.1N]:R@FHG
MQ7;BI!XXCDI-H?IIE!C!T:^2(W(2ZJW1<<FME=@'3R   Y1.B &WPC5'\ZPO
MWFOSU-?D.[+!*[1=5JYARVK7D>*%XKXLK]LKB0!H2&GJ38]U-^-1G0J*P)EK
M6EY6Y5O%^?1;]0(94<FFP(X0'<55476&/S.X*U)PQ"BPZ5DPID2\>K-8O-!6
M&)3K0DG")SK&0'2^S+-0"M"[NP;M810>Z-,1 B.TCPNJ^=!%-,OH(J-P-)(2
M=4*\'DM$G]?[$"Z\V$\[D)'D3?H@Z6^$OYFZB($R5!7$Z0]TC^.S2,R6#/4I
ME5=GP<(&N7H#54)<K>$NP84/80@;D!2EJ(8,)=!WH-4EM"(TF2]J*:YP(^%R
M25F%8?^&^+F/+8A_7!+8=BAR;R[A'AIDS!GIG$(#CW2F'1W.)4"-MDL>M$^_
M8Z.0M0FO#!R@H4,H5S%DW[<EP8PNVF:S)M$GSN46[^2&3ZT-UY&V06'4'(,J
MZ)W@$++H5T17S8&)X3M%L)5$&:9N9G9KES66RO6U[5%X\]G)KDIW[5GF#4LQ
M96C! (K*)R8-8[VC&$5(#[41*)$(&.$/$7)R+V)0G )*R^*J:2U4!75[22S5
MG1H>-2'U0Z-81 @[S, 9.*0CF,\R&A!O5U;B*)2"E\[D!:5>0[HFIP,S/OLT
M1F" QEYLHXLJ5&P9+[JJFQ2&6;E8Z'*HPU[[*G;C'1MKVX.7V&DT^3/Q#3+8
M(AIUC;8*@2?,'#.X8\G*"!EUP]?S*B.&C987;2GN#48I%N2=Z8A1&5=C!K,/
M:LA"_,6\1+6[[M9$H>MC.-R"CQ")QI+-RW8N*J@/*G%I@X(([5:;6JJOHC3_
MKP;=_OHOA.*)?6OJ1K KMI8QRFF@B++V/+ .DF\]LDN"2AK/-%5>(1V8Z<IY
M@U9*;X:J!A55">$%#O7T5/C8Q'&7Y;+'60WS)E'3+I5'BTS)%9H_J@W+MC 1
M,=6+EP-.RD@-^>[>UP\?(/.6MSL0O2GB'68,=R^3IDC\)+?W/.H^&ZP@&FZP
M<W'.TZK)+2/K]Z9G"F.[9&,9H"OE919.DP%C#$=,LP2/ZG"G%BJ/;I\T&#?W
MD09RC.04[QR&(Q.']BXI.X?P!CW!$!&"N7;7O]1ZU3X5UA3I[H9Y]W@4GF*3
MKY@UOXNH!J;:!W,L_8)Q$0 5\TUKF?0QJ)?;,B^AJC!ZGO(]D FLW\AA,'&I
M29/_IKJAN^=M'F$$<P%-<='HGOF<.$@9*#89G0VF!_]IR%<IV"-4]J8D0[);
M:1<?[$G49,\M;H!F@V9K$DC+X)W)Z4U1_.D99K#H;J)<)Q4\*#&[H\O">T[V
M(0"]GSTA0=FNJTWG)0-M>>AMO$]O6LO)/2K@5:$!X+6A/629#S\A(SRR?>J5
M$U79_;R\$L> W^$!OZ^. ;_;"?A]=0SX'0-^?UQ&JXF WUKOIB%^++>Z3Q/K
M.TS48PK/2;$=CI"PCN"1NV.L''G&J7:.N328%LJ3&-U H"AL'*J9PW4FE171
M+W/!,":ZQCWM%KM.:L497\(:P\>G)RVY1WQ*1BANJB;.6TP9$P8%K8<EKAQI
M&B<(.H9U<) Y?5ZNB\J'_S0*)5HC073-\ @Y36E$PUJW\3@8"-1Q!,>LC(_<
M!&_'TCGB "+GN>>R# Z;>45KQO6'_,(KM6MW>N)6ZZK9[DHX"D02-+8P_7?)
M#CJ$C"9947#LMYO"9+.GW75:,6BX6U*UBXK=X-A<ROQ&3GP)@WT@]'3_?(N[
MM$T^GDID,CXI,'?-SNO$;I L*6/^:5S+%CF><7(:I\=2>RB"XUJEXTS!<V]*
M2N"IDW**M V"O9A/FB&!F01^L1*J&NA\TW)PDC?EJ.N&J"S]3I'<I@HPZ9^Y
M]QG<E+<VHC62,-<@WP]-Q?'$!O&:[IT7^'"!D%?S*A33MEG=V,\^9'7GV65S
M3>:6>P_6J6 D)6L%:=/&U7$M5-N;9N3:BE#6*H,2J;3$0EE?-9*JA/)E6-M,
M=IY4,(ZFQ$8".&S)#G3.0"_!Z..\9"4@LEC3F]9&77L1.Y.F<+)'0XLU^X*D
M<V3[DXES5"%RKA4C=QC+/B]T5'\EZ7#H,,4YA/0:XK3?]U'-JF^"PT6U!VRX
M]TG7Q-K)J)1A4I\N8+3B@H384<A64G&P(<DM[S0&2+L%(15W25A??O"='I4'
M1C1:[3'LJ+%^7F*,6YM$)N0X*P^81B4D\.1X4EQ9Y0)<;/>T.@D=$5!LPP?B
M9Q(MV8AY<CH)@R_S>3:;RE(8S-PX,5_-CZB\\/BB9,N)JCG"'YAUC8 1Y->L
MP23- SU%NR,;V->-\G6B,+-XP-EV>I(JIQ.GVK$\?E^N-BN5!L.4*H:3/*6R
M]E@S(01CARF@RO07<80-BGU(3OT-94D&%*R6F8/)-W=E;LFPK-E8<HE.GTU.
M4:UA>IDZB7W.ES1M).ZMG(C;/(L?>!@C'($_9C#A='+XC)J(:0'72]'*/9O*
M]_9GRV#Q1+G)IS$AZHB69_"_JW4_T;1XQCG.&Z3('\)Y^R=S(W]]="/?CAOY
MZZ,;^>A&_OQWQ"&7!-N,G*6,F-\U:S@Q(RZ< 02O9&<<RJNVG"6N?YT'5Q;#
MAU%323D:.^?>I=3"PM])=^Y"OSI@K=C 8]/8)^QP23%Q%R#>B%C\4+%VBY0K
M,37]0\U@^EH7O ,%'D2OJ!M^*Q5%YY*&.T+T,\.,+TY_PJ7?D74?D#P^?+ O
MR^,+:&!5D^\,E_NYA *(YO'(T[B759^./JG3#$_2TJ$SQI=0+7G.E_P(FH79
M9=&NJ@1O5R"*(R\-.ZYTS9SS]0$7GL"&[$+Q9FK-P(I(/G(I?( ?"*<Y4;TU
MEO8%EK^H^'..$=GB&XW"LWW$R%;V3'$IVMK%&CQ2PJ?I&!38?3.L.4GI2.>^
ME-HT];SH\V%BABSZ:CLPFX\S11'#?03R TDJB9B!@ID5$<<U[$UU::$7>1G/
M1L22IR=V-D;>3/LT)>@3_UN\;):#'NU;[B85>^$B0CQC<H%.$F\$/K7Q;'D7
MZD=74PQ.F&,AQ0_.NSU,O&!0?0ID)^RK*U^.::5D-I&8&)UKXXC1$L9[A(ZC
M8\O+OH$O*Q^"3PHVZ0RVU/8*.*<6;CI.3/L0_$$MS+_S9%D%^<<(4';AIL,'
MY_FN*CY4;Q+%3WSZQ>5V)M0@S+\HO8+3T_2EGGC*ZJ5_!D)"YK+002S@$'D$
M>1ZR1Y5\-<315LW"L\HI'XKPWTN.F)4GABA**B7E49DDJN]-C</$JW-, :#J
MZ,L/0[<BDM>Z\P)[2B@VU@[%H E^Q$5[IVNHY8RGO^*VL= H!C.''*.F4 IV
M>L9%OLSK#'93DF;NA$0:*HL/]U46?R&/&GJ^G_=S9@)_PK' 0;Z/I%XH5_"(
M:=J6A '-G6@)IPHKBQO/K]409HNL/HJSO2,:ZW !'^V[@&]\H%S3[;(GPI>-
MR_DX^W_PLJ&%?,-7C?6*WY7I/=P@>(*$;+'P&H0E&)O^LH3;,H -;"Q9V+H'
MT934:?$,YZ,0(@48*0H$!XJN!"4B)/<J_$UYNB73H8D8UNI&D^AUO1+@].,X
MA)-NFTF,14QW9L"2/*:F5:9JY.XS@ ]F 0PQ>*+VBO 3$8A_%T%EE%WJ;TVF
MON1[4[(S*%K!F9H84\*KFK O7E7>9\@R9LM3K'6L9%Q(?X;7C<(A^6+#%6>R
MM&T,K)+N^T;V& ,;DU'WL8F+32',D$L-R>TU>WA_6CP$)=.M$* P%QY-!F@$
M"RE*L"*SMHL#I+PJE+9"R$%>S] 5OZU'90Q.3Q+=Y.M%B-'^6TZ**HAS226.
MRH8G:]R/U0DRYWPP7LAD*0Z,,)7-NI*@%68":MCRF&AP>(3HFV.$Z'8B1-\<
M(T3'"-&?Q<,1DW)3PCA%\ DXS(X%\4>9NG-\>7K6HFET@-Z&,:FW.F,E/1_)
M._GN9A6%2E]3_$+!FP')K_9O9:YVK>YK67N(Z GUK/>7Q48\LU+AI!UC>*S_
MUG/=6Q7G%=Q.;/?'?H^[8;,>SJ%".GF3J(TYJ6&C5O"[-X#$US;-EI]'%+*D
MEJAF'O)VO=-WQ.$BZ$V[[L.NQ47?!\!NR<H)#<#/_)/J-$1?+P9'50?G>$'T
MDK9 MM5MQ/P\$6K;?]!<GWC8BCI[:D[K)8*6X9BU4@EM=$,<.T![1<JL1AZX
M$(+^E.H(=9?EVF?<#LO"&B;M$6K>,Q\Y=7_)1"5=[%SN9K9-(>)X!QE%WZK'
ML<=J)R=\5#PW:B8(B1'_]F#G,WT32Y([5K1UZ#3YX@:GR0^__9A,M4!'R=$1
M,O&__R\5#B1'ZP(GZO^[$UOK< 4(INF5V)LHB)Y1L6;VJ!(GSPNB@!I"QL40
M=A-A8BWG;(H+>+)T;="'^H3TFX&X6'I*_//,H$1]RY-%_LQ]R=Q*<<4)5[D+
MK=:EK.=3X2D1=\P.98O(D>0B@9;*K.R&B8\W]KE0*D_/<X<IF+AXFH79-\.+
M/F:+YYJ6-=([7E(A "ZOS6\1W(E&:!DS@]7JWF/ I:NV)GDT%%H,4CLYR*G^
M1.4@;QXY>C8D",)YF-SQV99]7*W4X>LTZ(8**^=VNE$78KBMUDS/366<D-!J
M*Y/O6DFB,=K,2V2_X@PBF$N\M =>06G2__CT1$;"50"WX<@DM.;'2J2&O&RR
M!+DN#^_5DK(G%WE&+%2]JQ>\<1OC>>T:=H&U&T=<L7APX#G<#YZC/Q'CW$:W
ML!F7S%8H^V8VC*\)PKWEI9!<!61P=82(:(0_:CI4QD>4D0*L-?;$MM1W$2!_
MZ""+-$\9([E/-UK4L^PCMF>NGQ.V(P@R'I8&?T,$<!F!2@1:0>%I9L'#-5H2
M@1_"15"2;82M+5#XE%$TL+_IY-8-][SHU"DX* &CQ491@G+"&OTJ,+-UO5MW
M4FR/ XEZW$3_9CR[%% D_794?A5-1.%G&?5B9YFPB-6+!J2SN9B:2XGYLCRU
M<5\<FJUJQNI\J /D:?3BTF<<FL,>8*X<YRMN9N@M[IE+SR%W+<_B1!$L71=N
MJJ/W(OFA&L]W0P\]W)(%9>%GI>A](9QVGQ^@]V?*%Z-8]>G):WLS;TFF/.4C
MF/U[T<.>%)5KQ\GSMF' ELK1]?>-$7"*]? ,X^C"RD]/H,%-6?-?/@:7#R)P
M'FOA(W((U%HJ;8*Y6[4J4>LDH]L;PK[$%Z%,RAXIE+$9I1_ND&IPX8P6XIDQ
ML4(8%W4B%Q=E+OO'3. N$"QZ3UCX76Z9ZK$/:V)]QA@6.L\)O3*2CI[,/K"J
M^Y[MH)? SW41Z!6LTT3UN*PW;4(+#1IG'S04CBRA(D2ZK'@HS6);FDF)OU(7
ME/6[6"Z+LAUZF_*4<B)$):<GGD,P9E1+NCQJKY?\_^U=66\;QY9^%Z#_T#!P
M 0N@G<7)W)ME#+2HML6$(C4D9<<8S$.+;%H]X7:Y2-'\^JFSUJE>*-.K'/$E
MD:7NKNU4U5F^\YUJS3IT9Z2K(<L]KB,QTOH[CQ5$"/Q1"CU"97PQ(=7DN *3
MK;SD/5KP>R?Q*8M+*L%4&Z63X"]]KE(EI.O8 #B1<8VKMKI;"O>@^6U-*7I:
M<*VEB97PYN#6795BA+B>0BF[#_/M'N;[US[,]V7"?/_:A_GV8;Y[G2SL-#%G
M!VXFBQ08@ \/SO6Z(-6KD^4$!*JZQ6;>CT"D$U0VIX%6U@Q_TL(Z#>^V:/A<
M [J(\%KQ7)2Y5JP)50A1J_A& E\:Z4(^3[X:92U5XJL8ENZX[;3H>YBO@*0H
MM2U^-+Q^ U%+Z6*1I1.:E-T _'?8K%E ]CE>@@*BL*5TJ#"KT.:6B*B!?UN4
MKW@YTQD_>528=U#6<.[?V0L5V8B)]5.@4P/]&8V BW=IJC5>9Y(29WT23B@F
M$KX&ET:-GF9<%.K=( UZ6/06<=$#UROMJA==9'OAXE;N,PME(@J_5G[SKJ0Z
MNX2T8FYAJ+3,:JX?ST9'A04>KI&>G[2P"G=E[7PVJG# I9$$Y!M:J_=ZGH]$
M:QW--Y=KZ10^902/*D^F:XUF:F$E^I*ILY2C_HIY# WA@W<O7>?SB47>8[%/
M=\RN@75_[1X3>BAPB5]2.8Y)GHV)+2=ZK1SRF=MQAJ: F>T-(--6WXUK2I'Z
MFM'AEIO<FD GE:T"5PT[ 3.FKIK<XM>E#':(WK86'48=A=[P$L;CO7%4=X8-
M7;*IW!HN,ZD<-3?<PDA9/*+@M \#D!N(C:)"OXO#"O]:-1ZL;,KK2-M0CC9B
M+](;XC%4]M"R%_);O O$;#MJB&LRG4G6B^2J<'V"Y7Q,[C-PGD+-+22HQ-@Q
M<S?F:ZXH>WP$[DAU'Y@CP"!$QB*F-TY,F4U9/(W5;N85U3!!VZ<Z?\*MRE!8
MKK;N8;]=Z'E_JKW[D5J#YK>;V!0&YM/H,WNTOGR:]JZZU F%U^3<L7'#.IB*
MAG]LRA<?;":*52[;N#*PV&I6M4MBW),HDL=V4.V=U>;R"2M?G@NF1J6IZ3_V
M5REGY7O%87$&[/N,*XR#K;$@C\?01_$8"A"#SXHZF'E=UN?Q\DE)O=#S(&"%
M=].F#/?/>,L#NN6V@%'V[=5M8L)$!_E2#>5EPU,3JWY?YTY0@@1=5FZT_Q%Q
M,@5#,/T^>L>.%U;&%S8\/ @'4W[8GO'ZS=(2P,ER38%5(,7U+:TT4A$V;YIU
M2^SZ,4NG&GA]&A5J:T&_;%A0+F+DYTIAF8ON(LS3,$W>)=J0/W#$L3'_FD_G
M@%E>CM"FN>65I'!HY9XK =R%AJ\H"R3E59* -H>*@8T:TX]8.2:0BR.S4G13
M%640'PCH >N&%>26IE1H8)'AP5BZ_&"VR4>^ZQBCG8=X>"!)U!Y0QH(@I*F
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MZV)R$#J5;3"?&L,T130EZ7B435?X=@%CE7'"$HT_HHU.-/!=A/9<1T4\2=;
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M?UK&N6YRP1E/<[0"C3,BM3U9&SM-"DH0- Z#?H3&F/>(E/DJ9W\"[T?$4ET
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M(ZR(,BIJ4,>$7@=VF]U#]CHJFP0'UJ$: \+7[;/CZB,9&?*OCC,"3>XFZ.5
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MPTO\S&$1]BJL$V7N4CRRA9>P'\+@^T0!?[F/ G[3*. O]U' ^RC@3U4Z-<B
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MN&%&Q.#4U!A>5R"*IC3V$S"V=)@E#E;_[38? '6C!P"]]M,\GM0N0..JI^T
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MW6#<?+B/-P'<]BSQHW3*]V_-$O^>I+A_L#%XR> @\,*E69*/D3ZDN$!U,PL
M2B0=?I;YXQGL*JX)Q@%HWUP:W9+1K_'F\>7;0[A*6@FM*(XF'@$N(3M!&.8
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MK071;IR'/E]1(GB&U@K37;D,28QD>:(F\4W$RP(2!;1E',QAJXCVI%^!:1V
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MSZK=P&B9"0J"@,9I\)EL% N=C$F'/'[QTS[^!;@0Y7- .1\1 T;VU=,7SP]
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M9G,^VO)Q0HJ+3(!-!7*_49S$("PT@Q+TQ;7G;2$C#5],9WA:&Q&/U$8L;MI
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M=Z3Z3E![M 5JD]_D2R;DDG&\A^PS3FR:2T!2>#Q*=7*M66)(0+:8.Z^,8\
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M!Z:7V\I " "7H'"U429@;M'&.0H.7%<":$P1G[A5<X%*8S6N[4=*?8B!(FG
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MMM7M"LEOI-VHFGF0SXM^9$LSK9S)3AS;OK:DJU-=B&U4!#%#,$DOL!X"RS%
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M2B#^Q5NT_2./3WJG'Q&S'I\-SSMO_S]02P,$%     @ T8.35:+;Z76S"@
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M!-SYLT(;+37,&)3=4<HYY93X6B&V^*+[(0BB=LV+N$8+#M %U7:474X$-F,
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M?-&YBA@)M6TNMF&4D3 W<Q$E. DB')?+(YKNB'>'6*.EI_D2G Z]'PSU,]G
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M.3(R,#AK+FAT;5!+ 0(4 Q0    ( -&#DU4!&VIWO7(  /FQ @ *
M      "  4\A  !E>#$P7S$N:'1M4$L! A0#%     @ T8.355K<J<PVF@
MVG8#  H              ( !-)0  &5X,3!?,BYH=&U02P$"% ,4    " #1
M@Y-5[@T-]#TR  !X" $ "@              @ &2+@$ 97@Q,%\S+FAT;5!+
M 0(4 Q0    ( -&#DU47?_%TD3(   $, 0 )              "  ?=@ 0!E
M>#1?,2YH=&U02P$"% ,4    " #1@Y-5HMOI=;,*  !](@  "@
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M;6Q02P$"% ,4    " #1@Y-5YDD(V5D(  !T8P  %0              @ '
MP@$ ;FEL92TR,#(R,3(Q.5]P<F4N>&UL4$L%!@     +  L DP(  $S+ 0
!  $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
